<!DOCTYPE html>

<html>
  <body>
    <script>
      const CSVToJSON = (csv) => {
        const lines = csv.split("\n");
        // Choix du type de séparateur du CSV
        const keys = lines[0].split(";");
        return lines.slice(1).map((line) => {
          return line.split(";").reduce((acc, cur, i) => {
            const toAdd = {};
            toAdd[keys[i]] = cur;
            return { ...acc, ...toAdd };
          }, {});
        });
      };
// Copie Colle le CSV a convertir en JSON (rend un object JSON par ligne du CSV)
      const convert = `ID;Pays;Institution;Institutions;Equipes;Titre;TypeCoop;Motcle1;Motcle2;Motcle3;Motcle4;Motcle5;Budget;Bailleurs;Debut;Fin;Nb Copublications;PI;Role;StatutGM;Références;Lien;Nbpartenaires;Resume
ZIKAlliance;France;AGENCE NATIONALE DE LA SECURITE SANITAIRE DE L ALIMENTATION DE L ENVIRONNEMENT ET DU TRAVAIL;Agence Nationale De La Securite Sanitaire De L Alimentation De L Environnement Et Du Travail;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Chine;UNIVERSIDADE FEDERAL DE MINAS GERAIS;Universidade Federal De Minas Gerais;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Brésil;UNIVERSIDADE FEDERAL DE GOIAS;Universidade Federal De Goias;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Colombie;Universidad Industrial de Santander;Universidad Industrial De Santander;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Equateur;SOSECALI C LTDA;Sosecali C Ltda;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Brésil;Laboratorio Nacional de Computacao Cientifica;Laboratorio Nacional De Computacao Cientifica;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Mexique;INSTITUTO NACIONAL DE SALUD PUBLICA;Instituto Nacional De Salud Publica;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Mexique;INSTITUTO MEXICANO DEL SEGURO SOCIAL;Instituto Mexicano Del Seguro Social;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Cuba;INSTITUTO DE MEDICINA TROPICAL PEDRO KOURI;Instituto De Medicina Tropical Pedro Kouri;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France (Polynésie);INSTITUT LOUIS MALARDE;Institut Louis Malarde;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Brésil;Oswaldo Cruz Foundation (Fiocruz);Oswaldo Cruz Foundation (Fiocruz);;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Brésil;FUNDACAO FACULDADE DE MEDICINA;Fundacao Faculdade De Medicina;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Brésil;FUNDACAO BAHIANA DE INFECTOLOGIA;Fundacao Bahiana De Infectologia;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Pays-Bas;ACADEMISCH ZIEKENHUIS GRONINGEN;Academisch Ziekenhuis Groningen;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Norvège;FOLKEHELSEINSTITUTTET;Folkehelseinstituttet;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Allemagne;Bernhard-Nocht-Institut für Tropenmedizin;Bernhard-Nocht-Institut Für Tropenmedizin;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Allemagne;Charité - Universitätsmedizin Berlin;Charité - Universitätsmedizin Berlin;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Belgique;JANSSEN PHARMACEUTICA NV;Janssen Pharmaceutica Nv;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Belgique;KATHOLIEKE UNIVERSITEIT LEUVEN;Katholieke Universiteit Leuven;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Pays-Bas;ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM;Erasmus Universitair Medisch Centrum Rotterdam;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Suisse;EIDGENOESSISCHES DEPARTEMENT DES INNERN;Eidgenoessisches Departement Des Innern;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;coordinateur;;;;;
ZIKAlliance;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT;Institut De Recherche Pour Le Developpement;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Suisse;FONDAZIONE PER L ISTITUTO DI RICERCA IN BIOMEDICINA;Fondazione Per L Istituto Di Ricerca In Biomedicina;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;Institut national de la santé et de la recherche médicale;Institut National De La Santé Et De La Recherche Médicale;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Italie;FONDAZIONE EDMUND MACH;Fondazione Edmund Mach;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Royaume-Uni;LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER;London School Of Hygiene And Tropical Medicine Royal Charter;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Arbovirus et Insectes Vecteurs;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Sénégal;INSTITUT PASTEUR DE DAKAR;Institut Pasteur De Dakar;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Chine;Institut Pasteur of Shanghai, Chinese Academy of Sciences;Institut Pasteur Of Shanghai, Chinese Academy Of Sciences;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Belgique;UNIVERSITE DE LIEGE;Universite De Liege;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Espagne;INSTITUT DE RECERCA I TECNOLOGIA AGROALIMENTARIES;Institut De Recerca I Tecnologia Agroalimentaries;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Pays-Bas;STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS;Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV ;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev ;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Allemagne;OTTO-VON-GUERICKE-UNIVERSITAET MAGDEBURG;Otto-Von-Guericke-Universitaet Magdeburg;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Allemagne;STIFTUNG TIERAERZTLICHE HOCHSCHULE HANNOVER;Stiftung Tieraerztliche Hochschule Hannover;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Suisse;University of Zurich;University Of Zurich;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Pérou;UNIVERSIDAD PERUANA CAYETANO HEREDIA;Universidad Peruana Cayetano Heredia;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;Institut Pasteur de Nouvelle Calédonie;Institut Pasteur De Nouvelle Calédonie;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Royaume-Uni;UNIVERSITY OF GLASGOW;University Of Glasgow;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Espagne;UNIVERSITAT DE BARCELONA;Universitat De Barcelona;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Italie;UNIVERSITA DEGLI STUDI DI SIENA;Universita Degli Studi Di Siena;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Allemagne;UNIVERSITATSKLINIKUM BONN;Universitatsklinikum Bonn;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;UNIVERSITE LYON 1 CLAUDE BERNARD;Universite Lyon 1 Claude Bernard;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Allemagne;UNIVERSITATSKLINIKUM HEIDELBERG;Universitatsklinikum Heidelberg;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Pays-Bas;WAGENINGEN UNIVERSITY;Wageningen University;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;Portugal;UNIVERSIDADE NOVA DE LISBOA;Universidade Nova De Lisboa;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
ZIKAlliance;France;UNIVERSITE RENNES II;Universite Rennes Ii;;A global alliance for Zika virus control and prevention;Projet scientifique;Zika;One Health;Infectious diseases;;;11 964 209,00 €;Commission Européenne;01/10/2016;30/09/2021;;;;;;;;
SoNAR-Global;Malte;UNIVERSITA TA MALTA;Universita Ta Malta;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 €;Commission Européenne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Autriche;MEDIZINISCHE UNIVERSITAET WIEN;Medizinische Universitaet Wien;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 €;Commission Européenne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Thaïlande;MAHIDOL UNIVERSITY;Mahidol University;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 €;Commission Européenne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Bangladesh;BRAC UNIVERSITY;Brac University;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 €;Commission Européenne;01/01/2019;31/12/2021;;;coordinateur;;;;;
SoNAR-Global;Sénégal;CENTRE REGIONAL DE RECHERCHE ET DE FORMATION A LA PRISE EN CHARGE CLINIQUE DU VIH SIDA ET MALADIES ASSOCIEES DE DAKAR CRCF;Centre Regional De Recherche Et De Formation A La Prise En Charge Clinique Du Vih Sida Et Maladies Associees De Dakar Crcf;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 €;Commission Européenne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Ouganda;MAKERERE UNIVERSITY;Makerere University;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 €;Commission Européenne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Royaume-Uni;INSTITUTE OF DEVELOPMENT STUDIES;Institute Of Development Studies;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 €;Commission Européenne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Italie;FONDAZIONE CENTRO STUDI INVESTIMENTI SOCIALI - CENSIS;Fondazione Centro Studi Investimenti Sociali - Censis;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 €;Commission Européenne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 €;Commission Européenne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Pays-Bas;STICHTING AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT;Stichting Amsterdam Institute For Global Health And Development;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 €;Commission Européenne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Allemagne;LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN;Ludwig-Maximilians-Universitaet Muenchen;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 €;Commission Européenne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Pays-Bas;STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG;Stichting Nederlands Instituut Voor Onderzoek Van De Gezondheidszorg;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 €;Commission Européenne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Slovénie;UNIVERZA V LJUBLJANI;Univerza V Ljubljani;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 €;Commission Européenne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Royaume-Uni;UNIVERSITY COLLEGE LONDON;University College London;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 €;Commission Européenne;01/01/2019;31/12/2021;;;;;;;;
SoNAR-Global;Ukraine;STATE INSTITUTION PUBLIC HEALTH CENTER OF THE MINISTRY OF HEALTH OF UKRAINE;State Institution Public Health Center Of The Ministry Of Health Of Ukraine;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance;Projet scientifique;antibiotic resistance;infectious diseases;open-access platform;;;4 306 347,50 €;Commission Européenne;01/01/2019;31/12/2021;;;;;;;;
LeiSHield-MATI;France;ACOBIOM;Acobiom;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 €;Commission Européenne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;Maroc;Institut Pasteur Du Maroc;Institut Pasteur Du Maroc;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 €;Commission Européenne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;Iran;INSTITUT PASTEUR D'IRAN;Institut Pasteur D'Iran;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 €;Commission Européenne;01/04/2018;31/03/2022;;;coordinateur;;;;;
LeiSHield-MATI;Algérie;Institut Pasteur d'Algérie;Institut Pasteur D'Algérie;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 €;Commission Européenne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 €;Commission Européenne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;Belgique;PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE;Prins Leopold Instituut Voor Tropische Geneeskunde;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 €;Commission Européenne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;France;INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT;Institut De Recherche Pour Le Developpement;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 €;Commission Européenne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;Tunisie;INSTITUT PASTEUR DE TUNIS;Institut Pasteur De Tunis;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 €;Commission Européenne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;Suède;GOETEBORGS UNIVERSITET;Goeteborgs Universitet;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 €;Commission Européenne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 €;Commission Européenne;01/04/2018;31/03/2022;;;;;;;;
LeiSHield-MATI;République Tchèque;UNIVERZITA KARLOVA;Univerzita Karlova;;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis;Projet scientifique;Leishmania ;parasitology;public and environmental health;;;1 750 500,00 €;Commission Européenne;01/04/2018;31/03/2022;;;;;;;;
AFRIPOX;République Centrafricaine;Institut Pasteur de Bangui;Institut Pasteur De Bangui;Arbovirus, emerging viruses and zoonos;A One Health study of monkeypox: human infection, animal reservoir, disease ecology and diagnostic tools;Projet scientifique;monkeypox;one health;zoonoses ;;;569 365,66 €;ANR;01/10/2019;30/09/2021;;;;;Grant Manager 602;;;
AFRIPOX;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Unité de Recherche et d'Expertise Epidémiologie des Maladies Emergentes;A One Health study of monkeypox: human infection, animal reservoir, disease ecology and diagnostic tools;Projet scientifique;monkeypox;one health;zoonoses ;;;569 365,66 €;ANR;01/10/2019;30/09/2021;;Arnaud FONTANET;coordinateur;;Grant Manager 602;;;
AFRIPOX;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Epidémio.& Physiopatho.Virus Oncogènes ;A One Health study of monkeypox: human infection, animal reservoir, disease ecology and diagnostic tools;Projet scientifique;monkeypox;one health;zoonoses ;;;569 365,66 €;ANR;01/10/2019;30/09/2021;;Antoine GESSAIN;;;Grant Manager 602;;;
AFRIPOX;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Unité de recherche et d'expertise Environnement et risques infectieux;A One Health study of monkeypox: human infection, animal reservoir, disease ecology and diagnostic tools;Projet scientifique;monkeypox;one health;zoonoses ;;;569 365,66 €;ANR;01/10/2019;30/09/2021;;Jean-Claude MANUGUERRA;;;Grant Manager 602;;;
LoveFood2Market;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;A portable MicroNanoBioSystem and Instrument for ultra-fast analysis of pathogens in food: Innovation from LOVE-FOOD lab prototype to a pre-commercial instrument;Projet scientifique;foodborne pathogen;data analysis;food safety;;;3 151 732,50 €;Commission Européenne;01/02/2016;30/04/2019;;;;;;;;
LoveFood2Market;Allemagne;JOBST TECHNOLOGIES GMBH;Jobst Technologies Gmbh;;A portable MicroNanoBioSystem and Instrument for ultra-fast analysis of pathogens in food: Innovation from LOVE-FOOD lab prototype to a pre-commercial instrument;Projet scientifique;foodborne pathogen;data analysis;food safety;;;3 151 732,50 €;Commission Européenne;01/02/2016;30/04/2019;;;;;;;;
LoveFood2Market;Grèce;IDRYMA TECHNOLOGIAS KAI EREVNAS;Idryma Technologias Kai Erevnas;;A portable MicroNanoBioSystem and Instrument for ultra-fast analysis of pathogens in food: Innovation from LOVE-FOOD lab prototype to a pre-commercial instrument;Projet scientifique;foodborne pathogen;data analysis;food safety;;;3 151 732,50 €;Commission Européenne;01/02/2016;30/04/2019;;;;;;;;
LoveFood2Market;France;SENSEOR SAS;Senseor Sas;;A portable MicroNanoBioSystem and Instrument for ultra-fast analysis of pathogens in food: Innovation from LOVE-FOOD lab prototype to a pre-commercial instrument;Projet scientifique;foodborne pathogen;data analysis;food safety;;;3 151 732,50 €;Commission Européenne;01/02/2016;30/04/2019;;;coordinateur;;;;;
LoveFood2Market;République Tchèque;UNIVERZITA PARDUBICE;Univerzita Pardubice;;A portable MicroNanoBioSystem and Instrument for ultra-fast analysis of pathogens in food: Innovation from LOVE-FOOD lab prototype to a pre-commercial instrument;Projet scientifique;foodborne pathogen;data analysis;food safety;;;3 151 732,50 €;Commission Européenne;01/02/2016;30/04/2019;;;;;;;;
LoveFood2Market;Grèce;MAKEDONIKI VIOMIHANIA GALAKTOS ANONIMOS ETERIA (MEVGAL SA);Makedoniki Viomihania Galaktos Anonimos Eteria (Mevgal Sa);;A portable MicroNanoBioSystem and Instrument for ultra-fast analysis of pathogens in food: Innovation from LOVE-FOOD lab prototype to a pre-commercial instrument;Projet scientifique;foodborne pathogen;data analysis;food safety;;;3 151 732,50 €;Commission Européenne;01/02/2016;30/04/2019;;;;;;;;
LoveFood2Market;Grèce;NATIONAL CENTER FOR SCIENTIFIC RESEARCH 'DEMOKRITOS';National Center For Scientific Research 'Demokritos';;A portable MicroNanoBioSystem and Instrument for ultra-fast analysis of pathogens in food: Innovation from LOVE-FOOD lab prototype to a pre-commercial instrument;Projet scientifique;foodborne pathogen;data analysis;food safety;;;3 151 732,50 €;Commission Européenne;01/02/2016;30/04/2019;;;;;;;;
AEGIS;Suède;ASTRAZENECA AB;Astrazeneca Ab;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;coordinateur;;;;;
AEGIS;Ukraine;ENAMINE LIMITED LIABILITY COMPANY,RESEARCH AND PRODUCTION ENTERPRISE;Enamine Limited Liability Company,Research And Production Enterprise;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Pologne;Jagiellonian University in Krakow;Jagiellonian University In Krakow;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Allemagne;Boeters & Lieck;Boeters & Lieck;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;3;
AEGIS;Pologne;Jagiellonian University in Krakow;Jagiellonian University In Krakow;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;3;
AEGIS;Suisse;EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH;Eidgenoessische Technische Hochschule Zuerich;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;3;
AEGIS;Espagne;ASTEX;Astex;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;France;EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION;Eurordis - European Organisation For Rare Diseases Association;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Bio-Informatique Structurale;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Italie;GIOTTO BIOTECH SRL;Giotto Biotech Srl;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Plate-Forme de criblage chémogénomique et biologique (PF-CCB);Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Pays-Bas;RIJKSUNIVERSITEIT GRONINGEN;Rijksuniversiteit Groningen;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Allemagne;HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH;Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Suisse;NOVARTIS PHARMA AG;Novartis Pharma Ag;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Suède;RIDGEVIEW INSTRUMENTS AB;Ridgeview Instruments Ab;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Allemagne;PHILIPPS UNIVERSITAET MARBURG;Philipps Universitaet Marburg;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Italie;UNIVERSITA DEGLI STUDI DI FIRENZE;Universita Degli Studi Di Firenze;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Allemagne;RUHR-UNIVERSITAET BOCHUM;Ruhr-Universitaet Bochum;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Allemagne;TECHNISCHE UNIVERSITAET MUENCHEN;Technische Universitaet Muenchen;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Pays-Bas;TECHNISCHE UNIVERSITEIT EINDHOVEN;Technische Universiteit Eindhoven;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Pays-Bas;TelesisPharma;Telesispharma;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Suède;UPPSALA UNIVERSITET;Uppsala Universitet;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AEGIS;Allemagne;UNTERNEHMERTUM GMBH;Unternehmertum Gmbh;;Accelerated Early staGe drug diScovery;Projet scientifique;training platform;drug discovery;biology;;;3 836 995,92 €;Commission Européenne;01/01/2016;31/12/2019;;;;;;;;
AMR-1;Australie;Peter Doherty Institute for Infection and Immunity;Peter Doherty Institute For Infection And Immunity;;Accord collaboratif de recherche sur AMR ;Juridique;Recherche AMR;Financement;;;;;;01/01/2019;01/01/2021;;;;;;;;
AMR-1;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;Accord collaboratif de recherche sur AMR ;Juridique;Recherche AMR;Financement;;;;;;01/01/2019;01/01/2021;;;;;;;;
AMR-1;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Accord collaboratif de recherche sur AMR ;Juridique;Recherche AMR;Financement;;;;;;01/01/2019;01/01/2021;;;;;;;;
IPBBR-2;Brésil;Universidade de São Paulo (USP);Universidade De São Paulo (Usp);;Accord de coopération;Juridique;coopération;accord;Institut Pasteur au Brésil;;;;;31/12/2020;31/12/2025;;;;;;;;
IPBBR-2;Brésil;Fundação Oswaldo Cruz (Fiocruz);Fundação Oswaldo Cruz (Fiocruz);;Accord de coopération;Juridique;coopération;accord;Institut Pasteur au Brésil;;;;;31/12/2020;31/12/2025;;;;;;;;
IPBBR-2;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Accord de coopération;Juridique;coopération;accord;Institut Pasteur au Brésil;;;;;31/12/2020;31/12/2025;;;;;;;;
IVO-1;Australie;Walter & Eliza Hall Institute of Medical Research ;Walter & Eliza Hall Institute Of Medical Research ;;Accord de coopération générale portant sur l'affectation du Pr Ivo Mueller à l'IP pour une période définie, ainsi que sur des projets ou activités de recherche conjoints prolongé 2 fois via des avenants;Juridique;Affectation du Pr Ivo Muller;;;;;;;01/01/2016;01/01/2021;;;;;;;;
IVO-1;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Accord de coopération générale portant sur l'affectation du Pr Ivo Mueller à l'IP pour une période définie, ainsi que sur des projets ou activités de recherche conjoints prolongé 2 fois via des avenants;Juridique;Affectation du Pr Ivo Muller;;;;;;;01/01/2016;01/01/2021;;;;;;;;
?;Australie;Monash University;Monash University;;Accord de coopération sur des activités de recherche conjointes, des programmes doctoraux et les conseil scientifiques dans le RIIP;Juridique;;;;;;;;01/01/2015;01/01/2020;;;;;;;;
?;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Accord de coopération sur des activités de recherche conjointes, des programmes doctoraux et les conseil scientifiques dans le RIIP;Juridique;;;;;;;;01/01/2015;01/01/2020;;;;;;;;
GVN-1;Australie;Peter Doherty Institute for Infection and Immunity;Peter Doherty Institute For Infection And Immunity;;Accord de coopération sur des activités de recherche conjointes, des programmes doctoraux, les conseil scientifiques dans le Réseau et l'édition 2017 du symposium Global Virus Network (GVN);;;;;;;;;01/01/2016;01/01/2021;;;;;;;;
GVN-1;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Accord de coopération sur des activités de recherche conjointes, des programmes doctoraux, les conseil scientifiques dans le Réseau et l'édition 2017 du symposium Global Virus Network (GVN);;;;;;;;;01/01/2016;01/01/2021;;;;;;;;
?;Australie;Monash University;Monash University;;Accord de coopération sur un programme doctoral;Juridique;;;;;;;;01/01/2018;01/01/2023;;;;;;;;
?;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Accord de coopération sur un programme doctoral;Juridique;;;;;;;;01/01/2018;01/01/2023;;;;;;;;
WorldMosquitoProgram;Australie;Monash University;Monash University;;Accord de coopération sur World Mosquito Program;Juridique;dengue;arboviral diseases;;;;;;01/01/2018;;;;;;;;;
WorldMosquitoProgram;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Accord de coopération sur World Mosquito Program;Juridique;dengue;arboviral diseases;;;;;;02/01/2018;;;;;;;;;
WorldMosquitoProgram;France;Institut Pasteur de Nouvelle Calédonie;Institut Pasteur De Nouvelle Calédonie;;Accord de coopération sur World Mosquito Program;Juridique;dengue;arboviral diseases;;;;;;03/01/2018;;;;;;;;;
WorldMosquitoProgram;France;Ville de Nouméa;Ville De Nouméa;;Accord de coopération sur World Mosquito Program;Juridique;dengue;arboviral diseases;;;;;;04/01/2018;;;;;;;;;
BIRDY2-MTA;Australie;Burnet Institute;Burnet Institute;;Accord de transfert de matériel (MTA) dans le cadre du projet BIRDY2;Juridique;sepsis;néonatal;biomarqueur;neutrophile;diagnostic;;;;;;;;;;;;
BIRDY2-MTA;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Accord de transfert de matériel (MTA) dans le cadre du projet BIRDY2;Juridique;sepsis;néonatal;biomarqueur;neutrophile;diagnostic;;;;;;;;;;;;
BIRDY2-MTA;Madagascar;Institut Pasteur de Madagascar;Institut Pasteur De Madagascar;;Accord de transfert de matériel (MTA) dans le cadre du projet BIRDY2;Juridique;sepsis;néonatal;biomarqueur;neutrophile;diagnostic;;;;;;;;;;;;
LEPTOXINFECTION;Uruguay;Institut Pasteur de Montevideo;Institut Pasteur De Montevideo;;Adaptation of pathogenic Leptospira to oxidative stress: its contribution to virulence and host colonization;Projet scientifique;leptospirosis;transcriptomics;proteomics;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;coordinateur;;;;;
LEPTOXINFECTION;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie des Spirochètes;Adaptation of pathogenic Leptospira to oxidative stress: its contribution to virulence and host colonization;Projet scientifique;leptospirosis;transcriptomics;proteomics;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
LEPTOXINFECTION;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie et Génétique de la paroi bactérienne;Adaptation of pathogenic Leptospira to oxidative stress: its contribution to virulence and host colonization;Projet scientifique;leptospirosis;transcriptomics;proteomics;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
TBVAC2020;Afrique du Sud;UNIVERSITY OF CAPE TOWN;University Of Cape Town;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Afrique du Sud;STELLENBOSCH UNIVERSITY;Stellenbosch University;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Afrique du Sud;KWAZULU NATAL RESEARCH INSTITUTE FOR TB-HIV (K-RITH) NPC;Kwazulu Natal Research Institute For Tb-Hiv (K-Rith) Npc;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Allemagne;Friedrich-Loeffler-Institut;Friedrich-Loeffler-Institut;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Allemagne;UNIVERSITAET ULM;Universitaet Ulm;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Australie;THE UNIVERSITY OF SYDNEY;The University Of Sydney;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Belgique;GLAXOSMITHKLINE BIOLOGICALS SA;Glaxosmithkline Biologicals Sa;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Belgique;SCIENSANO;Sciensano;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Belgique;UNIVERSITE LIBRE DE BRUXELLES;Universite Libre De Bruxelles;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Belgique;UNIVERSITEIT GENT;Universiteit Gent;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Corée du Sud;YONSEI UNIVERSITY;Yonsei University;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Corée du Sud;INTERNATIONAL TUBERCULOSIS RESEARCH CENTER;International Tuberculosis Research Center;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Danemark;STATENS SERUM INSTITUT;Statens Serum Institut;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Espagne;INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL;Institut De Investigacio En Ciencies De La Salut Germans Trias I Pujol;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Espagne;UNIVERSIDAD DE ZARAGOZA;Universidad De Zaragoza;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Etats-Unis;AERAS GLOBAL TB VACCINE FOUNDATION;Aeras Global Tb Vaccine Foundation;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Pathogenomique mycobacterienne integree;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;France;Institut Pasteur de Lille;Institut Pasteur De Lille;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;France;TRANSGENE SA;Transgene Sa;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Irlande;UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN;University College Dublin, National University Of Ireland, Dublin;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Italie;AZIENDA OSPEDALIERA UNIVERSITARIA POLICLINICO PAOLO GIACCONE DI PALERMO;Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Di Palermo;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Italie;ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO;Istituto Nazionale Per Le Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura A Carattere Scientifico;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Italie;ISTITUTO SUPERIORE DI SANITA;Istituto Superiore Di Sanita;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;coordinateur;;;;;
TBVAC2020;Pays-Bas;STICHTING BIOMEDICAL PRIMATE RESEARCH CENTER;Stichting Biomedical Primate Research Center;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Pays-Bas;STICHTING TUBERCULOSIS VACCINE INITIATIVE;Stichting Tuberculosis Vaccine Initiative;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Royaume-Uni;BANGOR UNIVERSITY;Bangor University;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Royaume-Uni;Department of Health;Department Of Health;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;http://cordis.europa.eu/project/id/730879;;
TBVAC2020;Royaume-Uni;IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE;Imperial College Of Science Technology And Medicine;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Royaume-Uni;LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER;London School Of Hygiene And Tropical Medicine Royal Charter;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Royaume-Uni;THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS;The Secretary Of State For Environment, Food And Rural Affairs;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Royaume-Uni;UNITED KINGDOM RESEARCH AND INNOVATION;United Kingdom Research And Innovation;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Royaume-Uni;UNIVERSITY OF STRATHCLYDE;University Of Strathclyde;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Suisse;CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS;Centre Hospitalier Universitaire Vaudois;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Suisse;EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH;Eidgenoessische Technische Hochschule Zuerich;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Suisse;Universität Basel;Universität Basel;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Suisse;UNIVERSITE DE GENEVE;Universite De Geneve;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Suisse;UNIVERSITE DE LAUSANNE;Universite De Lausanne;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
TBVAC2020;Suisse;University of Zurich;University Of Zurich;;Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development;Projet scientifique;vaccine;tuberculosis;;;;18 200 000,00 €;Commission Européenne;01/01/2015;30/06/2019;;;;;;;;
Afribiota;République Centrafricaine;Institut Pasteur de Bangui;Institut Pasteur De Bangui;;Afribiota;Santé publique;Malnutrition;;;;;2 084 126,00 €;Fondation Total / Nutricia Research Fondation / Fondation Pasteur Suisse;07/07/1905;;;;;;;;;
Afribiota;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Unité de Pathogénie Microbienne Moléculaire;Afribiota;Santé publique;Malnutrition;;;;;2 084 126,00 €;Fondation Total / Nutricia Research Fondation / Fondation Pasteur Suisse;07/07/1905;;;;;;;;;
Afribiota;Madagascar;Institut Pasteur de Madagascar;Institut Pasteur De Madagascar;;Afribiota;Santé publique;Malnutrition;;;;;2 084 126,00 €;Fondation Total / Nutricia Research Fondation / Fondation Pasteur Suisse;07/07/1905;;;;;;;;;
ALPACA;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 €;Commission Européenne;01/01/2021;31/12/2024;;;coordinateur;;;;;
ALPACA;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 €;Commission Européenne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Slovaquie;GENETON S.R.O.;Geneton S.R.O.;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 €;Commission Européenne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 €;Commission Européenne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;France;INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE;Institut National De Recherche En Informatique Et Automatique;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 €;Commission Européenne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Royaume-Uni;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;The Chancellor Masters And Scholars Of The University Of Cambridge;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 €;Commission Européenne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Algorithmes pour les séquences biologiques - Bioinformatics;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 €;Commission Européenne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Allemagne;HEINRICH-HEINE-UNIVERSITAET DUESSELDORF;Heinrich-Heine-Universitaet Duesseldorf;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 €;Commission Européenne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Pays-Bas;STICHTING NEDERLANDSE WETENSCHAPPELIJK ONDERZOEK INSTITUTEN;Stichting Nederlandse Wetenschappelijk Onderzoek Instituten;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 €;Commission Européenne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Italie;UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA;Universita' Degli Studi Di Milano-Bicocca;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 €;Commission Européenne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Allemagne;UNIVERSITAET BIELEFELD;Universitaet Bielefeld;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 €;Commission Européenne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Slovaquie;UNIVERZITA KOMENSKEHO V BRATISLAVE;Univerzita Komenskeho V Bratislave;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 €;Commission Européenne;01/01/2021;31/12/2024;;;;;;;;
ALPACA;Italie;UNIVERSITA DI PISA;Universita Di Pisa;;ALgorithms for PAngenome Computational Analysis;Projet scientifique;genome;data;Algorithmics;;;3 725 035,20 €;Commission Européenne;01/01/2021;31/12/2024;;;;;;;;
AnEiCA;Cameroun;Pasteur Center in Cameroon;Pasteur Center In Cameroon;;Animal Enteroviruses in Central Africa, from field to assay tubes: search for zoonotic enterovirus transmission and study of genetic exchanges between animal and human enteroviruses;Projet scientifique;enterovirus;zoonoses;;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
AnEiCA;République Centrafricaine;Institut Pasteur de Bangui;Institut Pasteur De Bangui;;Animal Enteroviruses in Central Africa, from field to assay tubes: search for zoonotic enterovirus transmission and study of genetic exchanges between animal and human enteroviruses;Projet scientifique;enterovirus;zoonoses;;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
AnEiCA;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Epigénomique, Prolifération et Identité Cellulaire;Animal Enteroviruses in Central Africa, from field to assay tubes: search for zoonotic enterovirus transmission and study of genetic exchanges between animal and human enteroviruses;Projet scientifique;enterovirus;zoonoses;;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;;
RESIST-3;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;Antibody persistence after abridged intradermal rabies PEP: The RESIST-3 study ;Projet scientifique;rabies;antibody response;;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
RESIST-3;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Lyssavirus ;Antibody persistence after abridged intradermal rabies PEP: The RESIST-3 study ;Projet scientifique;rabies;antibody response;;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
RESIST-3;Madagascar;Institut Pasteur de Madagascar;Institut Pasteur De Madagascar;;Antibody persistence after abridged intradermal rabies PEP: The RESIST-3 study ;Projet scientifique;rabies;antibody response;;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;;;;https://cordis.europa.eu/project/id/676559;;
AReST;France;Hôpital Saint-Louis;Hôpital Saint-Louis;;Antifungal Resistance: From Surveillance to Treatment;Projet scientifique;Infectious diseases;antifungal drug resistance;;;;499 222 € ;Agence Nationale de la Recherche;01/01/2020;31/12/2022;;;;Avenant signé;Grant Manager 566;;;
AReST;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie et Pathogenicite Fongiques;Antifungal Resistance: From Surveillance to Treatment;Projet scientifique;Infectious diseases;antifungal drug resistance;;;;499 222 € ;Agence Nationale de la Recherche;01/01/2020;31/12/2022;;;;Avenant signé;Grant Manager 566;;;
AReST;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Mycologie Moléculaire;Antifungal Resistance: From Surveillance to Treatment;Projet scientifique;Infectious diseases;antifungal drug resistance;;;;499 222 € ;Agence Nationale de la Recherche;01/01/2020;31/12/2022;;;;Avenant signé;Grant Manager 566;;;
AReST;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Neuropathologie expérimentale;Antifungal Resistance: From Surveillance to Treatment;Projet scientifique;Infectious diseases;antifungal drug resistance;;;;499 222 € ;Agence Nationale de la Recherche;01/01/2020;31/12/2022;;;;Avenant signé;Grant Manager 566;;;
AReST;Allemagne;Helmholtz Zentrum für Infektionsforschung GmbH;Helmholtz Zentrum Für Infektionsforschung Gmbh;;Antifungal Resistance: From Surveillance to Treatment;Projet scientifique;Infectious diseases;antifungal drug resistance;;;;499 222 € ;Agence Nationale de la Recherche;01/01/2020;31/12/2022;;;;Avenant signé;Grant Manager 566;;;
AReST;Allemagne;Helmholtz-Institut für Pharmazeutische Forschung Saarland;Helmholtz-Institut für Pharmazeutische Forschung Saarland;;Antifungal Resistance: From Surveillance to Treatment;Projet scientifique;Infectious diseases;antifungal drug resistance;;;;499 222 € ;Agence Nationale de la Recherche;01/01/2020;31/12/2022;;;;Avenant signé;Grant Manager 566;;;
AReST;Allemagne;LEIBNIZ-INSTITUT FUER NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE EV HANS-KNOELL-INSTITUT;Leibniz-Institut Fuer Naturstoff-Forschung Und Infektionsbiologie Ev Hans-Knoell-Institut;;Antifungal Resistance: From Surveillance to Treatment;Projet scientifique;Infectious diseases;antifungal drug resistance;;;;499 222 € ;Agence Nationale de la Recherche;01/01/2020;31/12/2022;;;;Avenant signé;Grant Manager 566;;;
AReST;Allemagne;Universität zu Köln;Universität Zu Köln;;Antifungal Resistance: From Surveillance to Treatment;Projet scientifique;Infectious diseases;antifungal drug resistance;;;;499 222 € ;Agence Nationale de la Recherche;01/01/2020;31/12/2022;;;;Avenant signé;Grant Manager 566;;;
VITAL;République Centrafricaine;Institut Pasteur de Bangui;Institut Pasteur De Bangui;;Ascorbate-deficiency: a novel diarrhea risk-factor?;Projet scientifique;Diarrheal diseases;case-control study;epidemics;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
VITAL;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Epidémiologie des Maladies Emergentes;Ascorbate-deficiency: a novel diarrhea risk-factor?;Projet scientifique;Diarrheal diseases;case-control study;epidemics;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;coordinateur;;;;;
VITAL;France;Institut Pasteur de Guyane;Institut Pasteur De Guyane;;Ascorbate-deficiency: a novel diarrhea risk-factor?;Projet scientifique;Diarrheal diseases;case-control study;epidemics;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
ASEAN-1;Laos;National Center for Laboratory and Epidemiology (NCLE);National Center For Laboratory And Epidemiology (Ncle);;ASEAN-Australia Health Security Fellowships aimed at improving regional capacity to deliver field epidemiology training;Formation;Epidémiologie;;;;;;;01/01/2018;03/01/2022;;;;;;;;
ASEAN-1;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;ASEAN-Australia Health Security Fellowships aimed at improving regional capacity to deliver field epidemiology training;Formation;Epidémiologie;;;;;;;01/01/2018;02/01/2022;;;;;;;;
ASEAN-1;Myanmar;Central Epidemiology Unit (CEU);Central Epidemiology Unit (Ceu);;ASEAN-Australia Health Security Fellowships aimed at improving regional capacity to deliver field epidemiology training;Formation;Epidémiologie;;;;;;;01/01/2018;04/01/2022;;;;;;;;
ASEAN-1;Australie;Australian National University (ANU);Australian National University (Anu);;ASEAN-Australia Health Security Fellowships aimed at improving regional capacity to deliver field epidemiology training;Formation;Epidémiologie;;;;;;;01/01/2018;01/01/2022;;;;;;;;
ADONIS;France;AGENCE NATIONALE DE LA SECURITE SANITAIRE DE L ALIMENTATION DE L ENVIRONNEMENT ET DU TRAVAIL;Agence Nationale De La Securite Sanitaire De L Alimentation De L Environnement Et Du Travail;;Assessing Determinants of the Non-Decreasing Incidence of Salmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 559;;;
ADONIS;Autriche;Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH;Österreichische Agentur Für Gesundheit Und Ernährungssicherheit Gmbh;;Assessing Determinants of the Non-Decreasing Incidence of Salmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 559;;;
ADONIS;Danemark;Statens Serum Institut;Statens Serum Institut;;Assessing Determinants of the Non-Decreasing Incidence of Salmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 559;;;
ADONIS;Belgique;Sciensano;Sciensano;;Assessing Determinants of the Non-Decreasing Incidence of Salmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 559;;;
ADONIS;Royaume-Uni;Public Health England;Public Health England;;Assessing Determinants of the Non-Decreasing Incidence of Salmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 559;;;
ADONIS;Pays-Bas;National Institute for Public Health and the Environment;National Institute For Public Health And The Environment;;Assessing Determinants of the Non-Decreasing Incidence of Salmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 559;;;
ADONIS;France;Institut Pasteur (Paris);Institut Pasteur (Paris);CNR Escherichia coli, Shigella et Salmonella;Assessing Determinants of the Non-Decreasing Incidence of Salmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 559;;;
ADONIS;Royaume-Uni;The Secretary of State for Environment, Food and Rural Affairs;The Secretary Of State For Environment, Food And Rural Affairs;;Assessing Determinants of the Non-Decreasing Incidence of Salmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 559;;;
ADONIS;Italie;Istituto Superiore di Sanità;Istituto Superiore Di Sanità;;Assessing Determinants of the Non-Decreasing Incidence of Salmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;coordinateur;;Grant Manager 559;;;
ADONIS;Italie;ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA LOMBARDIA E DELL'EMILIA ROMAGNA BRUNO UBERTINI;Istituto Zooprofilattico Sperimentale Della Lombardia E Dell'Emilia Romagna Bruno Ubertini;;Assessing Determinants of the Non-Decreasing Incidence of Salmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 559;;;
ADONIS;Espagne;UNIVERSIDAD COMPLUTENSE DE MADRID;Universidad Complutense De Madrid;;Assessing Determinants of the Non-Decreasing Incidence of Salmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 559;;;
ADONIS;Portugal;Instituto Nacional de Saúde Dr. Ricardo Jorge;Instituto Nacional De Saúde Dr. Ricardo Jorge;;Assessing Determinants of the Non-Decreasing Incidence of Salmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 559;;;
ADONIS;Pologne;Pa?stwowy Instytut Weterynaryjny-Pa?stwowy Instytut Badawczy;Pa?stwowy Instytut Weterynaryjny-Pa?stwowy Instytut Badawczy;;Assessing Determinants of the Non-Decreasing Incidence of Salmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 559;;;
ADONIS;Portugal;National Institute for Agrarian and Veterinarian Research I. P;National Institute For Agrarian And Veterinarian Research I. P;;Assessing Determinants of the Non-Decreasing Incidence of Salmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 559;;;
ADONIS;Pays-Bas;Wageningen Bioveterinary Research;Wageningen Bioveterinary Research;;Assessing Determinants of the Non-Decreasing Incidence of Salmonella;Projet scientifique;zoonoses;Salmonella;;;;3 000 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 559;;;
nonapplica;Royaume-Uni;Liverpool School of Tropical Medicine;Liverpool School Of Tropical Medicine;;Assessing the entomological risk of emergence of massive Dengue, Zika and Chikungunya outbreaks;Post-doc;entomology;dengue;zika;chikungunya;;314 569,21 €;Wellcome Trust;01/02/2018;28/02/2019;;;;;Grant Manager 20;;;
nonapplica;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Arbovirus et Insectes Vecteurs;Assessing the entomological risk of emergence of massive Dengue, Zika and Chikungunya outbreaks;Post-doc;entomology;dengue;zika;chikungunya;;314 569,21 €;Wellcome Trust;01/02/2018;28/02/2019;;;coordinateur;;Grant Manager 20;;;
AIMS-2-TRIALS;Belgique;AUTISME-EUROPE AISBL;Autisme-Europe Aisbl;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Royaume-Uni;AUTISTICA;Autistica;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Belgique;BIOSCI CONSULTING BVBA;Biosci Consulting Bvba;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;France;ARTTIC;Arttic;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;France;ASSISTANCE PUBLIQUE HOPITAUX DE PARIS;Assistance Publique Hopitaux De Paris;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;http://cordis.europa.eu/project/id/676559;;
AIMS-2-TRIALS;Royaume-Uni;BIRKBECK COLLEGE - UNIVERSITY OF LONDON;Birkbeck College - University Of London;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;France;CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE TOURS;Centre Hospitalier Regional Universitaire De Tours;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Afrique du Sud;STELLENBOSCH UNIVERSITY;Stellenbosch University;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Belgique;JANSSEN PHARMACEUTICA NV;Janssen Pharmaceutica Nv;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Pays-Bas;DEMCON ADVANCED MECHATRONICS ENSCHEDE B.V;Demcon Advanced Mechatronics Enschede B.V;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Suisse;F. HOFFMANN-LA ROCHE AG;F. Hoffmann-La Roche Ag;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Etats-Unis;AUTISM SPEAKS INC. NON PROFIT CORPORATION;Autism Speaks Inc. Non Profit Corporation;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Royaume-Uni;King's College London;King'S College London;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Suède;KAROLINSKA INSTITUTET;Karolinska Institutet;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Espagne;FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA;Fundacio Clinic Per A La Recerca Biomedica;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Italie;Fondazione Stella Maris;Fondazione Stella Maris;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Pays-Bas;NOLDUS INFORMATION TECHNOLOGY BV;Noldus Information Technology Bv;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Royaume-Uni;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;The Chancellor Masters And Scholars Of The University Of Cambridge;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Allemagne;GEORG-AUGUST-UNIVERSITAET GOETTINGEN ;Georg-August-Universitaet Goettingen ;Universitatmedizin Goettingen;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Génétique humaine et fonctions cognitives;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Belgique;UCB BIOPHARMA SRL;Ucb Biopharma Srl;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Pays-Bas;RIJKSUNIVERSITEIT GRONINGEN;Rijksuniversiteit Groningen;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Espagne;FUNDAZIOA POLICLINICA GIPUZKOA FUNDACION;Fundazioa Policlinica Gipuzkoa Fundacion;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Suisse;NOVARTIS PHARMA AG;Novartis Pharma Ag;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Allemagne;JOHANN WOLFGANG GOETHE UNIVERSITAT FRANKFURT AM MAIN;Johann Wolfgang Goethe Universitat Frankfurt Am Main;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Israël;TEVA PHARMACEUTICAL INDUSTRIES LIMITED;Teva Pharmaceutical Industries Limited;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Pays-Bas;STICHTING BURO ECNP;Stichting Buro Ecnp;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Allemagne;KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN;Klinikum Rechts Der Isar Der Technischen Universitat Munchen;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Espagne;SerVICIO MADRILENO DE SALUD;Servicio Madrileno De Salud;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Espagne;STARLAB BARCELONA SL;Starlab Barcelona Sl;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Pays-Bas;STICHTING KATHOLIEKE UNIVERSITEIT;Stichting Katholieke Universiteit;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;coordinateur;;Grant Manager 240;;;
AIMS-2-TRIALS;Suisse;Universität Basel;Universität Basel;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Belgique;UNIVERSITEIT GENT;Universiteit Gent;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Espagne;UNIVERSIDAD DE SALAMANCA;Universidad De Salamanca;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Portugal;UNIVERSIDADE DE COIMBRA;Universidade De Coimbra;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Etats-Unis;THE SIMONS FOUNDATION, INC;The Simons Foundation, Inc;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Irlande;THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN;The Provost, Fellows, Foundation Scholars & The Other Members Of Board, Of The College Of The Holy & Undivided Trinity Of Queen Elizabeth Near Dublin;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Pays-Bas;UNIVERSITAIR MEDISCH CENTRUM UTRECHT;Universitair Medisch Centrum Utrecht;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Royaume-Uni;UNIVERSITY OF BRISTOL;University Of Bristol;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Allemagne;UNIVERSITAET ULM;Universitaet Ulm;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Suède;UPPSALA UNIVERSITET;Uppsala Universitet;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Royaume-Uni;UNIVERSITY OF GLASGOW;University Of Glasgow;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Royaume-Uni;UNIVERSITY OF NEWCASTLE UPON TYNE;University Of Newcastle Upon Tyne;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
AIMS-2-TRIALS;Allemagne;ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT;Zentralinstitut Fuer Seelische Gesundheit;;Autism Innovative Medicine Studies - 2 - trials;Projet scientifique;autism spectrum disorder;biomarkers;data;clinical research;autism policies;113 274 914,75 €;Commission Européenne;01/06/2018;31/05/2023;;;;;Grant Manager 240;;;
BlockRabies;Mali;Université des Sciences, des Techniques et des Technologies de Bamako;Université Des Sciences, Des Techniques Et Des Technologies De Bamako;;Blockchain high coverage rabies post-exposure prophylaxis to achieve zero human rabies deaths in Africa;Projet scientifique;Diseases;Rabies;Infectious diseases;;;2 250 000,00 €;Commission Européenne;01/04/2020;01/03/2024;;;;;Grant Manager 687;;;
BlockRabies;Côte d'Ivoire;Swiss Centre for Scientific Research;Swiss Centre For Scientific Research;;Blockchain high coverage rabies post-exposure prophylaxis to achieve zero human rabies deaths in Africa;Projet scientifique;Diseases;Rabies;Infectious diseases;;;2 250 000,00 €;Commission Européenne;01/04/2020;01/03/2024;;;;;Grant Manager 687;;;
BlockRabies;Côte d'Ivoire;Ministère de Resources Animales et Halieutiques;Ministère De Resources Animales Et Halieutiques;;Blockchain high coverage rabies post-exposure prophylaxis to achieve zero human rabies deaths in Africa;Projet scientifique;Diseases;Rabies;Infectious diseases;;;2 250 000,00 €;Commission Européenne;01/04/2020;01/03/2024;;;;;Grant Manager 687;EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS | ERA4TB Project | H2020 | CORDIS | European Commission (europa.eu);;
BlockRabies;Mali;Laboratoire Central Vétérinaire;Laboratoire Central Vétérinaire;;Blockchain high coverage rabies post-exposure prophylaxis to achieve zero human rabies deaths in Africa;Projet scientifique;Diseases;Rabies;Infectious diseases;;;2 250 000,00 €;Commission Européenne;01/04/2020;01/03/2024;;;;;Grant Manager 687;;;
BlockRabies;Côte d'Ivoire;Institut National d'Hygiène Publique;Institut National D'Hygiène Publique;;Blockchain high coverage rabies post-exposure prophylaxis to achieve zero human rabies deaths in Africa;Projet scientifique;Diseases;Rabies;Infectious diseases;;;2 250 000,00 €;Commission Européenne;01/04/2020;01/03/2024;;;;;Grant Manager 687;;;
BlockRabies;Suisse;Health Information Traceability;Health Information Traceability;;Blockchain high coverage rabies post-exposure prophylaxis to achieve zero human rabies deaths in Africa;Projet scientifique;Diseases;Rabies;Infectious diseases;;;2 250 000,00 €;Commission Européenne;01/04/2020;01/03/2024;;;;;Grant Manager 687;;;
BlockRabies;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Lyssavirus, épidémiologie et neuropathologie;Blockchain high coverage rabies post-exposure prophylaxis to achieve zero human rabies deaths in Africa;Projet scientifique;Diseases;Rabies;Infectious diseases;;;2 250 000,00 €;Commission Européenne;01/04/2020;01/03/2024;;;Coordinateur;;Grant Manager 687;;;
BlockRabies;Suisse;Swiss Tropical and Public Health Institute*;Swiss Tropical And Public Health Institute*;;Blockchain high coverage rabies post-exposure prophylaxis to achieve zero human rabies deaths in Africa;Projet scientifique;Diseases;Rabies;Infectious diseases;;;2 250 000,00 €;Commission Européenne;01/04/2020;01/03/2024;;;;;Grant Manager 687;;;
FRMPTC;Autriche;University of Vienna;University Of Vienna;;c-di-AMP in bacterial metabolism and host-pathogen interaction;Projet scientifique;Infectious diseases;Streptococcus infections;;;;370 258,00 €;Fondation pour la Recherche Médicale;01/02/2019;01/02/2022;;;;Projet financé;Grant Manager 489;;;
FRMPTC;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie Bactéries pathog.à Gram-positif;c-di-AMP in bacterial metabolism and host-pathogen interaction;Projet scientifique;Infectious diseases;Streptococcus infections;;;;370 258,00 €;Fondation pour la Recherche Médicale;01/02/2019;01/02/2022;;;;Projet financé;Grant Manager 489;;;
FRMPTC;Etats-Unis;University of Massachusetts Medical School;University Of Massachusetts Medical School;;c-di-AMP in bacterial metabolism and host-pathogen interaction;Projet scientifique;Infectious diseases;Streptococcus infections;;;;370 258,00 €;Fondation pour la Recherche Médicale;01/02/2019;01/02/2022;;;Coordinateur;Projet financé;Grant Manager 489;;;
BIGPICTURE;Allemagne;BAYER AKTIENGESELLSCHAFT;Bayer Aktiengesellschaft;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Italie;AZIENDA OSPEDALIERA PER L EMERGENZA CANNIZZARO;Azienda Ospedaliera Per L Emergenza Cannizzaro;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Belgique;CYTOMINE;Cytomine;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Allemagne;BOEHRINGER INGELHEIM INTERNATIONALGMBH;Boehringer Ingelheim Internationalgmbh;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Belgique;EUROPEAN SOCIETY OF PATHOLOGY;European Society Of Pathology;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Irlande;DECIPHEX LIMITED;Deciphex Limited;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Belgique;JANSSEN PHARMACEUTICA NV;Janssen Pharmaceutica Nv;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Autriche;MEDIZINISCHE UNIVERSITAT GRAZ;Medizinische Universitat Graz;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Autriche;MEDIZINISCHE UNIVERSITAET WIEN;Medizinische Universitaet Wien;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Allemagne;DIN DEUTSCHES INSTITUT FUER NORMUNG E.V.;Din Deutsches Institut Fuer Normung E.V.;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Suisse;F. HOFFMANN-LA ROCHE AG;F. Hoffmann-La Roche Ag;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Autriche;BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM (BBMRI-ERIC);Biobanks And Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric);;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Finlande;CSC-IT Center for Science Ltd;Csc-It Center For Science Ltd;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;France;INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS;Institut De Recherches Internationales Servier Iris;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Finlande;HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ;Helsingin Ja Uudenmaan Sairaanhoitopiirin Kuntayhtymä;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Danemark;NOVO NORDISK A/S;Novo Nordisk A/S;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Suisse;HAUTE ECOLE SPECIALISEE DE SUISSE OCCIDENTALE;Haute Ecole Specialisee De Suisse Occidentale;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Allemagne;FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.;Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Royaume-Uni;PFIZER LIMITED;Pfizer Limited;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Belgique;THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA;The European Institute For Innovation Through Health Data;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Belgique;TIME.LEX;Time.Lex;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Etats-Unis;DIGITAL PATHOLOGY ASSOCIATION INC;Digital Pathology Association Inc;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Pays-Bas;PHIT BV;Phit Bv;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;https://cordis.europa.eu/project/id/777394;;
BIGPICTURE;Allemagne;GBG FORSCHUNGS GMBH;Gbg Forschungs Gmbh;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Belgique;UCB BIOPHARMA SRL;Ucb Biopharma Srl;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Suède;LINKOPINGS UNIVERSITET;Linkopings Universitet;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Belgique;UNIVERSITE DE LIEGE;Universite De Liege;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Royaume-Uni;THE LEEDS TEACHING HOSPITALS NATIONAL HEALTH SERVICE TRUST;The Leeds Teaching Hospitals National Health Service Trust;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;coordinateur;;Grant Manager 839;;;
BIGPICTURE;Suisse;NOVARTIS PHARMA AG;Novartis Pharma Ag;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Suède;OSTERGOTLANDS LANS LANDSTING;Ostergotlands Lans Landsting;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Suède;SECTRA AB;Sectra Ab;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Pays-Bas;STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS;Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Pays-Bas;STICHTING KATHOLIEKE UNIVERSITEIT;Stichting Katholieke Universiteit;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Allemagne;PHILIPPS UNIVERSITAET MARBURG;Philipps Universitaet Marburg;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Pays-Bas;STICHTING LYGATURE;Stichting Lygature;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Allemagne;TECHNISCHE UNIVERSITAET MUENCHEN;Technische Universitaet Muenchen;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Royaume-Uni;THE UNIVERSITY OF WARWICK;The University Of Warwick;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Pays-Bas;TECHNISCHE UNIVERSITEIT EINDHOVEN;Technische Universiteit Eindhoven;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Pays-Bas;TTOPSTART BV;Ttopstart Bv;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;France;OWKIN FRANCE;Owkin France;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;France;SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT;Sanofi-Aventis Recherche & Developpement;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Pays-Bas;UNIVERSITAIR MEDISCH CENTRUM UTRECHT;Universitair Medisch Centrum Utrecht;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Suède;UPPSALA UNIVERSITET;Uppsala Universitet;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
BIGPICTURE;Hongrie;SEMMELWEIS EGYETEM;Semmelweis Egyetem;;Central Repository for Digital Pathology;Projet scientifique;pathology;artificial intelligence;data;;;32 319 825,00 €;Commission Européenne;01/02/2021;31/01/2027;;;;;Grant Manager 839;;;
APPRISE-1;Australie;Peter Doherty Institute for Infection and Immunity;Peter Doherty Institute For Infection And Immunity;;Collaboration sur l'épidémiologie et la recherche clinique visant à faciliter la formation professionnelle et à développer puis à mettre en œuvre la recherche clinique en contexte épidémique (APPRISE–REACTING workshop);;;;;;;;;;;;;;;;;;
APPRISE-1;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;Collaboration sur l'épidémiologie et la recherche clinique visant à faciliter la formation professionnelle et à développer puis à mettre en œuvre la recherche clinique en contexte épidémique (APPRISE–REACTING workshop);;;;;;;;;;;;;;;;;;
CANDY;Royaume-Uni;ADD INFORMATION SERVICES;Add Information Services;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 330;;;
CANDY;Allemagne;ARTTIC INNOVATION GMBH;Arttic Innovation Gmbh;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 330;;;
CANDY;Belgique;AUTISME-EUROPE AISBL;Autisme-Europe Aisbl;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 330;;;
CANDY;France;ARTTIC;Arttic;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 330;;;
CANDY;France;ASSISTANCE PUBLIQUE HOPITAUX DE PARIS;Assistance Publique Hopitaux De Paris;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 330;;;
CANDY;Royaume-Uni;BIRKBECK COLLEGE - UNIVERSITY OF LONDON;Birkbeck College - University Of London;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 330;;;
CANDY;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 330;;;
CANDY;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 330;;;
CANDY;Royaume-Uni;KING'S COLLEGE LONDON;King'S College London;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 330;;;
CANDY;Suède;KAROLINSKA INSTITUTET;Karolinska Institutet;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;coordinateur;;Grant Manager 330;;;
CANDY;Pays-Bas;NOLDUS INFORMATION TECHNOLOGY BV;Noldus Information Technology Bv;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 330;;;
CANDY;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 330;;;
CANDY;Pays-Bas;RIJKSUNIVERSITEIT GRONINGEN;Rijksuniversiteit Groningen;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 330;;;
CANDY;Pays-Bas;STICHTING KATHOLIEKE UNIVERSITEIT;Stichting Katholieke Universiteit;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 330;;;
CANDY;Suisse;Universität Basel;Universität Basel;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 330;;;
CANDY;Belgique;UNIVERSITEIT GENT;Universiteit Gent;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 330;;;
CANDY;Allemagne;UNIVERSITAET ULM;Universitaet Ulm;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy;Projet scientifique;neurology;microbiome;epilepsy;;;6 000 000,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 330;http://cordis.europa.eu/project/id/777394;;
COSYN;Royaume-Uni;CARDIFF UNIVERSITY;Cardiff University;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 €;Commission Européenne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Allemagne;CEGAT GMBH;Cegat Gmbh;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 €;Commission Européenne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Suisse;F. HOFFMANN-LA ROCHE AG;F. Hoffmann-La Roche Ag;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 €;Commission Européenne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Danemark;REGION HOVEDSTADEN;Region Hovedstaden;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 €;Commission Européenne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 €;Commission Européenne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Suède;KAROLINSKA INSTITUTET;Karolinska Institutet;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 €;Commission Européenne;01/01/2016;31/12/2020;;;;;;;;
COSYN;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Génétique humaine et fonctions cognitives;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 €;Commission Européenne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Allemagne;LIFE AND BRAIN GMBH;Life And Brain Gmbh;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 €;Commission Européenne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 €;Commission Européenne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Danemark;H. LUNDBECK AS;H. Lundbeck As;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 €;Commission Européenne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Pays-Bas;STICHTING VU;Stichting Vu;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 €;Commission Européenne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Pays-Bas;SYNAPTOLOGICS BV;Synaptologics Bv;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 €;Commission Européenne;01/01/2016;31/12/2020;;;;;;;;
COSYN;Allemagne;UNIVERSITATSKLINIKUM BONN;Universitatsklinikum Bonn;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 €;Commission Européenne;01/01/2016;31/12/2020;;;coordinateur;;;;;
COSYN;Pays-Bas;VERENIGING SAMENWERKENDE OUDER- EN PATIENTENORGANISATIES;Vereniging Samenwerkende Ouder- En Patientenorganisaties;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders;Projet scientifique;intellectual disability;autism;schizophrenia;therapy;;5 925 000,00 €;Commission Européenne;01/01/2016;31/12/2020;;;;;;A global alliance for Zika virus control and prevention | ZIKAlliance Project | H2020 | CORDIS | European Commission (europa.eu);54;
IGNITE;Allemagne;BAYERISCHE AKADEMIE DER WISSENSCHAFTEN;Bayerische Akademie Der Wissenschaften;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;coordinateur;;;A global alliance for Zika virus control and prevention | ZIKAlliance Project | H2020 | CORDIS | European Commission (europa.eu);54;
IGNITE;Belgique;Fourmy;Fourmy;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Bulgarie;PENSOFT PUBLISHERS;Pensoft Publishers;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Irlande;NATIONAL UNIVERSITY OF IRELAND GALWAY;National University Of Ireland Galway;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Croatie;FACULTY OF SCIENCE UNIVERSITY OF ZAGREB;Faculty Of Science University Of Zagreb;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Australie;Board of the Queensland Museum;Board Of The Queensland Museum;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Portugal;CENTRO INTERDISCIPLINAR DE INVESTIGACAO MARINHA E AMBIENTAL;Centro Interdisciplinar De Investigacao Marinha E Ambiental;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;France;INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE;Institut National De Recherche En Informatique Et Automatique;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;France;INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT;Institut National De Recherche Pour L'Agriculture, L'Alimentation Et L'Environnement;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Allemagne;GENERALDIREKTION DER STAATLICHE NATURWISSENSCHAFTLICHEN SAMMLUNGEN BAYERNS;Generaldirektion Der Staatliche Naturwissenschaftlichen Sammlungen Bayerns;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Allemagne;HITS GGMBH;Hits Ggmbh;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Belgique;UNIVERSITE LIBRE DE BRUXELLES;Universite Libre De Bruxelles;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Norvège;UNIVERSITETET I BERGEN;Universitetet I Bergen;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Allemagne;LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN;Ludwig-Maximilians-Universitaet Muenchen;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Royaume-Uni;UNIVERSITY COLLEGE LONDON;University College London;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
IGNITE;Royaume-Uni;UNIVERSITY OF BRISTOL;University Of Bristol;;Comparative genomics of non-model invertebrates;Projet scientifique;invertebrate genomics;;;;;3 810 631,42 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;54;
HERCULES;Italie;AB ANALITICA SRL;Ab Analitica Srl;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 €;Commission Européenne;01/01/2016;30/06/2021;;;coordinateur;;;;54;
HERCULES;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 €;Commission Européenne;01/01/2016;30/06/2021;;;;;;;54;
HERCULES;Suède;KAROLINSKA INSTITUTET ;Karolinska Institutet ;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 €;Commission Européenne;01/01/2016;30/06/2021;;;;;;;54;
HERCULES;Royaume-Uni;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;The Chancellor Masters And Scholars Of The University Of Cambridge;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 €;Commission Européenne;01/01/2016;30/06/2021;;;;;;;54;
HERCULES;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 €;Commission Européenne;01/01/2016;30/06/2021;;;;;;;54;
HERCULES;Italie;ISTITUTO SUPERIORE DI SANITA;Istituto Superiore Di Sanita;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 €;Commission Européenne;01/01/2016;30/06/2021;;;;;;;54;
HERCULES;Finlande;TURUN YLIOPISTO;Turun Yliopisto;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 €;Commission Européenne;01/01/2016;30/06/2021;;;;;;;54;
HERCULES;Italie;UNIVERSITA DEGLI STUDI DI TRIESTE;Universita Degli Studi Di Trieste;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 €;Commission Européenne;01/01/2016;30/06/2021;;;;;;;54;
HERCULES;Finlande;VARSINAIS-SUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA;Varsinais-Suomen Sairaanhoitopiirin Kuntayhtyma;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis;Projet scientifique;ovarian cancer;drug resistance;data analysis;;;5 994 868,75 €;Commission Européenne;01/01/2016;30/06/2021;;;;;;;54;
MECHABIOME;Hong-Kong;HKU-Pasteur Research Pole;Hku-Pasteur Research Pole;;Computational imaging of the spatiotemporal distribution of forces in gut tissue: a study of the cross talk between cell mechanics, microbiome and infectious processes;Projet scientifique;cell mechanics;;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;54;
MECHABIOME;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Analyse d'images biologiques;Computational imaging of the spatiotemporal distribution of forces in gut tissue: a study of the cross talk between cell mechanics, microbiome and infectious processes;Projet scientifique;cell mechanics;;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;54;
MECHABIOME;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie Cellulaire et Infection;Computational imaging of the spatiotemporal distribution of forces in gut tissue: a study of the cross talk between cell mechanics, microbiome and infectious processes;Projet scientifique;cell mechanics;;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;54;
IF-EBOla;France;ABSISKEY;Absiskey;;Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy;Projet scientifique;Ebola;virology;homeostasis ;therapy;;1 992 770,00 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;54;
IF-EBOla;Israël;BEN-GURION UNIVERSITY OF THE NEGEV;Ben-Gurion University Of The Negev;;Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy;Projet scientifique;Ebola;virology;homeostasis ;therapy;;1 992 770,00 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;54;
IF-EBOla;France;FABENTECH;Fabentech;;Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy;Projet scientifique;Ebola;virology;homeostasis ;therapy;;1 992 770,00 €;Commission Européenne;01/11/2014;31/10/2017;;;coordinateur;;;;54;
IF-EBOla;Canada;UNIVERSITY OF MANITOBA;University Of Manitoba;;Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy;Projet scientifique;Ebola;virology;homeostasis ;therapy;;1 992 770,00 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;54;
IF-EBOla;France;INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT;Institut De Recherche Pour Le Developpement;;Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy;Projet scientifique;Ebola;virology;homeostasis ;therapy;;1 992 770,00 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;54;
IF-EBOla;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy;Projet scientifique;Ebola;virology;homeostasis ;therapy;;1 992 770,00 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;54;
IF-EBOla;Italie;ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO;Istituto Nazionale Per Le Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura A Carattere Scientifico;;Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy;Projet scientifique;Ebola;virology;homeostasis ;therapy;;1 992 770,00 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;54;
IF-EBOla;Etats-Unis;ORION INTEGRATED BIOSCIENCES INC.;Orion Integrated Biosciences Inc.;;Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy;Projet scientifique;Ebola;virology;homeostasis ;therapy;;1 992 770,00 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;54;
FunHoMic;France;BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE;Bioaster Fondation De Cooperation Scientifique;Microbiota Program -Proteomics & Metabolomics Technology Unit;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 10;;54;
FunHoMic;France;BIOSE;Biose;R&D Department;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 10;;54;
FunHoMic;Royaume-Uni;EVOTEC (UK) LIMITED;Evotec (Uk) Limited;Anti-infectives Discovery;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 10;;54;
FunHoMic;Belgique;PRODIGEST;Prodigest;R&D technology;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 10;;54;
FunHoMic;Pays-Bas;MIMETAS BV;Mimetas Bv;Application Development R&D;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 €;Commission Européenne;01/01/2019;31/12/2022;;;coordinateur;;Grant Manager 10;;54;
FunHoMic;Espagne;FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA;Fundacio Hospital Universitari Vall D'Hebron - Institut De Recerca;Gastroenterol ogy Department;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 10;;54;
FunHoMic;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie et Pathogenicite Fongiques;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 10;;54;
FunHoMic;Royaume-Uni;THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN;The University Court Of The University Of Aberdeen;Rowett Institute/MRC Centre for Medical Mycology;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 10;;54;
FunHoMic;Allemagne;LEIBNIZ-INSTITUT FUER NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE EV HANS-KNOELL-INSTITUT;Leibniz-Institut Fuer Naturstoff-Forschung Und Infektionsbiologie Ev Hans-Knoell-Institut;Department Microbial Pathogenicity Mechanisms & Research Group Microbial Immunology;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 10;;54;
FunHoMic;Pays-Bas;STICHTING KATHOLIEKE UNIVERSITEIT;Stichting Katholieke Universiteit;Department of Internal Medicine;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 10;;54;
FunHoMic;Belgique;UNIVERSITEIT GENT;Universiteit Gent;Department of Biotechnology;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 10;;54;
FunHoMic;Suisse;University of Zurich;University Of Zurich;Section of Immunolgy, Vetsuisse Faculty;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 10;;54;
FunHoMic;France;UNIVERSITE CLERMONT AUVERGNE;Universite Clermont Auvergne;UMR Fromage;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 10;;54;
FunHoMic;Pays-Bas;UNIVERSITEIT LEIDEN;Universiteit Leiden;Division of Systems Biomedicine and Pharmacology;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 10;;54;
FunHoMic;France;UNIVERSITE DE PARIS Descartes;Universite De Paris Descartes;Ecole Doctorale Bio SPC;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 10;;54;
FunHoMic;France;UNIVERSITE DE PARIS Diderot;Universite De Paris Diderot;Ecole Doctorale BioSPC;Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections;Projet scientifique;Infectious diseases;Candidasis;;;;3 530 871,36 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 10;;54;
DeSiReS: Dengue Severe Immune Response Studies;Italie;Cenci Bolognetti Foundation;Cenci Bolognetti Foundation;;Dengue virus-mosquito-host interactions: assessing type I interferon mediated immune processes and immunological effects of mosquito salivary glands on Dengue infection;Projet scientifique;dengue;entomology;immunology;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards. | One Health EJP Project | H2020 | CORDIS | European Commission (europa.eu);45;
DeSiReS: Dengue Severe Immune Response Studies;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;Dengue virus-mosquito-host interactions: assessing type I interferon mediated immune processes and immunological effects of mosquito salivary glands on Dengue infection;Projet scientifique;dengue;entomology;immunology;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards. | One Health EJP Project | H2020 | CORDIS | European Commission (europa.eu);45;
DeSiReS: Dengue Severe Immune Response Studies;Côte d'Ivoire;Institut Pasteur de Côte d'Ivoire;Institut Pasteur De Côte D'Ivoire;;Dengue virus-mosquito-host interactions: assessing type I interferon mediated immune processes and immunological effects of mosquito salivary glands on Dengue infection;Projet scientifique;dengue;entomology;immunology;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;45;
DeSiReS: Dengue Severe Immune Response Studies;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Immunologie Translationnelle;Dengue virus-mosquito-host interactions: assessing type I interferon mediated immune processes and immunological effects of mosquito salivary glands on Dengue infection;Projet scientifique;dengue;entomology;immunology;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;45;
E-DYNAMICS;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;Determinants of the expansion of dengue minority stereotypes;Projet scientifique;dengue;arbovirus;serotype;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;45;
E-DYNAMICS;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Génomique évolutive des virus à ARN;Determinants of the expansion of dengue minority stereotypes;Projet scientifique;dengue;arbovirus;serotype;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;45;
E-DYNAMICS;France;Institut Pasteur de Nouvelle Calédonie;Institut Pasteur De Nouvelle Calédonie;;Determinants of the expansion of dengue minority stereotypes;Projet scientifique;dengue;arbovirus;serotype;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;45;
SHERLOCK4HAT;Guinée;Institut Pasteur de Guinée;Institut Pasteur De Guinée;;Development of a field-adapted CRISPR-based method   for the diagnosis of sleeping sickness.;Projet scientifique;trypanosomes;tsetse fly;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;45;
SHERLOCK4HAT;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie cellulaire des Trypanosomes;Development of a field-adapted CRISPR-based method   for the diagnosis of sleeping sickness.;Projet scientifique;trypanosomes;tsetse fly;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;45;
SHERLOCK4HAT;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Plate-forme ICAReB - Investigation clinique et accés aux ressources Biologiques;Development of a field-adapted CRISPR-based method   for the diagnosis of sleeping sickness.;Projet scientifique;trypanosomes;tsetse fly;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;45;
SHERLOCK4HAT;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie moléculaire des Trypanosomes;Development of a field-adapted CRISPR-based method  for the diagnosis of sleeping sickness.;Projet scientifique;trypanosomes;tsetse fly;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;45;
CAMPYVAC;Canada;INRS - Centre Armand-Frappier Santé Biotechnologie;Inrs - Centre Armand-Frappier Santé Biotechnologie;;Development of heptose-containing semi-synthetic glycoconjugate vaccines against campylobacteriosis;Projet scientifique;Campylobacteriosi;vaccine;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;coordinateur;;;;45;
CAMPYVAC;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Chimie des biomolécules;Development of heptose-containing semi-synthetic glycoconjugate vaccines against campylobacteriosis;Projet scientifique;Campylobacteriosi;vaccine;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;45;
DIPs 2;Tunisie;Faculté de Médecine de Tunis;Faculté De Médecine De Tunis;;DIPS 2;Santé publique;DIPs;Renforcement;Diagnostic;;;200 000,00 €;DCI Monaco;;;;;;;;;45;
DIPs 2;Tunisie;Institut Pasteur de Tunis;Institut Pasteur De Tunis;;DIPS 2;Santé publique;DIPs;Renforcement;Diagnostic;;;200 000,00 €;DCI Monaco;11/07/1905;;;;;;;;45;
DIPs 2;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Direction internationale Pôle des opérations;DIPS 2;Santé publique;DIPs;Renforcement;Diagnostic;;;200 000,00 €;DCI Monaco;11/07/1905;;;;;;;;45;
DIPs 2;France;Institut Pasteur (Paris);Institut Pasteur (Paris);BIOMICS;DIPS 2;Santé publique;DIPs;Renforcement;Diagnostic;;;200 000,00 €;DCI Monaco;;;;;;;;;45;
CoPyMe;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Pathogenèse de Helicobacter;E. coli and H. pylori as models for the role of DNA methylation in the relation between bacteria and cancer ;Projet scientifique;colorectal cancer;gastric cancer;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;coordinateur;;;;45;
CoPyMe;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Polarite Cellulaire, Migration et Cancer;E. coli and H. pylori as models for the role of DNA methylation in the relation between bacteria and cancer ;Projet scientifique;colorectal cancer;gastric cancer;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;45;
CoPyMe;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Chimie Biologique Epigénétique;E. coli and H. pylori as models for the role of DNA methylation in the relation between bacteria and cancer ;Projet scientifique;colorectal cancer;gastric cancer;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;45;
CoPyMe;Grèce;Hellenic Pasteur Institute;Hellenic Pasteur Institute;;E. coli and H. pylori as models for the role of DNA methylation in the relation between bacteria and cancer ;Projet scientifique;colorectal cancer;gastric cancer;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;45;
EbolaMoDRAD;Allemagne;AJ INNUSCREEN GMBH;Aj Innuscreen Gmbh;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Belgique;CORIS BIOCONCEPT SPRL;Coris Bioconcept Sprl;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Royaume-Uni;Department of Health;Department Of Health;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Italie;CLONIT SRL;Clonit Srl;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Suède;FOLKHALSOMYNDIGHETEN;Folkhalsomyndigheten;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;France;INSERM TRANSFERT SA;Inserm Transfert Sa;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Danemark;STATENS SERUM INSTITUT;Statens Serum Institut;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Italie;EMERGENCY LIFE SUPPORT FOR CIVILIAN WAR VICTIMS ONG ONLUS;Emergency Life Support For Civilian War Victims Ong Onlus;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Danemark;KOBENHAVNS UNIVERSITET;Kobenhavns Universitet;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Sénégal;INSTITUT PASTEUR DE DAKAR;Institut Pasteur De Dakar;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Italie;ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO;Istituto Nazionale Per Le Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura A Carattere Scientifico;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Suède;STOCKHOLMS UNIVERSITET;Stockholms Universitet;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;Royaume-Uni;THE UNIVERSITY OF STIRLING;The University Of Stirling;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
EbolaMoDRAD;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;coordinateur;;;;45;
EbolaMoDRAD;Finlande;TURUN YLIOPISTO;Turun Yliopisto;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics;Projet scientifique;Ebola;diagnostic;;;;4 300 935,00 €;Commission Européenne;01/02/2015;31/01/2018;;;;;;;45;
AMOHI ;France;Institut de Médecine et d'Epidémiologie Appliquée;Institut De Médecine Et D'Epidémiologie Appliquée;;Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patients initiating medication-assisted treatment;Projet scientifique;HIV;cellular immune activation;;;;336 070,00 €;US National Institute on Drug abuse;01/08/2019;31/12/2024;;;coordinateur;convention démarrée;Grant Manager 975;;45;
AMOHI ;Vietnam;Institut Pasteur in Ho Chi Minh City;Institut Pasteur In Ho Chi Minh City;;Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patients initiating medication-assisted treatment;Projet scientifique;HIV;cellular immune activation;;;;336 070,00 €;US National Institute on Drug abuse;01/08/2019;31/12/2024;;;;convention démarrée;Grant Manager 975;;45;
AMOHI ;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie cellulaire des lymphocytes;Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patients initiating medication-assisted treatment;Projet scientifique;HIV;cellular immune activation;;;;336 070,00 €;US National Institute on Drug abuse;01/08/2019;31/12/2024;;Daniel SCOTT-ALGARA;;convention démarrée;Grant Manager 975;;45;
AMOHI ;Etats-Unis;University of Pennsylvania;University Of Pennsylvania;HIV Prevention Research Division;Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patients initiating medication-assisted treatment;Projet scientifique;HIV;cellular immune activation;;;;336 070,00 €;US National Institute on Drug abuse;01/08/2019;31/12/2024;;;;convention démarrée;Grant Manager 975;;45;
AMOHI ;Etats-Unis;Wistar Institute;Wistar Institute;;Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patients initiating medication-assisted treatment;Projet scientifique;HIV;cellular immune activation;;;;336 070,00 €;US National Institute on Drug abuse;01/08/2019;31/12/2024;;;;convention démarrée;Grant Manager 975;;45;
ELIXIR-EXCELERATE;République Tchèque;CESNET ZAJMOVE SDRUZENI PRAVNICKYCH OSOB;Cesnet Zajmove Sdruzeni Pravnickych Osob;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;Coordinateur;;;Research Infrastructures for the control of vector-borne diseases | INFRAVEC2 Project | H2020 | CORDIS | European Commission (europa.eu);23;
ELIXIR-EXCELERATE;France;CENTRE DE COOPERATION INTERNATIONALE EN RECHERCHE AGRONOMIQUE POUR LEDEVELOPPEMENT - C.I.R.A.D. EPIC;Centre De Cooperation Internationale En Recherche Agronomique Pour Ledeveloppement - C.I.R.A.D. Epic;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;Research Infrastructures for the control of vector-borne diseases | INFRAVEC2 Project | H2020 | CORDIS | European Commission (europa.eu);23;
ELIXIR-EXCELERATE;Espagne;AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS;Agencia Estatal Consejo Superior De Investigaciones Cientificas;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Danemark;University of Southern Denmark;University Of Southern Denmark;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Danemark;University of Copenhagen;University Of Copenhagen;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Portugal;CENTRO DE CIENCIAS DO MAR DO ALGARVE;Centro De Ciencias Do Mar Do Algarve;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Espagne;BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION;Barcelona Supercomputing Center - Centro Nacional De Supercomputacion;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Royaume-Uni;EARLHAM INSTITUTE;Earlham Institute;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Danemark;Technical University of Denmark;Technical University Of Denmark;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Finlande;CSC-IT Center for Science Ltd;Csc-It Center For Science Ltd;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Royaume-Uni;HERIOT-WATT UNIVERSITY;Heriot-Watt University;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Portugal;FUNDACAO CALOUSTE GULBENKIAN;Fundacao Calouste Gulbenkian;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;République Tchèque;Masarykova univerzita;Masarykova Univerzita;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Espagne;FUNDACIO CENTRE DE REGULACIO GENOMICA;Fundacio Centre De Regulacio Genomica;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Grèce;ATHINA-EREVNITIKO KENTRO KAINOTOMIAS STIS TECHNOLOGIES TIS PLIROFORIAS, TON EPIKOINONION KAI TIS GNOSIS;Athina-Erevnitiko Kentro Kainotomias Stis Technologies Tis Pliroforias, Ton Epikoinonion Kai Tis Gnosis;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;France;INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT;Institut National De Recherche Pour L'Agriculture, L'Alimentation Et L'Environnement;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Norvège;NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NTNU;Norges Teknisk-Naturvitenskapelige Universitet Ntnu;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Royaume-Uni;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;The Chancellor Masters And Scholars Of The University Of Cambridge;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Grèce;BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING;Biomedical Sciences Research Center Alexander Fleming;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Suède;LINKOPINGS UNIVERSITET;Linkopings Universitet;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Espagne;FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA);Fundacio Institut De Recerca Biomedica (Irb Barcelona);;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;23;
ELIXIR-EXCELERATE;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Portugal;INESC ID - INSTITUTO DE ENGENHARIADE SISTEMAS E COMPUTADORES, INVESTIGACAO E DESENVOLVIMENTO EM LISBOA;Inesc Id - Instituto De Engenhariade Sistemas E Computadores, Investigacao E Desenvolvimento Em Lisboa;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Espagne;FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM;Fundacio Institut Mar D Investigacions Mediques Imim;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Espagne;FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III;Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Espagne;FUNDACION DE LA COMUNIDAD VALENCIANA CENTRO DE INVESTIGACION PRINCIPEFELIPE;Fundacion De La Comunidad Valenciana Centro De Investigacion Principefelipe;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Espagne;FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD;Fundacion Publica Andaluza Progreso Y Salud;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Portugal;INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA;Instituto De Biologia Experimental E Tecnologica;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Slovénie;NACIONALNI INSTITUT ZA BIOLOGIJO;Nacionalni Institut Za Biologijo;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Israël;THE HEBREW UNIVERSITY OF JERUSALEM;The Hebrew University Of Jerusalem;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Pays-Bas;STICHTING DTL PROJECTS;Stichting Dtl Projects;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Suisse;SIB INSTITUT SUISSE DE BIOINFORMATIQUE;Sib Institut Suisse De Bioinformatique;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Norvège;UNIVERSITETET I BERGEN;Universitetet I Bergen;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Espagne;UNIVERSIDAD DE MALAGA;Universidad De Malaga;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Royaume-Uni;THE UNIVERSITY OF MANCHESTER;The University Of Manchester;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Israël;WEIZMANN INSTITUTE OF SCIENCE;Weizmann Institute Of Science;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Norvège;UNIVERSITETET I OSLO;Universitetet I Oslo;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Grèce;IDRYMA TECHNOLOGIAS KAI EREVNAS;Idryma Technologias Kai Erevnas;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Estonie;University of Tartu;University Of Tartu;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Espagne;UNIVERSIDAD POMPEU FABRA;Universidad Pompeu Fabra;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Slovénie;UNIVERZA V LJUBLJANI;Univerza V Ljubljani;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;République Tchèque;USTAV ORGANICKE CHEMIE A BIOCHEMIE, AV CR, V.V.I.;Ustav Organicke Chemie A Biochemie, Av Cr, V.V.I.;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Suède;UPPSALA UNIVERSITET;Uppsala Universitet;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Belgique;Vlaams Instituut voor Biotechnologie;Vlaams Instituut Voor Biotechnologie;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Danemark;Aarhus University;Aarhus University;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
ELIXIR-EXCELERATE;Norvège;UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET;Universitetet I Tromsoe - Norges Arktiske Universitet;;ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences;Projet scientifique;Bioinformatics;data ;exchange;interoperability;storage;19 051 482,00 €;Commission Européenne;01/09/2015;31/08/2019;;;;;;;139;
IAV-m6A;Etats-Unis;DUKE UNIVERSITY;Duke University;;Elucidating the role of m6A RNA methylation on the replication and pathogenesis of influenza A virus;Projet scientifique;virology;RNA virus;;;;264 668,40 €;Commission Européenne;01/06/2017;31/05/2020;;;;;;;139;
IAV-m6A;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Virologie structurale;Elucidating the role of m6A RNA methylation on the replication and pathogenesis of influenza A virus;Projet scientifique;virology;RNA virus;;;;264 668,40 €;Commission Européenne;01/06/2017;31/05/2020;;;coordinateur;;;;139;
Ebola_Tx;France;ETABLISSEMENT FRANCAIS DU SANG;Etablissement Francais Du Sang;;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.;Projet scientifique;Ebola;therapy;epidemics;;;2 892 171,00 €;Commission Européenne;01/11/2014;31/10/2016;;;coordinateur;;;;139;
Ebola_Tx;Belgique;PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE;Prins Leopold Instituut Voor Tropische Geneeskunde;;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.;Projet scientifique;Ebola;therapy;epidemics;;;2 892 171,00 €;Commission Européenne;01/11/2014;31/10/2016;;;;;;;139;
Ebola_Tx;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.;Projet scientifique;Ebola;therapy;epidemics;;;2 892 171,00 €;Commission Européenne;01/11/2014;31/10/2016;;;;;;;139;
Ebola_Tx;Royaume-Uni;LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER;London School Of Hygiene And Tropical Medicine Royal Charter;;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.;Projet scientifique;Ebola;therapy;epidemics;;;2 892 171,00 €;Commission Européenne;01/11/2014;31/10/2016;;;;;;;139;
Ebola_Tx;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.;Projet scientifique;Ebola;therapy;epidemics;;;2 892 171,00 €;Commission Européenne;01/11/2014;31/10/2016;;;;;;;139;
Ebola_Tx;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.;Projet scientifique;Ebola;therapy;epidemics;;;2 892 171,00 €;Commission Européenne;01/11/2014;31/10/2016;;;;;;;139;
Ebola_Tx;Royaume-Uni;THE UNIVERSITY OF LIVERPOOL;The University Of Liverpool;;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.;Projet scientifique;Ebola;therapy;epidemics;;;2 892 171,00 €;Commission Européenne;01/11/2014;31/10/2016;;;;;;;139;
Ebola_Tx;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.;Projet scientifique;Ebola;therapy;epidemics;;;2 892 171,00 €;Commission Européenne;01/11/2014;31/10/2016;;;;;;;139;
paratransgenesis based on RNAi and Asaia bacterium in Anopheles;Iran;Institut Pasteur d'Iran;Institut Pasteur D'Iran;;Engineering Asaia to induce RNA interference in larval and adult Anopheles: a tool for vector genetics and paratransgenesis;Projet scientifique;malaria;;;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
paratransgenesis based on RNAi and Asaia bacterium in Anopheles;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Génétique et Génomique des Insectes Vecteurs;Engineering Asaia to induce RNA interference in larval and adult Anopheles: a tool for vector genetics and paratransgenesis;Projet scientifique;malaria;;;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
paratransgenesis based on RNAi and Asaia bacterium in Anopheles;France;Institut Pasteur de Guyane;Institut Pasteur De Guyane;;Engineering Asaia to induce RNA interference in larval and adult Anopheles: a tool for vector genetics and paratransgenesis;Projet scientifique;malaria;;;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;139;
SURVEV68;Côte d'Ivoire;Institut Pasteur de Côte d'Ivoire;Institut Pasteur De Côte D'Ivoire;;Enterovirus 68 investigation in children with acute respiratory infection and acute flaccid myelitis in two Subsaharan african countries.;Projet scientifique;enterovirus;pediatrics;;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
SURVEV68;Sénégal;Institut Pasteur de Dakar;Institut Pasteur De Dakar;;Enterovirus 68 investigation in children with acute respiratory infection and acute flaccid myelitis in two Subsaharan african countries.;Projet scientifique;enterovirus;pediatrics;;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
SURVEV68;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Populations virales et pathogenèse;Enterovirus 68 investigation in children with acute respiratory infection and acute flaccid myelitis in two Subsaharan african countries.;Projet scientifique;enterovirus;pediatrics;;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;139;
EVinCA&M;Cameroun;Pasteur Center in Cameroon;Pasteur Center In Cameroon;;Epidemiology and Genetic Diversity of Enteroviruses in Central Africa and in Madagascar: uncovering the hidden parts of the enterovirus ecosystems;Projet scientifique;enterovirus;ecosystems;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
EVinCA&M;République Centrafricaine;Institut Pasteur de Bangui;Institut Pasteur De Bangui;;Epidemiology and Genetic Diversity of Enteroviruses in Central Africa and in Madagascar: uncovering the hidden parts of the enterovirus ecosystems;Projet scientifique;enterovirus;ecosystems;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
EVinCA&M;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Populations virales et pathogenèse;Epidemiology and Genetic Diversity of Enteroviruses in Central Africa and in Madagascar: uncovering the hidden parts of the enterovirus ecosystems;Projet scientifique;enterovirus;ecosystems;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;139;
EVinCA&M;Madagascar;Institut Pasteur de Madagascar;Institut Pasteur De Madagascar;;Epidemiology and Genetic Diversity of Enteroviruses in Central Africa and in Madagascar: uncovering the hidden parts of the enterovirus ecosystems;Projet scientifique;enterovirus;ecosystems;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
ETHOMOS;Niger;CERMES Niger;Cermes Niger;;Ethomics for mosquitoes;Projet scientifique;mosquito-borne diseases;arbovirus;;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;139;
ETHOMOS;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Décision et processus Bayesiens;Ethomics for mosquitoes;Projet scientifique;mosquito-borne diseases;arbovirus;;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
ETHOMOS;France;Institut Pasteur de Guyane;Institut Pasteur De Guyane;;Ethomics for mosquitoes;Projet scientifique;mosquito-borne diseases;arbovirus;;;;50 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;139;
EuroGCT;Pays-Bas;ACADEMISCH ZIEKENHUIS GRONINGEN;Academisch Ziekenhuis Groningen;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;CARDIFF UNIVERSITY;Cardiff University;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Allemagne;BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL;Bundesinstitut Fur Impfstoffe Und Biomedizinische Arzneimittel;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;CELL THERAPY CATAPULT LIMITED;Cell Therapy Catapult Limited;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Espagne;ASOCIACION INSTITUTO BIODONOSTIA;Asociacion Instituto Biodonostia;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Suisse;EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH;Eidgenoessische Technische Hochschule Zuerich;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Hongrie;BIOTALENTUM TUDASFEJLESZTO KFT;Biotalentum Tudasfejleszto Kft;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;France;ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK;Ecrin European Clinical Research Infrastructure Network;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Pays-Bas;KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW;Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;République Tchèque;FAKULTNI NEMOCNICE U SV. ANNY V BRNE;Fakultni Nemocnice U Sv. Anny V Brne;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE;Imperial College Of Science Technology And Medicine;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Espagne;FUNDACIO CENTRE DE REGULACIO GENOMICA;Fundacio Centre De Regulacio Genomica;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Pologne;Jagiellonian University in Krakow;Jagiellonian University In Krakow;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Autriche;UNIVERSITAET INNSBRUCK;Universitaet Innsbruck;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;KING'S COLLEGE LONDON;King'S College London;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Irlande;NATIONAL UNIVERSITY OF IRELAND GALWAY;National University Of Ireland Galway;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;République Tchèque;Masarykova univerzita;Masarykova Univerzita;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Autriche;INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH;Institut Fuer Molekulare Biotechnologie Gmbh;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Autriche;DEBRA AUSTRIA HILFE BEI EPIDERMOLYSIS BULLOSA;Debra Austria Hilfe Bei Epidermolysis Bullosa;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Suède;KAROLINSKA INSTITUTET;Karolinska Institutet;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Allemagne;FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.;Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;QUEEN MARGARET UNIVERSITY, EDINBURGH;Queen Margaret University, Edinburgh;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Danemark;KOBENHAVNS UNIVERSITET;Kobenhavns Universitet;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;The Chancellor Masters And Scholars Of The University Of Cambridge;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Allemagne;GERMAN STEMCELL NETWORK (GSCN) - DEUTSCHES STAMMZELLNETZWERK EV;German Stemcell Network (Gscn) - Deutsches Stammzellnetzwerk Ev;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Allemagne;HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH;Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Suède;LUNDS UNIVERSITET;Lunds Universitet;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Belgique;UNIVERSITE LIBRE DE BRUXELLES;Universite Libre De Bruxelles;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;coordinateur;;;;139;
EuroGCT;Finlande;ITA-SUOMEN YLIOPISTO;Ita-Suomen Yliopisto;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Italie;UNIVERSITA DEGLI STUDI DI MILANO;Universita Degli Studi Di Milano;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;THE UNIVERSITY OF EXETER;The University Of Exeter;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;THE UNIVERSITY OF MANCHESTER;The University Of Manchester;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Allemagne;STAMMZELLNETZWERK.NRW EV;Stammzellnetzwerk.Nrw Ev;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Italie;UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA;Universita Degli Studi Di Modena E Reggio Emilia;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;THE UNIVERSITY OF SHEFFIELD;The University Of Sheffield;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Royaume-Uni;UNIVERSITY COLLEGE LONDON;University College London;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;France;SOCIETE FRANCAISE DE THERAPIE CELLULAIRE ET GENIQUE;Societe Francaise De Therapie Cellulaire Et Genique;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Allemagne;UNIVERSITAETSKLINIKUM FREIBURG;Universitaetsklinikum Freiburg;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Allemagne;UNIVERSITATSKLINIKUM BONN;Universitatsklinikum Bonn;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Pologne;UNIWERSYTET WARSZAWSKI;Uniwersytet Warszawski;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroGCT;Belgique;VRIJE UNIVERSITEIT BRUSSEL;Vrije Universiteit Brussel;;European consortium for communicating gene- and cell-based therapy information.;Projet scientifique;gene therapy;;;;;1 999 783,75 €;Commission Européenne;01/02/2021;31/01/2026;;;;;;;139;
EuroStemCell;Pays-Bas;ACADEMISCH ZIEKENHUIS GRONINGEN;Academisch Ziekenhuis Groningen;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Royaume-Uni;CARDIFF UNIVERSITY;Cardiff University;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;France;ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK;Ecrin European Clinical Research Infrastructure Network;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Pays-Bas;KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW;Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Royaume-Uni;KING'S COLLEGE LONDON;King'S College London;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Espagne;FUNDACIO CENTRE DE REGULACIO GENOMICA;Fundacio Centre De Regulacio Genomica;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;République Tchèque;Masarykova univerzita;Masarykova Univerzita;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Irlande;NATIONAL UNIVERSITY OF IRELAND GALWAY;National University Of Ireland Galway;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Autriche;INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH;Institut Fuer Molekulare Biotechnologie Gmbh;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Suède;KAROLINSKA INSTITUTET;Karolinska Institutet;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Danemark;KOBENHAVNS UNIVERSITET;Kobenhavns Universitet;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Italie;ISTITUTO EUROPEO DI ONCOLOGIA SRL;Istituto Europeo Di Oncologia Srl;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Royaume-Uni;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;The Chancellor Masters And Scholars Of The University Of Cambridge;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Allemagne;GERMAN STEMCELL NETWORK (GSCN) - DEUTSCHES STAMMZELLNETZWERK EV;German Stemcell Network (Gscn) - Deutsches Stammzellnetzwerk Ev;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;139;
EuroStemCell;Suède;LUNDS UNIVERSITET;Lunds Universitet;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;Principles of Polarity – Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity | PolarNet Project | H2020 | CORDIS | European Commission (europa.eu);;
EuroStemCell;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Royaume-Uni;THE UNIVERSITY OF BIRMINGHAM;The University Of Birmingham;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Allemagne;LIFE AND BRAIN GMBH;Life And Brain Gmbh;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Belgique;UNIVERSITE LIBRE DE BRUXELLES;Universite Libre De Bruxelles;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;coordinateur;;;;;
EuroStemCell;Belgique;UNIVERSITE LIBRE DE BRUXELLES;Universite Libre De Bruxelles;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Italie;UNIVERSITA DEGLI STUDI DI MILANO;Universita Degli Studi Di Milano;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Royaume-Uni;THE UNIVERSITY OF MANCHESTER;The University Of Manchester;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Italie;UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA;Universita Degli Studi Di Modena E Reggio Emilia;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Royaume-Uni;THE UNIVERSITY OF SHEFFIELD;The University Of Sheffield;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Italie;UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA;Universita Degli Studi Di Roma La Sapienza;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Hongrie;SZENT ISTVAN UNIVERSITY;Szent Istvan University;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Pologne;UNIWERSYTET WARSZAWSKI;Uniwersytet Warszawski;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;;;
EuroStemCell;Royaume-Uni;UNIVERSITY OF YORK;University Of York;;European Consortium for Communicating Stem Cell Research;Projet scientifique;stem cells;;;;;600 000,00 €;Commission Européenne;01/01/2015;31/03/2018;;;;;;Immune profiling to guide host-directed interventions to cure HBV infections | IP-cure-B Project | H2020 | CORDIS | European Commission (europa.eu);;
EMBRIC;Royaume-Uni;CAB INTERNATIONAL;Cab International;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Allemagne;EUROPEAN INFRASTRUCTURE OF OPEN SCREENING PLATFORMS FOR CHEMICAL BIOLOGY EUROPEAN RESEARCH INFRASTUCTURE CONSORTIUM (EU-OPENSCREEN ERIC);European Infrastructure Of Open Screening Platforms For Chemical Biology European Research Infrastucture Consortium (Eu-Openscreen Eric);;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Portugal;CENTRO DE CIENCIAS DO MAR DO ALGARVE;Centro De Ciencias Do Mar Do Algarve;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Allemagne;FORSCHUNGSVERBUND BERLIN EV;Forschungsverbund Berlin Ev;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Royaume-Uni;MARINE BIOLOGICAL ASSOCIATION OF THE UNITED KINGDOM;Marine Biological Association Of The United Kingdom;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Royaume-Uni;MARINE SCOTLAND;Marine Scotland;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;France;INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT;Institut National De Recherche Pour L'Agriculture, L'Alimentation Et L'Environnement;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;coordinateur;;;;;
EMBRIC;Israël;TEL AVIV UNIVERSITY;Tel Aviv University;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Allemagne;HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH;Helmholtz-Zentrum Fur Infektionsforschung Gmbh;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer | DECIDER Project | H2020 | CORDIS | European Commission (europa.eu);14;
EMBRIC;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Royaume-Uni;THE SCOTTISH ASSOCIATION FOR MARINESCIENCE LBG;The Scottish Association For Marinescience Lbg;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Norvège;SCALPRO AS;Scalpro As;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Allemagne;LEIBNIZ-INSTITUT DSMZ-DEUTSCHE SAMMLUNG VON MIKROORGANISMEN UND ZELLKULTUREN GMBH;Leibniz-Institut Dsmz-Deutsche Sammlung Von Mikroorganismen Und Zellkulturen Gmbh;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Royaume-Uni;THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS;The University Court Of The University Of St Andrews;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Grèce;HELLENIC CENTRE FOR MARINE RESEARCH;Hellenic Centre For Marine Research;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Italie;STAZIONE ZOOLOGICA ANTON DOHRN;Stazione Zoologica Anton Dohrn;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Norvège;UNIVERSITETET I BERGEN;Universitetet I Bergen;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Espagne;UNIVERSIDAD DE VIGO;Universidad De Vigo;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Espagne;UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA;Universidad Del Pais Vasco/ Euskal Herriko Unibertsitatea;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Belgique;UNIVERSITEIT GENT;Universiteit Gent;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Allemagne;TUNATECH GMBH;Tunatech Gmbh;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;Royaume-Uni;UNITED KINGDOM RESEARCH AND INNOVATION;United Kingdom Research And Innovation;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;14;
EMBRIC;France;SORBONNE UNIVERSITE;Sorbonne Universite;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;France;UNIVERSITE COTE D'AZUR;Universite Cote D'Azur;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;France;UNIVERSITE GUSTAVE EIFFEL;Universite Gustave Eiffel;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Norvège;UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET;Universitetet I Tromsoe - Norges Arktiske Universitet;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;;;
EMBRIC;Royaume-Uni;XELECT LIMITED;Xelect Limited;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy;Infrastructure;oceanography;bioeconomy;data;research infrastructure;;9 041 611,00 €;Commission Européenne;01/06/2015;31/05/2019;;;;;;A Global Social Sciences Network for Infectious Threats and Antimicrobial Resistance | SoNAR-Global Project | H2020 | CORDIS | European Commission (europa.eu);;
EuroBioTox;France;AGENCE NATIONALE DE LA SECURITE SANITAIRE DE L ALIMENTATION DE L ENVIRONNEMENT ET DU TRAVAIL;Agence Nationale De La Securite Sanitaire De L Alimentation De L Environnement Et Du Travail;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 €;Commission Européenne;01/06/2017;31/05/2022;;;coordinateur;;Grant Manager 121;;;
EuroBioTox;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 €;Commission Européenne;01/06/2017;31/05/2022;;;;;Grant Manager 121;;;
EuroBioTox;Belgique;JRC -JOINT RESEARCH CENTRE- EUROPEAN COMMISSION;Jrc -Joint Research Centre- European Commission;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 €;Commission Européenne;01/06/2017;31/05/2022;;;;;Grant Manager 121;;;
EuroBioTox;Suisse;EIDGENOSSISCHES DEPARTEMENT FUR VERTEIDIGUNG, BEVOLKERUNGSSCHUTZ UND SPORT;Eidgenossisches Departement Fur Verteidigung, Bevolkerungsschutz Und Sport;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 €;Commission Européenne;01/06/2017;31/05/2022;;;;;Grant Manager 121;;;
EuroBioTox;Belgique;SCIENSANO;Sciensano;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 €;Commission Européenne;01/06/2017;31/05/2022;;;;;Grant Manager 121;;;
EuroBioTox;Suisse;LUGINBUEHL WERNER;Luginbuehl Werner;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 €;Commission Européenne;01/06/2017;31/05/2022;;;;;Grant Manager 121;;;
EuroBioTox;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 €;Commission Européenne;01/06/2017;31/05/2022;;;;;Grant Manager 121;;;
EuroBioTox;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 €;Commission Européenne;01/06/2017;31/05/2022;;;;;Grant Manager 121;;;
EuroBioTox;Royaume-Uni;THE QUEEN'S UNIVERSITY OF BELFAST;The Queen'S University Of Belfast;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 €;Commission Européenne;01/06/2017;31/05/2022;;;;;Grant Manager 121;;;
EuroBioTox;Suède;TOTALFORSVARETS FORSKNINGSINSTITUT;Totalforsvarets Forskningsinstitut;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 €;Commission Européenne;01/06/2017;31/05/2022;;;;;Grant Manager 121;;;
EuroBioTox;Allemagne;ROBERT KOCH-INSTITUT;Robert Koch-Institut;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 €;Commission Européenne;01/06/2017;31/05/2022;;;;;Grant Manager 121;;;
EuroBioTox;Allemagne;TOXOGEN GMBH;Toxogen Gmbh;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 €;Commission Européenne;01/06/2017;31/05/2022;;;;;Grant Manager 121;;;
EuroBioTox;Suisse;ZURCHER HOCHSCHULE FUR ANGEWANDTE WISSENSCHAFTEN;Zurcher Hochschule Fur Angewandte Wissenschaften;;European programme for the establishment of validated procedures for the detection and identification of biological toxins;Projet scientifique;preparation;incident scenarios;biotoxin incidents;;;7 998 747,00 €;Commission Européenne;01/06/2017;31/05/2022;;;;;Grant Manager 121;;;
EPIC-XS;Suisse;EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH;Eidgenoessische Technische Hochschule Zuerich;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;;;
EPIC-XS;Allemagne;EBERHARD KARLS UNIVERSITAET TUEBINGEN;Eberhard Karls Universitaet Tuebingen;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;https://cordis.europa.eu/project/id/964568;;
EPIC-XS;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;;;
EPIC-XS;Estonie;University of Tartu;University Of Tartu;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;;;
EPIC-XS;Espagne;FUNDACIO CENTRE DE REGULACIO GENOMICA;Fundacio Centre De Regulacio Genomica;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;;;
EPIC-XS;République Tchèque;MIKROBIOLOGICKY USTAV AV CR V.V.I;Mikrobiologicky Ustav Av Cr V.V.I;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;;;
EPIC-XS;Autriche;FORSCHUNGSINSTITUT FUR MOLEKULARE PATHOLOGIE GESELLSCHAFT MBH;Forschungsinstitut Fur Molekulare Pathologie Gesellschaft Mbh;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;;;
EPIC-XS;Suède;KUNGLIGA TEKNISKA HOEGSKOLAN;Kungliga Tekniska Hoegskolan;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;European programme for the establishment of validated procedures for the detection and identification of biological toxins | EuroBioTox Project | H2020 | CORDIS | European Commission (europa.eu);;
EPIC-XS;Italie;ISTITUTO EUROPEO DI ONCOLOGIA SRL;Istituto Europeo Di Oncologia Srl;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;;;
EPIC-XS;Royaume-Uni;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;The Chancellor Masters And Scholars Of The University Of Cambridge;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;;;
EPIC-XS;Danemark;KOBENHAVNS UNIVERSITET;Kobenhavns Universitet;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;;;
EPIC-XS;Espagne;FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III;Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos Iii;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;;;
EPIC-XS;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;;;
EPIC-XS;Norvège;UNIVERSITETET I BERGEN;Universitetet I Bergen;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;coordinateur;;Grant Manager 64;;;
EPIC-XS;Allemagne;TECHNISCHE UNIVERSITAET MUENCHEN;Technische Universitaet Muenchen;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;;;
EPIC-XS;Grèce;IDRYMA TECHNOLOGIAS KAI EREVNAS;Idryma Technologias Kai Erevnas;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;;;
EPIC-XS;Belgique;Vlaams Instituut voor Biotechnologie;Vlaams Instituut Voor Biotechnologie;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;;;
EPIC-XS;Pays-Bas;UNIVERSITEIT UTRECHT;Universiteit Utrecht;;European Proteomics Infrastructure Consortium providing Access;Projet scientifique;Proteomics;bioinformatics;data;;;9 986 185,75 €;Commission Européenne;01/01/2019;31/12/2022;;;;;Grant Manager 64;;;
ERA4TB;France;BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE;Bioaster Fondation De Cooperation Scientifique;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Lettonie;LATVIJAS ORGANISKAS SINTEZES INSTITUTS;Latvijas Organiskas Sintezes Instituts;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Irlande;CRITICAL PATH INSTITUTE, LIMITED;Critical Path Institute, Limited;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;Towards an instrument-free future of molecular diagnostics at the point-of-care | FreeATPOC Project | H2020 | CORDIS | European Commission (europa.eu);;
ERA4TB;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Royaume-Uni;Department of Health;Department Of Health;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Belgique;JANSSEN PHARMACEUTICA NV;Janssen Pharmaceutica Nv;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;coordinateur;;Grant Manager 437;;;
ERA4TB;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;Synthetic bacterial lipid rafts to optimize industrial bioprocesses | Rafts4Biotech Project | H2020 | CORDIS | European Commission (europa.eu);;
ERA4TB;France;IMABIOTECH SAS;Imabiotech Sas;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Suisse;FONDATION INNOVATIVE MEDICINES FOR TUBERCULOSIS;Fondation Innovative Medicines For Tuberculosis;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Etats-Unis;BILL & MELINDA GATES FOUNDATION;Bill & Melinda Gates Foundation;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Allemagne;EVOTEC INTERNATIONAL GMBH;Evotec International Gmbh;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Allemagne;FORSCHUNGSZENTRUM BORSTEL;Forschungszentrum Borstel;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Belgique;SCIENSANO;Sciensano;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Royaume-Uni;NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE;National Institute For Health And Care Excellence;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Pays-Bas;QPS NETHERLANDS BV;Qps Netherlands Bv;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Etats-Unis;GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION;Global Alliance For Tb Drug Development Non Profit Organisation;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Suède;LUNDS UNIVERSITET ;Lunds Universitet ;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Pathogenomique mycobacterienne integree;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Espagne;GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL;Glaxosmithkline Investigacion Y Desarrollo Sl;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis | LeiSHield-MATI Project | H2020 | CORDIS | European Commission (europa.eu);;
ERA4TB;Allemagne;KLINIKUM DER UNIVERSITAET ZU KOELN;Klinikum Der Universitaet Zu Koeln;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Espagne;SERVICIO MADRILENO DE SALUD;Servicio Madrileno De Salud;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Espagne;SYNAPSE RESEARCH MANAGEMENT PARTNERS SL;Synapse Research Management Partners Sl;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Espagne;UNIVERSIDAD CARLOS III DE MADRID;Universidad Carlos Iii De Madrid;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Danemark;GRITSYSTEMS AS;Gritsystems As;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Espagne;UNIVERSIDAD DE ZARAGOZA;Universidad De Zaragoza;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Italie;UNIVERSITA DEGLI STUDI DI PADOVA;Universita Degli Studi Di Padova;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Italie;UNIVERSITA DEGLI STUDI DI PAVIA;Universita Degli Studi Di Pavia;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;France;Institut Pasteur de Lille;Institut Pasteur De Lille;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Royaume-Uni;UNIVERSITY OF DUNDEE;University Of Dundee;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;;;
ERA4TB;Suède;UPPSALA UNIVERSITET;Uppsala Universitet;;European Regimen accelerator for tuberculosis;Projet scientifique;tuberculosis;clinical medicine;artificial intelligence;;;89 815 600,00 €;Commission Européenne;01/01/2020;31/12/2025;;;;;Grant Manager 437;"TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development | TBVAC2020 Project | H2020 | CORDIS | European Commission (europa.eu)";;
EVAg;Chine;WUHAN INSTITUTE OF VIROLOGY, CHINESE ACADEMY OF SCIENCES;Wuhan Institute Of Virology, Chinese Academy Of Sciences;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Slovaquie;BIOMEDICINSKE CENTRUM SLOVENSKEJ AKADEMIE VIED;Biomedicinske Centrum Slovenskej Akademie Vied;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Allemagne;Bernhard-Nocht-Institut für Tropenmedizin;Bernhard-Nocht-Institut Für Tropenmedizin;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Allemagne;Charité - Universitätsmedizin Berlin;Charité - Universitätsmedizin Berlin;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Afrique du Sud;NATIONAL HEALTH LABORATORY SERVICES;National Health Laboratory Services;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Royaume-Uni;Department of Health;Department Of Health;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Afrique du Sud;AGRICULTURAL RESEARCH COUNCIL INSTITUTE FOR SOIL CLIMATE AND WATER;Agricultural Research Council Institute For Soil Climate And Water;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Pays-Bas;ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM;Erasmus Universitair Medisch Centrum Rotterdam;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;coordinateur;;;;;
EVAg;Suède;FOLKHALSOMYNDIGHETEN;Folkhalsomyndigheten;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;France;FONDATION MERIEUX;Fondation Merieux;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Allemagne;Friedrich-Loeffler-Institut;Friedrich-Loeffler-Institut;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Russie;FEDERAL STATE BUDGETARY SCIENTIFIC INSTITUTION CHUMAKOV INSTITUTE OF POLIOMYELITIS AND VIRAL ENCEPHALITIDES;Federal State Budgetary Scientific Institution Chumakov Institute Of Poliomyelitis And Viral Encephalitides;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Australie;COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION;Commonwealth Scientific And Industrial Research Organisation;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Russie;RESEARCH INSTITUTE OF VACCINES AND SERA II MECHNIKOV;Research Institute Of Vaccines And Sera Ii Mechnikov;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Italie;ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO;Istituto Nazionale Per Le Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura A Carattere Scientifico;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Royaume-Uni;THE PIRBRIGHT INSTITUTE LBG;The Pirbright Institute Lbg;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Royaume-Uni;THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS;The Secretary Of State For Environment, Food And Rural Affairs;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Russie;SMORODINTSEV RESEARCH INSTITUTE OF INFLUENZA OF THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION;Smorodintsev Research Institute Of Influenza Of The Ministry Of Health Of The Russian Federation;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Allemagne;ROBERT KOCH-INSTITUT;Robert Koch-Institut;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Suisse;Universität Basel;Universität Basel;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;Slovénie;UNIVERZA V LJUBLJANI;Univerza V Ljubljani;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVAg;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;European Virus Archive goes global;Projet scientifique;Virology;network;virus collection;;;10 792 868,00 €;Commission Européenne;01/04/2015;31/07/2020;;;;;;;;
EVA-GLOBAL;France;AGENCE NATIONALE DE LA SECURITE SANITAIRE DE L ALIMENTATION DE L ENVIRONNEMENT ET DU TRAVAIL;Agence Nationale De La Securite Sanitaire De L Alimentation De L Environnement Et Du Travail;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Slovaquie;Biomedicinske Centrum Slovenskej Akademie Vied;Biomedicinske Centrum Slovenskej Akademie Vied;Institute of Virology;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;France;CENTRE DE COOPERATION INTERNATIONALE EN RECHERCHE AGRONOMIQUE POUR LEDEVELOPPEMENT - C.I.R.A.D. EPIC;Centre De Cooperation Internationale En Recherche Agronomique Pour Ledeveloppement - C.I.R.A.D. Epic;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Allemagne;Bernhard-Nocht-Institut für Tropenmedizin;Bernhard-Nocht-Institut Für Tropenmedizin;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Belgique;EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS;European Research Infrastructure On Highly Pathogenic Agents;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Slovaquie;Biomedicinske Centrum Slovenskej Akademie Vied;Biomedicinske Centrum Slovenskej Akademie Vied;Department of Plant Virology;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Royaume-Uni;Department of Health;Department Of Health;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Allemagne;Charité - Universitätsmedizin Berlin;Charité - Universitätsmedizin Berlin;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Pays-Bas;Erasmus University Medical Center;Erasmus University Medical Center;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;France;FONDATION MERIEUX;Fondation Merieux;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;France;INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE;Institut National De La Recherche Agronomique;INRA Bordeaux-Aquitaine -UMR 1332 Biologie du Fruit et Pathologie;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;France;INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE;Institut National De La Recherche Agronomique;INRA PACA AVIGNON –UR407 Unité de Pathologie Végétale;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Italie;CONSIGLIO NAZIONALE DELLERICERCHE;Consiglio Nazionale Dellericerche;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;France;Institut national de la santé et de la recherche médicale;Institut National De La Santé Et De La Recherche Médicale;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Allemagne;Friedrich-Loeffler-Institut;Friedrich-Loeffler-Institut;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Chine;WUHAN INSTITUTE OF VIROLOGY, CHINESE ACADEMY OF SCIENCES;Wuhan Institute Of Virology, Chinese Academy Of Sciences;Chinese Academy of Science wuhang;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Chine;WUHAN INSTITUTE OF VIROLOGY, CHINESE ACADEMY OF SCIENCES;Wuhan Institute Of Virology, Chinese Academy Of Sciences;National Biosafety Laboratory;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century | IS_MIRRI21 Project | H2020 | CORDIS | European Commission (europa.eu);;
EVA-GLOBAL;Italie;Istituto di Ricovero e Cura a Carattere Scientifico;Istituto Di Ricovero E Cura A Carattere Scientifico;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Australie;COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION;Commonwealth Scientific And Industrial Research Organisation;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;Coordinateur;Avenant signé;;;;
EVA-GLOBAL;Sénégal;INSTITUT PASTEUR DE DAKAR;Institut Pasteur De Dakar;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Pays-Bas;RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU;Rijksinstituut Voor Volksgezondheid En Milieu;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Italie;ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO;Istituto Nazionale Per Le Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura A Carattere Scientifico;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Royaume-Uni;THE PIRBRIGHT INSTITUTE LBG;The Pirbright Institute Lbg;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Royaume-Uni;THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS;The Secretary Of State For Environment, Food And Rural Affairs;Animal Health and Veterinaries Agency;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Royaume-Uni;THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS;The Secretary Of State For Environment, Food And Rural Affairs;Centre for Environment, Fisheries and AquacultureScience;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Allemagne;JULIUS KUHN-INSTITUTBUNDESFORSCHUNGSINSTITUT FURKULTURPFLANZEN;Julius Kuhn-Institutbundesforschungsinstitut Furkulturpflanzen;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Lyssavirus, épidémiologie et neuropathologie;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus ;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Italie;ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA LOMBARDIA E DELL'EMILIA ROMAGNA BRUNO UBERTINI;Istituto Zooprofilattico Sperimentale Della Lombardia E Dell'Emilia Romagna Bruno Ubertini;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Italie;ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE;Istituto Zooprofilattico Sperimentale Delle Venezie;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Epidémio.& Physiopatho.Virus Oncogènes;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus ;Virus collection;Network;;11 602 750,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Génétique moléculaire des virus ARN;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus ;Virus collection;Network;;11 602 751,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Populations virales et pathogenèse;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus ;Virus collection;Network;;11 602 752,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Allemagne;LEIBNIZ-INSTITUT DSMZ-DEUTSCHE SAMMLUNG VON MIKROORGANISMEN UND ZELLKULTUREN GMBH;Leibniz-Institut Dsmz-Deutsche Sammlung Von Mikroorganismen Und Zellkulturen Gmbh;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;Accelerated Early staGe drug diScovery | AEGIS Project | H2020 | CORDIS | European Commission (europa.eu);;
EVA-GLOBAL;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Arbovirus et Insectes Vecteurs;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus ;Virus collection;Network;;11 602 753,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Environnement et risques infectieux;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus ;Virus collection;Network;;11 602 755,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Allemagne;PHILIPPS UNIVERSITAET MARBURG;Philipps Universitaet Marburg;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Allemagne;Robert Koch-Institut;Robert Koch-Institut;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Grèce;Hellenic Pasteur Institute;Hellenic Pasteur Institute;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Suisse;Universität Basel;Universität Basel;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Slovénie;Univerza v Ljubljani;Univerza V Ljubljani;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Etats-Unis;University of Florida;University Of Florida;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Hongrie;Nemzeti Népegészségügyi Központ;Nemzeti Népegészségügyi Központ;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;France;Université d'Aix Marseille;Université D'Aix Marseille;Coordination Team;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;France;Université d'Aix Marseille;Université D'Aix Marseille;Unité des Virus Emergents;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
EVA-GLOBAL;Russie;SMORODINTSEV RESEARCH INSTITUTE OF INFLUENZA OF THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION;Smorodintsev Research Institute Of Influenza Of The Ministry Of Health Of The Russian Federation;;European Virus Archive-Global;Projet scientifique;Organisms and Organs;Virus;Virus collection;Network;;11 602 748,75 €;Commission Européenne;01/01/2020;01/01/2024;;;;Avenant signé;;;;
REACTION;France;ASSOCIATION POUR LE DEVELOPPEMENT DE L'ENSEIGNEMENT ET DES RECHERCHES AUPRES DES UNIVERSITES, DES CENTRES DE RECHERCHE ET DES ENTREPRISES D'AQUITAINE;Association Pour Le Developpement De L'Enseignement Et Des Recherches Aupres Des Universites, Des Centres De Recherche Et Des Entreprises D'Aquitaine;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;;
REACTION;Allemagne;Bernhard-Nocht-Institut für Tropenmedizin;Bernhard-Nocht-Institut Für Tropenmedizin;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;;
REACTION;Royaume-Uni;Department of Health;Department Of Health;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 €;Commission Européenne;01/11/2014;31/10/2017;;;coordinateur;;;;;
REACTION;France;ECOLE NORMALE SUPERIEURE DE LYON;Ecole Normale Superieure De Lyon;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;;
REACTION;Pays-Bas;DRUG DISCOVERY FACTORY BV;Drug Discovery Factory Bv;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;;
REACTION;Suisse;FONDATION POUR L INSTITUT DE HAUTES ETUDES INTERNATIONALES ET DU DEVELOPPEMENT;Fondation Pour L Institut De Hautes Etudes Internationales Et Du Developpement;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;;
REACTION;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;;
REACTION;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;;
REACTION;Allemagne;RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG;Ruprecht-Karls-Universitaet Heidelberg;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;;
REACTION;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;;
REACTION;Sénégal;UNIVERSITE CHEIKH ANTA DIOP DE DAKAR;Universite Cheikh Anta Diop De Dakar;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;;
REACTION;Pays-Bas;UNIVERSITEIT UTRECHT;Universiteit Utrecht;;Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans;Projet scientifique;Ebola ;;;;;2 575 809,50 €;Commission Européenne;01/11/2014;31/10/2017;;;;;;;;
EVoSP;Brésil;Oswaldo Cruz Foundation (Fiocruz);Oswaldo Cruz Foundation (Fiocruz);;Evolution of regulatory interactions through the lens of antibiotic selective pressure;Projet scientifique;Polymyxins;antibiotics;antibioresistance;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;coordinateur;;;;;
EVoSP;Uruguay;Institut Pasteur in Montevideo;Institut Pasteur In Montevideo;;Evolution of regulatory interactions through the lens of antibiotic selective pressure;Projet scientifique;Polymyxins;antibiotics;antibioresistance;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
EVoSP;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Plate-Forme Cristallographie;Evolution of regulatory interactions through the lens of antibiotic selective pressure;Projet scientifique;Polymyxins;antibiotics;antibioresistance;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
EVoSP;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Plate-forme Technologique de RMN Biologique;Evolution of regulatory interactions through the lens of antibiotic selective pressure;Projet scientifique;Polymyxins;antibiotics;antibioresistance;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
RI-VIS;Belgique;EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS;European Research Infrastructure On Highly Pathogenic Agents;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 €;Commission Européenne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Pays-Bas;EATRIS ERIC;Eatris Eric;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 €;Commission Européenne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;France;ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK;Ecrin European Clinical Research Infrastructure Network;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 €;Commission Européenne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;France;EUROPEAN MARINE BIOLOGICAL RESOURCE CENTRE EUROPEAN RESEARCH INFRASTRUCTURE CONSORTIUM;European Marine Biological Resource Centre European Research Infrastructure Consortium;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 €;Commission Européenne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Royaume-Uni;EUROPEAN SOCIAL SURVEY EUROPEAN RESEARCH INFRASTRUCTURE CONSORTIUM;European Social Survey European Research Infrastructure Consortium;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 €;Commission Européenne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Allemagne;EUROPEAN INFRASTRUCTURE OF OPEN SCREENING PLATFORMS FOR CHEMICAL BIOLOGY EUROPEAN RESEARCH INFRASTUCTURE CONSORTIUM (EU-OPENSCREEN ERIC);European Infrastructure Of Open Screening Platforms For Chemical Biology European Research Infrastucture Consortium (Eu-Openscreen Eric);;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 €;Commission Européenne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Royaume-Uni;INSTRUCT-ERIC;Instruct-Eric;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 €;Commission Européenne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Allemagne;FORSCHUNGSZENTRUM JULICH GMBH;Forschungszentrum Julich Gmbh;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 €;Commission Européenne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Belgique;Service Public Fédéral de Programmation Politique Scientifique (Belspo);Service Public Fédéral De Programmation Politique Scientifique (Belspo);;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 €;Commission Européenne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Autriche;BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM (BBMRI-ERIC);Biobanks And Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric);;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 €;Commission Européenne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 €;Commission Européenne;01/02/2019;31/07/2021;;;;;;;;
RI-VIS;Allemagne;INFRAFRONTIER GMBH;Infrafrontier Gmbh;;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 €;Commission Européenne;01/02/2019;31/07/2021;;;coordinateur;;;;;
RI-VIS;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Collection Nle Cultures Micro-organismes;Expanding research infrastructure visibility to strengthen strategic partnerships;Infrastructure;research infrastructure;;;;;1 500 000,00 €;Commission Européenne;01/02/2019;31/07/2021;;;;;;;;
ZIKAVAX;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;Fast track development of a Zika vaccine based on measles vector;Projet scientifique;Zika;vaccine;epidemics;;;4 918 137,50 €;Commission Européenne;01/10/2016;31/12/2020;;;coordinateur;;;;;
ZIKAVAX;Allemagne;EUROPEAN VACCINE INITIATIVE EWIV;European Vaccine Initiative Ewiv;;Fast track development of a Zika vaccine based on measles vector;Projet scientifique;Zika;vaccine;epidemics;;;4 918 137,50 €;Commission Européenne;01/10/2016;31/12/2020;;;;;;European Proteomics Infrastructure Consortium providing Access | EPIC-XS Project | H2020 | CORDIS | European Commission (europa.eu);;
ZIKAVAX;Autriche;THEMIS BIOSCIENCE GMBH;Themis Bioscience Gmbh;;Fast track development of a Zika vaccine based on measles vector;Projet scientifique;Zika;vaccine;epidemics;;;4 918 137,50 €;Commission Européenne;01/10/2016;31/12/2020;;;;;;;;
ZIKAVAX;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Fast track development of a Zika vaccine based on measles vector;Projet scientifique;Zika;vaccine;epidemics;;;4 918 137,50 €;Commission Européenne;01/10/2016;31/12/2020;;;;;;;;
FiTeRaD;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;Field Tests for Rabies Diagnostic;Projet scientifique;rabies;first point of care tests;detection;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
FiTeRaD;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Lyssavirus, épidémiologie et neuropathologie;Field Tests for Rabies Diagnostic;Projet scientifique;rabies;first point of care tests;detection;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;;
FiTeRaD;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Chimie bioorganique des acides nucléiques;Field Tests for Rabies Diagnostic;Projet scientifique;rabies;first point of care tests;detection;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
FiTeRaD;Madagascar;Institut Pasteur de Madagascar;Institut Pasteur De Madagascar;;Field Tests for Rabies Diagnostic;Projet scientifique;rabies;first point of care tests;detection;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
MusVir;Hong-Kong;HKU-Pasteur Research Pole;Hku-Pasteur Research Pole;;Functional consequences of pathogen infection in tissue specific stem cells;Projet scientifique;stem cells;flu;influenza;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;coordinateur;;;;;
MusVir;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Cellules Souches et Développement - Stem Cells and Development;Functional consequences of pathogen infection in tissue specific stem cells;Projet scientifique;stem cells;flu;influenza;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
MusVir;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Neuropathologie expérimentale;Functional consequences of pathogen infection in tissue specific stem cells;Projet scientifique;stem cells;flu;influenza;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
HDM-FUN;France;CENTRE HOSPITALIER UNIVERSITAIRE VAUDOI;Centre Hospitalier Universitaire Vaudoi;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;;Avenant signé;Grant Manager 714;;;
HDM-FUN;Belgique;KATHOLIEKE UNIVERSITEIT LEUVEN;Katholieke Universiteit Leuven;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;;Avenant signé;Grant Manager 714;;;
HDM-FUN;Pays-Bas;HYCULT BIOTECHNOLOGY BV;Hycult Biotechnology Bv;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;;Avenant signé;Grant Manager 714;;;
HDM-FUN;France;Institut Imagine;Institut Imagine;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;;Avenant signé;Grant Manager 714;;;
HDM-FUN;Italie;INNOVATION ACTA S.R.L;Innovation Acta S.R.L;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;;Avenant signé;Grant Manager 714;;;
HDM-FUN;Etats-Unis;DUKE UNIVERSITY;Duke University;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;;Avenant signé;Grant Manager 714;;;
HDM-FUN;Roumanie;UNIVERSITATEADE MEDICINA SIFARMACIE IULIUHATIEGANUCLUJ-NAPOCA;Universitateade Medicina Sifarmacie Iuliuhatieganucluj-Napoca;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;;Avenant signé;Grant Manager 714;;;
HDM-FUN;Allemagne;JOHANN WOLFGANG GOETHE UNIVERSITAT FRANKFURT AM MAIN;Johann Wolfgang Goethe Universitat Frankfurt Am Main;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;;Avenant signé;Grant Manager 714;;;
HDM-FUN;Allemagne;JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG;Julius-Maximilians-Universitat Wurzburg;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;;Avenant signé;Grant Manager 714;Fast track development of a Zika vaccine based on measles vector | ZIKAVAX Project | H2020 | CORDIS | European Commission (europa.eu);;
HDM-FUN;Allemagne;LEIBNIZ-INSTITUT FUER NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE EV HANS-KNOELL-INSTITUT;Leibniz-Institut Fuer Naturstoff-Forschung Und Infektionsbiologie Ev Hans-Knoell-Institut;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;;Avenant signé;Grant Manager 714;;;
HDM-FUN;Grèce;FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLA;Foundation For Research And Technology Hella;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;;Avenant signé;Grant Manager 714;;;
HDM-FUN;Pays-Bas;Stichting Katholieke Universiteit;Stichting Katholieke Universiteit;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;;Avenant signé;Grant Manager 714;;;
HDM-FUN;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie et pathogenicite fongiques;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;Coordinateur;Avenant signé;Grant Manager 714;Rapid European SARS-CoV-2 Emergency research Response | RECoVER Project | H2020 | CORDIS | European Commission (europa.eu);;
HDM-FUN;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Immunologie des infections fongiques;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;;Avenant signé;Grant Manager 714;;;
HDM-FUN;Royaume-Uni;THE UNIVERSITYCOURT OF THEUNIVERSITY OFABERDEEN;The Universitycourt Of Theuniversity Ofaberdeen;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;;Avenant signé;Grant Manager 714;;;
HDM-FUN;Italie;UNIVERSITA DEGLI STUDI DI PERUGIA;Universita Degli Studi Di Perugia;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;;Avenant signé;Grant Manager 714;;;
HDM-FUN;Portugal;UNIVERSIDADEDO MINHO;Universidadedo Minho;;Host directed medicine in invasive fungal infection;Projet scientifique;Infectious diseases;antimicrobial drug resistance;;;;9 998 170,00 €;Commission Européenne;01/01/2020;01/01/2025;;;;Avenant signé;Grant Manager 714;;;
ZOOFOAMENV;Cameroun;Pasteur Center in Cameroon;Pasteur Center In Cameroon;;Host pathogens interactions in humans infected with zoonotic foamy viruses;Projet scientifique;retroviruses;foamy viruses;zoonoses ;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
ZOOFOAMENV;Chine;Institut Pasteur of Shanghai, Chinese Academy of Sciences;Institut Pasteur Of Shanghai, Chinese Academy Of Sciences;;Host pathogens interactions in humans infected with zoonotic foamy viruses;Projet scientifique;retroviruses;foamy viruses;zoonoses ;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
ZOOFOAMENV;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Epidémiologie et Physiopathologie des Virus Oncogènes;Host pathogens interactions in humans infected with zoonotic foamy viruses;Projet scientifique;retroviruses;foamy viruses;zoonoses ;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;coordinateur;;;;;
ZOOFOAMENV;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Virologie structurale;Host pathogens interactions in humans infected with zoonotic foamy viruses;Projet scientifique;retroviruses;foamy viruses;zoonoses ;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
IP-cure-B;Suisse;CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS;Centre Hospitalier Universitaire Vaudois;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 540;;;
IP-cure-B;Belgique;EUROPEAN LIVER PATIENTS ASSOCIATION;European Liver Patients Association;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 540;;;
IP-cure-B;France;HOSPICES CIVILS DE LYON;Hospices Civils De Lyon;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 540;;;
IP-cure-B;France;INSERM TRANSFERT SA;Inserm Transfert Sa;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 540;;;
IP-cure-B;France;Institut national de la santé et de la recherche médicale;Institut National De La Santé Et De La Recherche Médicale;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 540;;;
IP-cure-B;Italie;FONDAZIONE IRCCS CA' GRANDA - OSPEDALE MAGGIORE POLICLINICO;Fondazione Irccs Ca' Granda - Ospedale Maggiore Policlinico;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 €;Commission Européenne;01/01/2020;31/12/2024;;;coordinateur;;Grant Manager 540;European Virus Archive goes global | EVAg Project | H2020 | CORDIS | European Commission (europa.eu);;
IP-cure-B;Suède;KAROLINSKA INSTITUTET;Karolinska Institutet;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 540;;;
IP-cure-B;Espagne;FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA;Fundacio Hospital Universitari Vall D'Hebron - Institut De Recerca;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 540;;;
IP-cure-B;Etats-Unis;GILEAD SCIENCES INC;Gilead Sciences Inc;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 540;;;
IP-cure-B;Grèce;ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON;Ethniko Kai Kapodistriako Panepistimio Athinon;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 540;;;
IP-cure-B;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Immunité innée;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 540;;;
IP-cure-B;Italie;UNIVERSITA DEGLI STUDI DI PARMA;Universita Degli Studi Di Parma;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 540;;;
IP-cure-B;Allemagne;UNIVERSITAETSKLINIKUM FREIBURG;Universitaetsklinikum Freiburg;;Host-directed interventions to cure hepatitis B infections;Projet scientifique;hepatitis B;immunisation;vaccine;;;9 983 029,00 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 540;;;
HBP SGA1;Allemagne;BAUHAUS-UNIVERSITAET WEIMAR;Bauhaus-Universitaet Weimar;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suisse;CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS;Centre Hospitalier Universitaire Vaudois;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Grèce;ATHENS UNIVERSITY OF ECONOMICS AND BUSINESS - RESEARCH CENTER;Athens University Of Economics And Business - Research Center;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;BERGISCHE UNIVERSITAET WUPPERTAL;Bergische Universitaet Wuppertal;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;CARDIFF UNIVERSITY;Cardiff University;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;CINECA CONSORZIO INTERUNIVERSITARIO;Cineca Consorzio Interuniversitario;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Finlande;AALTO KORKEAKOULUSAATIO SR;Aalto Korkeakoulusaatio Sr;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;DE MONTFORT UNIVERSITY;De Montfort University;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV;Deutsches Zentrum Fur Neurodegenerative Erkrankungen Ev;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION;Barcelona Supercomputing Center - Centro Nacional De Supercomputacion;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;ECOLE NORMALE SUPERIEURE;Ecole Normale Superieure;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suisse;EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH;Eidgenoessische Technische Hochschule Zuerich;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Belgique;KATHOLIEKE UNIVERSITEIT LEUVEN;Katholieke Universiteit Leuven;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation | INCENTIVE Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA1;Israël;Bloomfield Science Museum Jerusalem (BSMJ);Bloomfield Science Museum Jerusalem (Bsmj);;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE;Institut Du Cerveau Et De La Moelle Epiniere;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE;Imperial College Of Science Technology And Medicine;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Norvège;NORGES MILJO-OG BIOVITENSKAPLIGE UNIVERSITET;Norges Miljo-Og Biovitenskaplige Universitet;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Slovénie;INSTITUT JOZEF STEFAN;Institut Jozef Stefan;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER;Consorci Institut D'Investigacions Biomediques August Pi I Sunyer;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Portugal;FUNDACAO D. ANNA SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD;Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE;Institut National De Recherche En Informatique Et Automatique;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;KING'S COLLEGE LONDON;King'S College London;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Pays-Bas;KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW;Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;FORSCHUNGSZENTRUM JULICH GMBH;Forschungszentrum Julich Gmbh;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Hongrie;DEBRECENI EGYETEM;Debreceni Egyetem;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;FONDAZIONE EUROPEAN BRAIN RESEARCHINSTITUTE RITA LEVI;Fondazione European Brain Researchinstitute Rita Levi;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;MEDICAL RESEARCH COUNCIL;Medical Research Council;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;MIDDLESEX UNIVERSITY HIGHER EDUCATION CORPORATION;Middlesex University Higher Education Corporation;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;FORTISS GMBH;Fortiss Gmbh;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.;Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suède;KAROLINSKA INSTITUTET;Karolinska Institutet;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA;Fundacio Institut De Bioenginyeria De Catalunya;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy | CANDY Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA1;Suède;KUNGLIGA TEKNISKA HOEGSKOLAN;Kungliga Tekniska Hoegskolan;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;FZI FORSCHUNGSZENTRUM INFORMATIK;Fzi Forschungszentrum Informatik;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;ISTITUTO NAZIONALE DI FISICA NUCLEARE;Istituto Nazionale Di Fisica Nucleare;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;HEINRICH-HEINE-UNIVERSITAET DUESSELDORF;Heinrich-Heine-Universitaet Duesseldorf;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suède;LINNEUNIVERSITETET;Linneuniversitetet;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Israël;TEL AVIV UNIVERSITY;Tel Aviv University;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Belgique;UNIVERSITE DE LIEGE;Universite De Liege;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Autriche;TECHNISCHE UNIVERSITAET GRAZ;Technische Universitaet Graz;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Grèce;ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON;Ethniko Kai Kapodistriako Panepistimio Athinon;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Autriche;OSTERREICHISCHE STUDIENGESELLSCHAFTFUR KYBERNETIK VEREIN;Osterreichische Studiengesellschaftfur Kybernetik Verein;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Autriche;MEDIZINISCHE UNIVERSITAT INNSBRUCK;Medizinische Universitat Innsbruck;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;HITS GGMBH;Hits Ggmbh;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;ISTITUTO SUPERIORE DI SANITA;Istituto Superiore Di Sanita;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Autriche;INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA;Institute Of Science And Technology Austria;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;HUMBOLDT-UNIVERSITAET ZU BERLIN;Humboldt-Universitaet Zu Berlin;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;SustainAble Farming for Effective Aquaculture | SAFE-Aqua Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA1;Allemagne;JOHANN WOLFGANG GOETHE UNIVERSITAT FRANKFURT AM MAIN;Johann Wolfgang Goethe Universitat Frankfurt Am Main;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Pays-Bas;STICHTING CENTRUM VOOR WISKUNDE EN INFORMATICA;Stichting Centrum Voor Wiskunde En Informatica;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;KARLSRUHER INSTITUT FUER TECHNOLOGIE;Karlsruher Institut Fuer Technologie;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN;The University Court Of The University Of Aberdeen;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suisse;SIB INSTITUT SUISSE DE BIOINFORMATIQUE;Sib Institut Suisse De Bioinformatique;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;Human Brain Project Specific Grant Agreement 1 | HBP SGA1 Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA1;Italie;LABORATORIO EUROPEO DI SPETTROSCOPIE NON LINEARI;Laboratorio Europeo Di Spettroscopie Non Lineari;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Hongrie;KIRSERLETI ORVOSTUDOMANYI KUTATOINTEZET;Kirserleti Orvostudomanyi Kutatointezet;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Israël;THE HEBREW UNIVERSITY OF JERUSALEM;The Hebrew University Of Jerusalem;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;POLITECNICO DI TORINO;Politecnico Di Torino;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;UNIVERSIDAD AUTONOMA DE MADRID;Universidad Autonoma De Madrid;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;SCUOLA NORMALE SUPERIORE;Scuola Normale Superiore;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Belgique;UNIVERSITEIT ANTWERPEN;Universiteit Antwerpen;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suisse;UNIVERSITAET BERN;Universitaet Bern;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA;Scuola Superiore Di Studi Universitari E Di Perfezionamento S Anna;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN;Rheinisch-Westfaelische Technische Hochschule Aachen;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Lyssavirus ???;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;UNIVERSIDAD DE CASTILLA - LA MANCHA;Universidad De Castilla - La Mancha;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Danemark;FONDEN TEKNOLOGIRADET;Fonden Teknologiradet;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;THE UNIVERSITY OF HERTFORDSHIRE HIGHER EDUCATION CORPORATION;The University Of Hertfordshire Higher Education Corporation;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suisse;Universität Basel;Universität Basel;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;UNIVERSIDAD DE GRANADA;Universidad De Granada;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;UNIVERSITA DEGLI STUDI DI MILANO;Universita Degli Studi Di Milano;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;THE UNIVERSITY OF MANCHESTER;The University Of Manchester;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Israël;WEIZMANN INSTITUTE OF SCIENCE;Weizmann Institute Of Science;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG;Ruprecht-Karls-Universitaet Heidelberg;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Turquie;SABANCI UNIVERSITESI;Sabanci Universitesi;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;TECHNISCHE UNIVERSITAET DRESDEN;Technische Universitaet Dresden;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suisse;UNIVERSITE DE GENEVE;Universite De Geneve;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;TECHNISCHE UNIVERSITAET MUENCHEN;Technische Universitaet Muenchen;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;TECHNISCHE UNIVERSITAT DARMSTADT;Technische Universitat Darmstadt;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Pays-Bas;STICHTING RADBOUD UNIVERSITEIT;Stichting Radboud Universiteit;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;THE UNIVERSITY OF SHEFFIELD;The University Of Sheffield;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;UNIVERSIDAD POLITECNICA DE MADRID;Universidad Politecnica De Madrid;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Norvège;UNIVERSITETET I OSLO;Universitetet I Oslo;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Pays-Bas;STICHTING VU;Stichting Vu;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;THE UNIVERSITY OF SUSSEX;The University Of Sussex;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;UCL Elizabeth Garrett Anderson Institute for Women’s Health;Ucl Elizabeth Garrett Anderson Institute For Women’S Health;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suisse;University of Zurich;University Of Zurich;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Belgique;UNIVERSITEIT GENT;Universiteit Gent;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Italie;UNIVERSITA DEGLI STUDI DI PAVIA;Universita Degli Studi Di Pavia;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Portugal;UNIVERSIDADE DO MINHO;Universidade Do Minho;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;UNIVERSIDAD POMPEU FABRA;Universidad Pompeu Fabra;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Danemark;DANMARKS TEKNISKE UNIVERSITET;Danmarks Tekniske Universitet;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;UNIVERSITAET BIELEFELD;Universitaet Bielefeld;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;UNIVERSITAET HAMBURG;Universitaet Hamburg;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;UNIVERSIDAD REY JUAN CARLOS;Universidad Rey Juan Carlos;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;UNIVERSITAETSKLINIKUM AACHEN;Universitaetsklinikum Aachen;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Grèce;POLYTECHNEIO KRITIS;Polytechneio Kritis;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;UNIVERSITY OF GLASGOW;University Of Glasgow;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Pays-Bas;UNIVERSITEIT MAASTRICHT;Universiteit Maastricht;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;UNIVERSITE DE BORDEAUX;Universite De Bordeaux;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Allemagne;UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF;Universitaetsklinikum Hamburg-Eppendorf;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Espagne;UNIVERSITAT DE BARCELONA;Universitat De Barcelona;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;coordinateur;;;;;
HBP SGA1;Royaume-Uni;UNIVERSITY OF LEEDS;University Of Leeds;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Finlande;TTY-SAATIO;Tty-Saatio;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Suède;UPPSALA UNIVERSITET;Uppsala Universitet;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Pays-Bas;UNIVERSITEIT VAN AMSTERDAM;Universiteit Van Amsterdam;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;UNIVERSITE LYON 1 CLAUDE BERNARD;Universite Lyon 1 Claude Bernard;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;UNIVERSITY OF SURREY;University Of Surrey;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;Royaume-Uni;UNIVERSITY OF THE WEST OF ENGLAND, BRISTOL;University Of The West Of England, Bristol;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA1;France;UNIVERSITE PIERRE ET MARIE CURIE - PARIS 6;Universite Pierre Et Marie Curie - Paris 6;;Human Brain Project Specific Grant Agreement 1;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;;;89 000 000,00 €;Commission Européenne;01/04/2016;31/03/2018;;;;;;;;
HBP SGA2;Allemagne;BAUHAUS-UNIVERSITAET WEIMAR;Bauhaus-Universitaet Weimar;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suisse;CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS;Centre Hospitalier Universitaire Vaudois;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;BERGISCHE UNIVERSITAET WUPPERTAL;Bergische Universitaet Wuppertal;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;CARDIFF UNIVERSITY;Cardiff University;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;CINECA CONSORZIO INTERUNIVERSITARIO;Cineca Consorzio Interuniversitario;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;DE MONTFORT UNIVERSITY;De Montfort University;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;ECOLE NORMALE SUPERIEURE;Ecole Normale Superieure;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV;Deutsches Zentrum Fur Neurodegenerative Erkrankungen Ev;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Finlande;AALTO KORKEAKOULUSAATIO SR;Aalto Korkeakoulusaatio Sr;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Belgique;KATHOLIEKE UNIVERSITEIT LEUVEN;Katholieke Universiteit Leuven;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION;Barcelona Supercomputing Center - Centro Nacional De Supercomputacion;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE;Institut Du Cerveau Et De La Moelle Epiniere;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Grèce;ATHENS UNIVERSITY OF ECONOMICS AND BUSINESS - RESEARCH CENTER;Athens University Of Economics And Business - Research Center;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Israël;Bloomfield Science Museum Jerusalem (BSMJ);Bloomfield Science Museum Jerusalem (Bsmj);;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE;Imperial College Of Science Technology And Medicine;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER;Consorci Institut D'Investigacions Biomediques August Pi I Sunyer;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE;Institut National De Recherche En Informatique Et Automatique;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;KING'S COLLEGE LONDON;King'S College London;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Slovénie;INSTITUT JOZEF STEFAN;Institut Jozef Stefan;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;FORSCHUNGSZENTRUM JULICH GMBH;Forschungszentrum Julich Gmbh;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Pays-Bas;KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW;Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;FONDAZIONE EUROPEAN BRAIN RESEARCHINSTITUTE RITA LEVI;Fondazione European Brain Researchinstitute Rita Levi;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Hongrie;DEBRECENI EGYETEM;Debreceni Egyetem;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Norvège;NORGES MILJO-OG BIOVITENSKAPLIGE UNIVERSITET;Norges Miljo-Og Biovitenskaplige Universitet;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;MIDDLESEX UNIVERSITY HIGHER EDUCATION CORPORATION;Middlesex University Higher Education Corporation;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;FORTISS GMBH;Fortiss Gmbh;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Portugal;FUNDACAO D. ANNA SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD;Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.;Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suède;KAROLINSKA INSTITUTET;Karolinska Institutet;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA;Fundacio Institut De Bioenginyeria De Catalunya;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suède;KUNGLIGA TEKNISKA HOEGSKOLAN;Kungliga Tekniska Hoegskolan;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;FZI FORSCHUNGSZENTRUM INFORMATIK;Fzi Forschungszentrum Informatik;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;ISTITUTO NAZIONALE DI FISICA NUCLEARE;Istituto Nazionale Di Fisica Nucleare;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;HEINRICH-HEINE-UNIVERSITAET DUESSELDORF;Heinrich-Heine-Universitaet Duesseldorf;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suède;LINNEUNIVERSITETET;Linneuniversitetet;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Belgique;UNIVERSITE DE LIEGE;Universite De Liege;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Israël;TEL AVIV UNIVERSITY;Tel Aviv University;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;HITS GGMBH;Hits Ggmbh;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;ISTITUTO SUPERIORE DI SANITA;Istituto Superiore Di Sanita;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;HUMBOLDT-UNIVERSITAET ZU BERLIN;Humboldt-Universitaet Zu Berlin;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Grèce;ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON;Ethniko Kai Kapodistriako Panepistimio Athinon;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;JOHANN WOLFGANG GOETHE UNIVERSITAT FRANKFURT AM MAIN;Johann Wolfgang Goethe Universitat Frankfurt Am Main;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Autriche;TECHNISCHE UNIVERSITAET GRAZ;Technische Universitaet Graz;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Autriche;OSTERREICHISCHE STUDIENGESELLSCHAFTFUR KYBERNETIK VEREIN;Osterreichische Studiengesellschaftfur Kybernetik Verein;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Autriche;MEDIZINISCHE UNIVERSITAT INNSBRUCK;Medizinische Universitat Innsbruck;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN;The University Court Of The University Of Aberdeen;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;KARLSRUHER INSTITUT FUER TECHNOLOGIE;Karlsruher Institut Fuer Technologie;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;LABORATORIO EUROPEO DI SPETTROSCOPIE NON LINEARI;Laboratorio Europeo Di Spettroscopie Non Lineari;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Autriche;INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA;Institute Of Science And Technology Austria;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suisse;SIB INSTITUT SUISSE DE BIOINFORMATIQUE;Sib Institut Suisse De Bioinformatique;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Israël;THE HEBREW UNIVERSITY OF JERUSALEM;The Hebrew University Of Jerusalem;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;POLITECNICO DI TORINO;Politecnico Di Torino;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;Central Repository for Digital Pathology | BIGPICTURE Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA2;Espagne;UNIVERSIDAD AUTONOMA DE MADRID;Universidad Autonoma De Madrid;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;SCUOLA NORMALE SUPERIORE;Scuola Normale Superiore;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Hongrie;KIRSERLETI ORVOSTUDOMANYI KUTATOINTEZET;Kirserleti Orvostudomanyi Kutatointezet;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA;Scuola Superiore Di Studi Universitari E Di Perfezionamento S Anna;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suisse;UNIVERSITAET BERN;Universitaet Bern;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Belgique;UNIVERSITEIT ANTWERPEN;Universiteit Antwerpen;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN;Rheinisch-Westfaelische Technische Hochschule Aachen;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;UNIVERSIDAD DE CASTILLA - LA MANCHA;Universidad De Castilla - La Mancha;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;THE UNIVERSITY OF HERTFORDSHIRE HIGHER EDUCATION CORPORATION;The University Of Hertfordshire Higher Education Corporation;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suisse;Universität Basel;Universität Basel;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;UNIVERSIDAD DE GRANADA;Universidad De Granada;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG;Ruprecht-Karls-Universitaet Heidelberg;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Pays-Bas;STICHTING NEDERLANDSE WETENSCHAPPELIJK ONDERZOEK INSTITUTEN;Stichting Nederlandse Wetenschappelijk Onderzoek Instituten;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;UNIVERSITA DEGLI STUDI DI MILANO;Universita Degli Studi Di Milano;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;THE UNIVERSITY OF MANCHESTER;The University Of Manchester;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;TECHNISCHE UNIVERSITAET DRESDEN;Technische Universitaet Dresden;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Danemark;FONDEN TEKNOLOGIRADET;Fonden Teknologiradet;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suisse;UNIVERSITE DE GENEVE;Universite De Geneve;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Israël;WEIZMANN INSTITUTE OF SCIENCE;Weizmann Institute Of Science;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;TECHNISCHE UNIVERSITAET MUENCHEN;Technische Universitaet Muenchen;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;TECHNISCHE UNIVERSITAT DARMSTADT;Technische Universitat Darmstadt;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Pays-Bas;STICHTING RADBOUD UNIVERSITEIT;Stichting Radboud Universiteit;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;THE UNIVERSITY OF SHEFFIELD;The University Of Sheffield;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;UNIVERSIDAD POLITECNICA DE MADRID;Universidad Politecnica De Madrid;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suisse;University of Zurich;University Of Zurich;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;THE UNIVERSITY OF SUSSEX;The University Of Sussex;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Pays-Bas;STICHTING VU;Stichting Vu;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Norvège;UNIVERSITETET I OSLO;Universitetet I Oslo;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Finlande;TAMPEREEN KORKEAKOULUSAATIO SR;Tampereen Korkeakoulusaatio Sr;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Italie;UNIVERSITA DEGLI STUDI DI PAVIA;Universita Degli Studi Di Pavia;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Portugal;UNIVERSIDADE DO MINHO;Universidade Do Minho;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Belgique;UNIVERSITEIT GENT;Universiteit Gent;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;UNIVERSITAET BIELEFELD;Universitaet Bielefeld;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;UNIVERSIDAD POMPEU FABRA;Universidad Pompeu Fabra;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;UNIVERSITY COLLEGE LONDON;University College London;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Turquie;SABANCI UNIVERSITESI;Sabanci Universitesi;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;UNIVERSITAET HAMBURG;Universitaet Hamburg;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Danemark;DANMARKS TEKNISKE UNIVERSITET;Danmarks Tekniske Universitet;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;SORBONNE UNIVERSITE;Sorbonne Universite;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;UNIVERSIDAD REY JUAN CARLOS;Universidad Rey Juan Carlos;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;UNIVERSITAETSKLINIKUM AACHEN;Universitaetsklinikum Aachen;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Pays-Bas;UNIVERSITEIT MAASTRICHT;Universiteit Maastricht;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis | HERCULES Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA2;Royaume-Uni;UNIVERSITY OF GLASGOW;University Of Glasgow;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;UNIVERSITE DE BORDEAUX;Universite De Bordeaux;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Allemagne;UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF;Universitaetsklinikum Hamburg-Eppendorf;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Espagne;UNIVERSITAT DE BARCELONA;Universitat De Barcelona;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;coordinateur;;;;;
HBP SGA2;Royaume-Uni;UNIVERSITY OF LEEDS;University Of Leeds;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suède;UPPSALA UNIVERSITET;Uppsala Universitet;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Pays-Bas;UNIVERSITEIT VAN AMSTERDAM;Universiteit Van Amsterdam;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;France;UNIVERSITE LYON 1 CLAUDE BERNARD;Universite Lyon 1 Claude Bernard;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Grèce;POLYTECHNEIO KRITIS;Polytechneio Kritis;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;http://cordis.europa.eu/project/id/687681;;
HBP SGA2;Royaume-Uni;UNIVERSITY OF SURREY;University Of Surrey;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Royaume-Uni;UNIVERSITY OF THE WEST OF ENGLAND, BRISTOL;University Of The West Of England, Bristol;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA2;Suisse;ZUERICH;Zuerich;;Human Brain Project Specific Grant Agreement 2;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;artificial intelligence;;88 000 000,00 €;Commission Européenne;01/04/2018;31/03/2020;;;;;;;;
HBP SGA3;Suisse;CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS;Centre Hospitalier Universitaire Vaudois;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;BERGISCHE UNIVERSITAET WUPPERTAL;Bergische Universitaet Wuppertal;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;France;CENTRE HOSPITALIER REGIONAL DE MARSEILLE ASSISTANCE PUBLIQUE-HOPITAUX MARSEILLE;Centre Hospitalier Regional De Marseille Assistance Publique-Hopitaux Marseille;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;France;CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE;Centre Hospitalier Regional Et Universitaire De Lille;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;Virus-X: Viral Metagenomics for Innovation Value | Virus-X Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;France;CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE;Centre Hospitalier Universitaire De Grenoble;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Belgique;EBRAINS;Ebrains;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Italie;CINECA CONSORZIO INTERUNIVERSITARIO;Cineca Consorzio Interuniversitario;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Royaume-Uni;DE MONTFORT UNIVERSITY;De Montfort University;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;Charité - Universitätsmedizin Berlin;Charité - Universitätsmedizin Berlin;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;France;ECOLE NORMALE SUPERIEURE;Ecole Normale Superieure;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Suisse;EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH;Eidgenoessische Technische Hochschule Zuerich;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV;Deutsches Zentrum Fur Neurodegenerative Erkrankungen Ev;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Belgique;KATHOLIEKE UNIVERSITEIT LEUVEN;Katholieke Universiteit Leuven;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Pays-Bas;ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM;Erasmus Universitair Medisch Centrum Rotterdam;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;Next generation precision antibody profiling - from science fiction to reality | TopSpec Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;France;INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE;Institut Du Cerveau Et De La Moelle Epiniere;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Espagne;BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION;Barcelona Supercomputing Center - Centro Nacional De Supercomputacion;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Royaume-Uni;IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE;Imperial College Of Science Technology And Medicine;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Grèce;ATHENS UNIVERSITY OF ECONOMICS AND BUSINESS - RESEARCH CENTER;Athens University Of Economics And Business - Research Center;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Espagne;CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER;Consorci Institut D'Investigacions Biomediques August Pi I Sunyer;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;France;INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE;Institut National De Recherche En Informatique Et Automatique;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Pays-Bas;KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW;Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;ALgorithms for PAngenome Computational Analysis | ALPACA Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Allemagne;FORSCHUNGSZENTRUM JULICH GMBH;Forschungszentrum Julich Gmbh;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Norvège;NORGES MILJO-OG BIOVITENSKAPLIGE UNIVERSITET;Norges Miljo-Og Biovitenskaplige Universitet;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;FORTISS GMBH;Fortiss Gmbh;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Grèce;ATHINA-EREVNITIKO KENTRO KAINOTOMIAS STIS TECHNOLOGIES TIS PLIROFORIAS, TON EPIKOINONION KAI TIS GNOSIS;Athina-Erevnitiko Kentro Kainotomias Stis Technologies Tis Pliroforias, Ton Epikoinonion Kai Tis Gnosis;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Italie;FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA;Fondazione Istituto Italiano Di Tecnologia;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Suède;KAROLINSKA INSTITUTET;Karolinska Institutet;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.;Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Espagne;FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA;Fundacio Institut De Bioenginyeria De Catalunya;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Suède;KUNGLIGA TEKNISKA HOEGSKOLAN;Kungliga Tekniska Hoegskolan;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;FZI FORSCHUNGSZENTRUM INFORMATIK;Fzi Forschungszentrum Informatik;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;GEORG-AUGUST-UNIVERSITAT GOTTINGEN STIFTUNG OFFENTLICHEN RECHTS;Georg-August-Universitat Gottingen Stiftung Offentlichen Rechts;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;HEINRICH-HEINE-UNIVERSITAET DUESSELDORF;Heinrich-Heine-Universitaet Duesseldorf;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Italie;ISTITUTO NAZIONALE DI FISICA NUCLEARE;Istituto Nazionale Di Fisica Nucleare;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;Training European Experts in Inflammation: from the molecular players to animal models and the bedside | INFLANET Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Suède;LINNEUNIVERSITETET;Linneuniversitetet;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Israël;TEL AVIV UNIVERSITY;Tel Aviv University;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Belgique;UNIVERSITE DE LIEGE;Universite De Liege;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;HITS GGMBH;Hits Ggmbh;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;HOCHSCHULE STRALSUND;Hochschule Stralsund;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;HUMBOLDT-UNIVERSITAET ZU BERLIN;Humboldt-Universitaet Zu Berlin;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Italie;ISTITUTO SUPERIORE DI SANITA;Istituto Superiore Di Sanita;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Grèce;ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON;Ethniko Kai Kapodistriako Panepistimio Athinon;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Italie;LABORATORIO EUROPEO DI SPETTROSCOPIE NON LINEARI;Laboratorio Europeo Di Spettroscopie Non Lineari;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Suisse;SICHH SWISS INTEGRATIVE CENTER FOR HUMAN HEALTH SA;Sichh Swiss Integrative Center For Human Health Sa;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Italie;POLITECNICO DI MILANO;Politecnico Di Milano;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine | TranSYS Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Italie;POLITECNICO DI TORINO;Politecnico Di Torino;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Israël;THE HEBREW UNIVERSITY OF JERUSALEM;The Hebrew University Of Jerusalem;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Autriche;TECHNISCHE UNIVERSITAET GRAZ;Technische Universitaet Graz;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Italie;SCUOLA INTERNAZIONALE SUPERIORE DI STUDI AVANZATI DI TRIESTE;Scuola Internazionale Superiore Di Studi Avanzati Di Trieste;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Autriche;MEDIZINISCHE UNIVERSITAT INNSBRUCK;Medizinische Universitat Innsbruck;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Espagne;UNIVERSIDAD AUTONOMA DE MADRID;Universidad Autonoma De Madrid;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Suisse;UNIVERSITAET BERN;Universitaet Bern;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Autriche;CONVELOP - COOPERATIVE KNOWLEDGE DESIGN GMBH;Convelop - Cooperative Knowledge Design Gmbh;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Italie;SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA;Scuola Superiore Di Studi Universitari E Di Perfezionamento S Anna;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN;Rheinisch-Westfaelische Technische Hochschule Aachen;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Pays-Bas;STICHTING KATHOLIEKE UNIVERSITEIT;Stichting Katholieke Universiteit;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;Elucidating the role of m6A RNA methylation on the replication and pathogenesis of influenza A virus. | IAV-m6A Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Belgique;UNIVERSITEIT ANTWERPEN;Universiteit Antwerpen;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Lyssavirus, épidémiologie et neuropathologie;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;MAnufacturing of TUmour-REactive Natural Killer cells | MATURE-NK Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Espagne;UNIVERSIDAD DE CASTILLA - LA MANCHA;Universidad De Castilla - La Mancha;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Royaume-Uni;THE UNIVERSITY OF HERTFORDSHIRE HIGHER EDUCATION CORPORATION;The University Of Hertfordshire Higher Education Corporation;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Suisse;Universität Basel;Universität Basel;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Espagne;UNIVERSIDAD DE GRANADA;Universidad De Granada;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Italie;UNIVERSITA DEGLI STUDI DI MILANO;Universita Degli Studi Di Milano;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG;Ruprecht-Karls-Universitaet Heidelberg;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Pays-Bas;STICHTING NEDERLANDSE WETENSCHAPPELIJK ONDERZOEK INSTITUTEN;Stichting Nederlandse Wetenschappelijk Onderzoek Instituten;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Hongrie;KIRSERLETI ORVOSTUDOMANYI KUTATOINTEZET;Kirserleti Orvostudomanyi Kutatointezet;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Royaume-Uni;THE UNIVERSITY OF MANCHESTER;The University Of Manchester;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;TECHNISCHE UNIVERSITAET DRESDEN;Technische Universitaet Dresden;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Danemark;FONDEN TEKNOLOGIRADET;Fonden Teknologiradet;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Italie;UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II;Universita Degli Studi Di Napoli Federico Ii;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Grèce;IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON;Idryma Iatroviologikon Ereunon Akademias Athinon;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Israël;WEIZMANN INSTITUTE OF SCIENCE;Weizmann Institute Of Science;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease | ImageInLife Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Allemagne;TECHNISCHE UNIVERSITAET MUENCHEN;Technische Universitaet Muenchen;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Royaume-Uni;THE UNIVERSITY OF SHEFFIELD;The University Of Sheffield;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Espagne;UNIVERSIDAD POLITECNICA DE MADRID;Universidad Politecnica De Madrid;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;TECHNISCHE UNIVERSITAT DARMSTADT;Technische Universitat Darmstadt;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Royaume-Uni;THE UNIVERSITY OF SUSSEX;The University Of Sussex;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Pays-Bas;STICHTING VU;Stichting Vu;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Italie;UNIVERSITA DEGLI STUDI DI PAVIA;Universita Degli Studi Di Pavia;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Norvège;UNIVERSITETET I OSLO;Universitetet I Oslo;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Royaume-Uni;UNIVERSITY COLLEGE LONDON;University College London;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Espagne;UNIVERSIDAD POMPEU FABRA;Universidad Pompeu Fabra;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;UNIVERSITAET HAMBURG;Universitaet Hamburg;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Belgique;UNIVERSITEIT GENT;Universiteit Gent;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Danemark;DANMARKS TEKNISKE UNIVERSITET;Danmarks Tekniske Universitet;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Portugal;UNIVERSIDADE DO MINHO;Universidade Do Minho;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Italie;UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA;Universita Degli Studi Di Roma La Sapienza;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Finlande;TAMPEREEN KORKEAKOULUSAATIO SR;Tampereen Korkeakoulusaatio Sr;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;UNIVERSITAETSKLINIKUM AACHEN;Universitaetsklinikum Aachen;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Espagne;UNIVERSIDAD REY JUAN CARLOS;Universidad Rey Juan Carlos;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;Unraveling Principles of PDZ-mediated Cell Signaling | PDZnet Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Royaume-Uni;UNIVERSITY OF GLASGOW;University Of Glasgow;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;UNIVERSITAETSKLINIKUM FREIBURG;Universitaetsklinikum Freiburg;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;France;UNIVERSITE DE BORDEAUX;Universite De Bordeaux;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF;Universitaetsklinikum Hamburg-Eppendorf;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Pays-Bas;UNIVERSITEIT MAASTRICHT;Universiteit Maastricht;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Allemagne;UNIVERSITAT TRIER;Universitat Trier;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Espagne;UNIVERSITAT DE BARCELONA;Universitat De Barcelona;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;France;UNIVERSITE GRENOBLE ALPES;Universite Grenoble Alpes;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;France;UNIVERSITE LYON 1 CLAUDE BERNARD;Universite Lyon 1 Claude Bernard;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;VIral and BacteRial Adhesin Network Training | ViBrANT Project | H2020 | CORDIS | European Commission (europa.eu);;
HBP SGA3;Pays-Bas;UNIVERSITEIT VAN AMSTERDAM;Universiteit Van Amsterdam;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Suède;UPPSALA UNIVERSITET;Uppsala Universitet;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;;;Grant Manager 1052;;;
HBP SGA3;Royaume-Uni;UNIVERSITY OF THE WEST OF ENGLAND, BRISTOL;University Of The West Of England, Bristol;;Human Brain Project Specific Grant Agreement 3;Projet scientifique;research infrastructure;neurosciences;neuroinformatics;data;;150 000 000,00 €;Commission Européenne;01/04/2020;31/03/2023;;;coordinateur;;Grant Manager 1052;;;
IS_MIRRI21;Portugal;Associação CCG/ZGDV - Centro de Computação Gráfica;Associação Ccg/Zgdv - Centro De Computação Gráfica;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 €;Commission Européenne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Pologne;INSTYTUT BIOTECHNOLOGII PRZEMYSLU ROLNO-SPOZYWCZEGO IM PROF WACLAWA DABROWSKIEGO - PANSTWOWY INSTYTUT BADAWCZY;Instytut Biotechnologii Przemyslu Rolno-Spozywczego Im Prof Waclawa Dabrowskiego - Panstwowy Instytut Badawczy;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 €;Commission Européenne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Lettonie;LATVIJAS UNIVERSITATE;Latvijas Universitate;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 €;Commission Européenne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Pays-Bas;"KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW;Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 €;Commission Européenne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;France;INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT;Institut National De Recherche Pour L'Agriculture, L'Alimentation Et L'Environnement;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 €;Commission Européenne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Belgique;Service Public Fédéral de Programmation Politique Scientifique (Belspo);Service Public Fédéral De Programmation Politique Scientifique (Belspo);;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 €;Commission Européenne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Russie;INSTITUT OF THE RUSSIAN ACADEMY OF SCIENCES SKRYABIN INSTITUTE OF BIOCHEMISTRY AND PHYSIOLOGY OF MICROORGANISMS RAS;Institut Of The Russian Academy Of Sciences Skryabin Institute Of Biochemistry And Physiology Of Microorganisms Ras;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 €;Commission Européenne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Grèce;ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON;Ethniko Kai Kapodistriako Panepistimio Athinon;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 €;Commission Européenne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Collection de l'Institut Pasteur;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 €;Commission Européenne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Centre de Ressources Biologiques de l'Institut Pasteur;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 €;Commission Européenne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Collection Nle Cultures Micro-organismes;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 €;Commission Européenne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Espagne;UNIVERSIDAD DE LAS PALMAS DE GRAN CANARIA;Universidad De Las Palmas De Gran Canaria;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 €;Commission Européenne;01/02/2020;31/01/2023;;;;;;Versatile Emerging infectious disease Observatory | VEO Project | H2020 | CORDIS | European Commission (europa.eu);;
IS_MIRRI21;Portugal;SOCIEDADE PORTUGUESA DE INOVACAO CONSULTADORIA EMPRESARIAL E FOMENTO DA INOVACAO SA;Sociedade Portuguesa De Inovacao Consultadoria Empresarial E Fomento Da Inovacao Sa;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 €;Commission Européenne;01/02/2020;31/01/2023;;;coordinateur;;;;;
IS_MIRRI21;Portugal;UNIVERSIDADE DO MINHO;Universidade Do Minho;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 €;Commission Européenne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Italie;UNIVERSITA DEGLI STUDI DI TORINO;Universita Degli Studi Di Torino;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 €;Commission Européenne;01/02/2020;31/01/2023;;;;;;;;
IS_MIRRI21;Espagne;UNIVERSITAT DE VALENCIA;Universitat De Valencia;;Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century;Projet scientifique;infrastucture;data ;biotechnology;;;4 914 855,71 €;Commission Européenne;01/02/2020;31/01/2023;;;;;;;;
DECIDER;Italie;AB ANALITICA SRL;Ab Analitica Srl;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 €;Commission Européenne;01/02/2021;31/01/2026;;;;;Grant Manager 1095;;;
DECIDER;Finlande;AIFORIA TECHNOLOGIES OY;Aiforia Technologies Oy;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 €;Commission Européenne;01/02/2021;31/01/2026;;;;;Grant Manager 1095;;;
DECIDER;Finlande;HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ;Helsingin Ja Uudenmaan Sairaanhoitopiirin Kuntayhtymä;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 €;Commission Européenne;01/02/2021;31/01/2026;;;;;Grant Manager 1095;;;
DECIDER;Espagne;BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION;Barcelona Supercomputing Center - Centro Nacional De Supercomputacion;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 €;Commission Européenne;01/02/2021;31/01/2026;;;;;Grant Manager 1095;;;
DECIDER;Danemark;KRAEFTENS BEKAEMPELSE;Kraeftens Bekaempelse;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 €;Commission Européenne;01/02/2021;31/01/2026;;;;;Grant Manager 1095;;;
DECIDER;Suède;KAROLINSKA INSTITUTET;Karolinska Institutet;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 €;Commission Européenne;01/02/2021;31/01/2026;;;coordinateur;;Grant Manager 1095;;;
DECIDER;Espagne;FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA);Fundacio Institut De Recerca Biomedica (Irb Barcelona);;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 €;Commission Européenne;01/02/2021;31/01/2026;;;;;Grant Manager 1095;;;
DECIDER;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 €;Commission Européenne;01/02/2021;31/01/2026;;;;;Grant Manager 1095;;;
DECIDER;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie computationnelle;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 €;Commission Européenne;01/02/2021;31/01/2026;;;;;Grant Manager 1095;;;
DECIDER;Italie;UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA;Universita Degli Studi Di Modena E Reggio Emilia;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 €;Commission Européenne;01/02/2021;31/01/2026;;;;;Grant Manager 1095;;;
DECIDER;Finlande;VARSINAIS-SUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA;Varsinais-Suomen Sairaanhoitopiirin Kuntayhtyma;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 €;Commission Européenne;01/02/2021;31/01/2026;;;;;Grant Manager 1095;;;
DECIDER;Allemagne;UNIVERSITATSKLINIKUM HEIDELBERG;Universitatsklinikum Heidelberg;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 €;Commission Européenne;01/02/2021;31/01/2026;;;;;Grant Manager 1095;;;
DECIDER;Danemark;2CUREX A/S;2Curex A/S;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 €;Commission Européenne;01/02/2021;31/01/2026;;;;;Grant Manager 1095;;;
DECIDER;Finlande;VEIL.AI OY;Veil.Ai Oy;;Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer;Projet scientifique;ovarian cancer;data ;;;;14 999 335,00 €;Commission Européenne;01/02/2021;31/01/2026;;;;;Grant Manager 1095;;;
ARBOsurv;Espagne;INMUNOLOGIA Y GENETICA APLICADA SA;Inmunologia Y Genetica Aplicada Sa;;Improving surveillance and control of arboviral diseases of animals in the Euro-African interface;Projet scientifique;Infectious diseases;animal diagnostics;animal health;;;5 964 650,00 €;Commission Européenne;08/09/2020;08/09/2020;;;Coordinateur;Financement rejeté;1217;;;
INCENTIVE;Allemagne;ASA SPEZIALENZYME GMBH;Asa Spezialenzyme Gmbh;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;coordinateur;;Grant Manager 691;;;
INCENTIVE;France;BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE;Bioaster Fondation De Cooperation Scientifique;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;Suisse;EUROVACC FOUNDATION;Eurovacc Foundation;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;Etats-Unis;HUMAN VACCINES PROJECT, INC;Human Vaccines Project, Inc;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;Espagne;FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA;Fundacion Privada Instituto De Salud Global Barcelona;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;Allemagne;HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH;Helmholtz-Zentrum Fur Infektionsforschung Gmbh;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;Pays-Bas;STICHTING HUMAN VACCINES PROJECT EUROPE;Stichting Human Vaccines Project Europe;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;Belgique;UNIVERSITE LIBRE DE BRUXELLES;Universite Libre De Bruxelles;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;Belgique;UNIVERSITEIT ANTWERPEN;Universiteit Antwerpen;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;Inde;INDIAN INSTITUTE OF TECHNOLOGY MADRAS (IITM);Indian Institute Of Technology Madras (Iitm);;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;Inde;NATIONAL INSTITUTE OF IMMUNOLOGY SOCIETY;National Institute Of Immunology Society;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;Inde;PUBLIC HEALTH FOUNDATION OF INDIA;Public Health Foundation Of India;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;Inde;SETH G S M COLLEGE AND K E M HOSPITAL DIAMOND JUBILEE SOCIETY;Seth G S M College And K E M Hospital Diamond Jubilee Society;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;Inde;TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE;Translational Health Science And Technology Institute;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;Norvège;UNIVERSITETET I BERGEN;Universitetet I Bergen;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;Etats-Unis;UGA RESEARCH FOUNDATION INC NON PROFIT CORP;Uga Research Foundation Inc Non Profit Corp;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;;;
INCENTIVE;Norvège;UNIVERSITETET I OSLO;Universitetet I Oslo;;Indo-European Consortium for Next Generation Influenza Vaccine Innovation;Projet scientifique;Influenza;vaccines;nucleic acid;clinical trial;;9 974 293,73 €;Commission Européenne;01/08/2020;31/07/2025;;;;;Grant Manager 691;Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries. | Ebola_Tx Project | H2020 | CORDIS | European Commission (europa.eu);;
InSCEMiX;Corée du Sud;Institut Pasteur Korea;Institut Pasteur Korea;;Inhibitor Screening, Cryo-Electron Microscopy, X-ray studies of CyaA;Projet scientifique;Whooping cough;biophysics;bio informatic;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
InSCEMiX;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biochimie des Interactions Macromoléculaires;Inhibitor Screening, Cryo-Electron Microscopy, X-ray studies of CyaA;Projet scientifique;Whooping cough;biophysics;bio informatic;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;;
InSCEMiX;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Technologie et service Biolmagerie Ultrastructurale ( UTechS UBI);Inhibitor Screening, Cryo-Electron Microscopy, X-ray studies of CyaA;Projet scientifique;Whooping cough;biophysics;bio informatic;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
InSCEMiX;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Plateforme Cristallographie;Inhibitor Screening, Cryo-Electron Microscopy, X-ray studies of CyaA;Projet scientifique;Whooping cough;biophysics;bio informatic;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
InSCEMiX;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Plateforme de Biophysique Moléculaire  ;Inhibitor Screening, Cryo-Electron Microscopy, X-ray studies of CyaA;Projet scientifique;Whooping cough;biophysics;bio informatic;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
InSCEMiX;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Plateforme Technologique de RMN Biologique  ;Inhibitor Screening, Cryo-Electron Microscopy, X-ray studies of CyaA;Projet scientifique;Whooping cough;biophysics;bio informatic;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
InSCEMiX;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Bio-Informatique Structurale  ;Inhibitor Screening, Cryo-Electron Microscopy, X-ray studies of CyaA;Projet scientifique;Whooping cough;biophysics;bio informatic;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
ICEI;Allemagne;BAUHAUS-UNIVERSITAET WEIMAR;Bauhaus-Universitaet Weimar;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders | COSYN Project | H2020 | CORDIS | European Commission (europa.eu);;
ICEI;Suisse;CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS;Centre Hospitalier Universitaire Vaudois;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;BERGISCHE UNIVERSITAET WUPPERTAL;Bergische Universitaet Wuppertal;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;CARDIFF UNIVERSITY;Cardiff University;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;CINECA CONSORZIO INTERUNIVERSITARIO;Cineca Consorzio Interuniversitario;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;DE MONTFORT UNIVERSITY;De Montfort University;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;Commissariat A L Energie Atomique Et Aux Energies Alternatives;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;ECOLE NORMALE SUPERIEURE;Ecole Normale Superieure;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suisse;EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH;Eidgenoessische Technische Hochschule Zuerich;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV;Deutsches Zentrum Fur Neurodegenerative Erkrankungen Ev;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Finlande;AALTO KORKEAKOULUSAATIO SR;Aalto Korkeakoulusaatio Sr;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Belgique;KATHOLIEKE UNIVERSITEIT LEUVEN;Katholieke Universiteit Leuven;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;Population genomics of co-evolution between non-retroviral RNA viruses and their hosts | NIRV_HOST_INT Project | H2020 | CORDIS | European Commission (europa.eu);;
ICEI;France;INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE;Institut Du Cerveau Et De La Moelle Epiniere;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;Zika Preparedness Latin American Network | ZikaPLAN Project | H2020 | CORDIS | European Commission (europa.eu);;
ICEI;Israël;Bloomfield Science Museum Jerusalem (BSMJ);Bloomfield Science Museum Jerusalem (Bsmj);;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE;Imperial College Of Science Technology And Medicine;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION;Barcelona Supercomputing Center - Centro Nacional De Supercomputacion;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER;Consorci Institut D'Investigacions Biomediques August Pi I Sunyer;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Grèce;ATHENS UNIVERSITY OF ECONOMICS AND BUSINESS - RESEARCH CENTER;Athens University Of Economics And Business - Research Center;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;KING'S COLLEGE LONDON;King'S College London;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Slovénie;INSTITUT JOZEF STEFAN;Institut Jozef Stefan;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE;Institut National De Recherche En Informatique Et Automatique;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Pays-Bas;KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW;Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;FONDAZIONE EUROPEAN BRAIN RESEARCHINSTITUTE RITA LEVI;Fondazione European Brain Researchinstitute Rita Levi;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;FORSCHUNGSZENTRUM JULICH GMBH;Forschungszentrum Julich Gmbh;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;MIDDLESEX UNIVERSITY HIGHER EDUCATION CORPORATION;Middlesex University Higher Education Corporation;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Norvège;NORGES MILJO-OG BIOVITENSKAPLIGE UNIVERSITET;Norges Miljo-Og Biovitenskaplige Universitet;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;FORTISS GMBH;Fortiss Gmbh;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.;Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suède;KAROLINSKA INSTITUTET;Karolinska Institutet;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA;Fundacio Institut De Bioenginyeria De Catalunya;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suède;KUNGLIGA TEKNISKA HOEGSKOLAN;Kungliga Tekniska Hoegskolan;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Hongrie;DEBRECENI EGYETEM;Debreceni Egyetem;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;FZI FORSCHUNGSZENTRUM INFORMATIK;Fzi Forschungszentrum Informatik;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Portugal;FUNDACAO D. ANNA SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD;Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;HEINRICH-HEINE-UNIVERSITAET DUESSELDORF;Heinrich-Heine-Universitaet Duesseldorf;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;ISTITUTO NAZIONALE DI FISICA NUCLEARE;Istituto Nazionale Di Fisica Nucleare;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suède;LINNEUNIVERSITETET;Linneuniversitetet;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;Expanding research infrastructure visibility to strengthen strategic partnerships | RI-VIS Project | H2020 | CORDIS | European Commission (europa.eu);;RI-VIS will increase the visibility of European RIs to broader scientific communities, industry and strategic partners in third countries
ICEI;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;HITS GGMBH;Hits Ggmbh;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;HUMBOLDT-UNIVERSITAET ZU BERLIN;Humboldt-Universitaet Zu Berlin;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;ISTITUTO SUPERIORE DI SANITA;Istituto Superiore Di Sanita;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Israël;TEL AVIV UNIVERSITY;Tel Aviv University;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Belgique;UNIVERSITE DE LIEGE;Universite De Liege;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;JOHANN WOLFGANG GOETHE UNIVERSITAT FRANKFURT AM MAIN;Johann Wolfgang Goethe Universitat Frankfurt Am Main;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;KARLSRUHER INSTITUT FUER TECHNOLOGIE;Karlsruher Institut Fuer Technologie;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN;The University Court Of The University Of Aberdeen;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Grèce;ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON;Ethniko Kai Kapodistriako Panepistimio Athinon;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suisse;SIB INSTITUT SUISSE DE BIOINFORMATIQUE;Sib Institut Suisse De Bioinformatique;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;LABORATORIO EUROPEO DI SPETTROSCOPIE NON LINEARI;Laboratorio Europeo Di Spettroscopie Non Lineari;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics – Sofia ref.: 115843 | EbolaMoDRAD Project | H2020 | CORDIS | European Commission (europa.eu);;The overall aim of EbolaMoDRAD was to develop and deliver rapid and bedside diagnostic tool(s) that will significantly increase our capacity to handle the Ebola Virus Disease (EVD) in West Africa and also future outbreaks. 
ICEI;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Israël;THE HEBREW UNIVERSITY OF JERUSALEM;The Hebrew University Of Jerusalem;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;POLITECNICO DI TORINO;Politecnico Di Torino;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;SCUOLA NORMALE SUPERIORE;Scuola Normale Superiore;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;UNIVERSIDAD AUTONOMA DE MADRID;Universidad Autonoma De Madrid;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA;Scuola Superiore Di Studi Universitari E Di Perfezionamento S Anna;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suisse;UNIVERSITAET BERN;Universitaet Bern;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN;Rheinisch-Westfaelische Technische Hochschule Aachen;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Belgique;UNIVERSITEIT ANTWERPEN;Universiteit Antwerpen;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;UNIVERSIDAD DE CASTILLA - LA MANCHA;Universidad De Castilla - La Mancha;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;UNIVERSIDAD DE GRANADA;Universidad De Granada;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;THE UNIVERSITY OF HERTFORDSHIRE HIGHER EDUCATION CORPORATION;The University Of Hertfordshire Higher Education Corporation;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Autriche;TECHNISCHE UNIVERSITAET GRAZ;Technische Universitaet Graz;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suisse;Universität Basel;Universität Basel;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG;Ruprecht-Karls-Universitaet Heidelberg;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;UNIVERSITA DEGLI STUDI DI MILANO;Universita Degli Studi Di Milano;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Autriche;OSTERREICHISCHE STUDIENGESELLSCHAFTFUR KYBERNETIK VEREIN;Osterreichische Studiengesellschaftfur Kybernetik Verein;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy | EMBRIC Project | H2020 | CORDIS | European Commission (europa.eu);;"The objectives of EMBRIC are to: (1) develop integrated workflows of high quality services for access to biological, analytical and data resources, and deploy common underpinning technologies and practices; (2) strengthen the connection of science with industry by engaging companies and by federating technology transfer (TT) services; (3) defragment RDI policies and involve maritime regions with the construction of EMBRIC"
ICEI;Autriche;MEDIZINISCHE UNIVERSITAT INNSBRUCK;Medizinische Universitat Innsbruck;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Autriche;INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA;Institute Of Science And Technology Austria;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;THE UNIVERSITY OF MANCHESTER;The University Of Manchester;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;TECHNISCHE UNIVERSITAET DRESDEN;Technische Universitaet Dresden;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Hongrie;KIRSERLETI ORVOSTUDOMANYI KUTATOINTEZET;Kirserleti Orvostudomanyi Kutatointezet;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Pays-Bas;STICHTING NEDERLANDSE WETENSCHAPPELIJK ONDERZOEK INSTITUTEN;Stichting Nederlandse Wetenschappelijk Onderzoek Instituten;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suisse;UNIVERSITE DE GENEVE;Universite De Geneve;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;TECHNISCHE UNIVERSITAET MUENCHEN;Technische Universitaet Muenchen;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Pays-Bas;STICHTING RADBOUD UNIVERSITEIT;Stichting Radboud Universiteit;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;THE UNIVERSITY OF SHEFFIELD;The University Of Sheffield;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suisse;University of Zurich;University Of Zurich;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;TECHNISCHE UNIVERSITAT DARMSTADT;Technische Universitat Darmstadt;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;THE UNIVERSITY OF SUSSEX;The University Of Sussex;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Pays-Bas;STICHTING VU;Stichting Vu;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;UNIVERSIDAD POLITECNICA DE MADRID;Universidad Politecnica De Madrid;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Danemark;FONDEN TEKNOLOGIRADET;Fonden Teknologiradet;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Italie;UNIVERSITA DEGLI STUDI DI PAVIA;Universita Degli Studi Di Pavia;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;UNIVERSITAET BIELEFELD;Universitaet Bielefeld;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Turquie;SABANCI UNIVERSITESI;Sabanci Universitesi;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;UNIVERSITY COLLEGE LONDON;University College London;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;UNIVERSIDAD POMPEU FABRA;Universidad Pompeu Fabra;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;SORBONNE UNIVERSITE;Sorbonne Universite;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Norvège;UNIVERSITETET I OSLO;Universitetet I Oslo;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;UNIVERSITAET HAMBURG;Universitaet Hamburg;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Israël;WEIZMANN INSTITUTE OF SCIENCE;Weizmann Institute Of Science;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Danemark;DANMARKS TEKNISKE UNIVERSITET;Danmarks Tekniske Universitet;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;UNIVERSITAETSKLINIKUM AACHEN;Universitaetsklinikum Aachen;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;UNIVERSIDAD REY JUAN CARLOS;Universidad Rey Juan Carlos;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Belgique;UNIVERSITEIT GENT;Universiteit Gent;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;Human Brain Project Specific Grant Agreement 2 | HBP SGA2 Project | H2020 | CORDIS | European Commission (europa.eu);;In the upcoming SGA2 funding period (2018-20), the HBP will continue to strengthen global brain research efforts by extending coordination with other brain initiatives and projects. Internally, it will continue its unique inter-disciplinary co-design approach, developing research infrastructure capabilities via use cases built around specific research needs.
ICEI;France;UNIVERSITE DE BORDEAUX;Universite De Bordeaux;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;UNIVERSITY OF GLASGOW;University Of Glasgow;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Allemagne;UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF;Universitaetsklinikum Hamburg-Eppendorf;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Pays-Bas;UNIVERSITEIT MAASTRICHT;Universiteit Maastricht;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Portugal;UNIVERSIDADE DO MINHO;Universidade Do Minho;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Finlande;TAMPEREEN KORKEAKOULUSAATIO SR;Tampereen Korkeakoulusaatio Sr;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;coordinateur;;;;;
ICEI;Royaume-Uni;UNIVERSITY OF LEEDS;University Of Leeds;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Suède;UPPSALA UNIVERSITET;Uppsala Universitet;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Pays-Bas;UNIVERSITEIT VAN AMSTERDAM;Universiteit Van Amsterdam;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Grèce;POLYTECHNEIO KRITIS;Polytechneio Kritis;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Espagne;UNIVERSITAT DE BARCELONA;Universitat De Barcelona;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;France;UNIVERSITE LYON 1 CLAUDE BERNARD;Universite Lyon 1 Claude Bernard;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;UNIVERSITY OF SURREY;University Of Surrey;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ICEI;Royaume-Uni;UNIVERSITY OF THE WEST OF ENGLAND, BRISTOL;University Of The West Of England, Bristol;;Interactive Computing E-Infrastructure for the Human Brain Project;Projet scientifique;neuroscience;platform;supercomputing;;;24 999 873,90 €;Commission Européenne;01/01/2018;31/03/2023;;;;;;;;
ObWein;France;Institut Imagine;Institut Imagine;;Intestinal homeostasis in the prevention of pediatric obesity and its consequences on health;Projet scientifique;Immune disorders;Inflammatory diseases;microbiota;;;50 000,00 €;Biostime Institute for Nutrition and Care;30/12/2019;29/12/2021;;;;Convention signée;Grant Manager 711;;;
ObWein;Etats-Unis;Georgia State University;Georgia State University;;Intestinal homeostasis in the prevention of pediatric obesity and its consequences on health;Projet scientifique;Immune disorders;Inflammatory diseases;microbiota;;;50 000,00 €;Biostime Institute for Nutrition and Care;30/12/2019;29/12/2021;;;Coordinateur;Convention signée;Grant Manager 711;;;
ObWein;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Microenvironnement et Immunité ;Intestinal homeostasis in the prevention of pediatric obesity and its consequences on health;Projet scientifique;Immune disorders;Inflammatory diseases;microbiota;;;50 000,00 €;Biostime Institute for Nutrition and Care;30/12/2019;29/12/2021;;;;Convention signée;Grant Manager 711;;;
ObWein;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Pathogénie Microbienne Moléculaire;Intestinal homeostasis in the prevention of pediatric obesity and its consequences on health;Projet scientifique;Immune disorders;Inflammatory diseases;microbiota;;;50 000,00 €;Biostime Institute for Nutrition and Care;30/12/2019;29/12/2021;;;;Convention signée;Grant Manager 711;;;
ObWein;France;Université d’Auvergne;Université D’Auvergne;;Intestinal homeostasis in the prevention of pediatric obesity and its consequences on health;Projet scientifique;Immune disorders;Inflammatory diseases;microbiota;;;50 000,00 €;Biostime Institute for Nutrition and Care;30/12/2019;29/12/2021;;;;Convention signée;Grant Manager 711;;;
ObWein;France;UNIVERSITE PIERRE ET MARIE CURIE - PARIS 6;Universite Pierre Et Marie Curie - Paris 6;;Intestinal homeostasis in the prevention of pediatric obesity and its consequences on health;Projet scientifique;Immune disorders;Inflammatory diseases;microbiota;;;50 000,00 €;Biostime Institute for Nutrition and Care;30/12/2019;29/12/2021;;;;Convention signée;Grant Manager 711;;;
FleaVec;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Unité de Recherche Yersinia;Investigating flea vectors towards understanding human bubonic plague persistence in Madagascar;Projet scientifique;plague;zoonoses;flea;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
FleaVec;Madagascar;Institut Pasteur de Madagascar;Institut Pasteur De Madagascar;;Investigating flea vectors towards understanding human bubonic plague persistence in Madagascar;Projet scientifique;plague;zoonoses;flea;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;;
FleaVec;France;Institut Pasteur de Lille;Institut Pasteur De Lille;;Investigating flea vectors towards understanding human bubonic plague persistence in Madagascar;Projet scientifique;plague;zoonoses;flea;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;coordinateur;;;;;
IP Guinée;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Direction internationale Pôle des opérations;IP Guinée;Institutionnelle;Création;Renforcement;;;;4 000 000,00 €;AFD;06/07/1905;;;;;;;;;
IP Guinée;Guinée;Institut Pasteur de Guinée;Institut Pasteur De Guinée;;IP Guinée;Institutionnelle;Création;Renforcement;;;;4 000 000,00 €;AFD;06/07/1905;;;;;;;;;
MATURE-NK;France;INNATE PHARMA;Innate Pharma;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 €;Commission Européenne;01/06/2018;31/05/2022;;;coordinateur;Grant Manager 26;;;;
MATURE-NK;Pays-Bas;GLYCOSTEM-THERAPEUTICS B.V.;Glycostem-Therapeutics B.V.;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 €;Commission Européenne;01/06/2018;31/05/2022;;;;Grant Manager 26;;;;
MATURE-NK;Allemagne;FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.;Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 €;Commission Européenne;01/06/2018;31/05/2022;;;;Grant Manager 26;;;;
MATURE-NK;Italie;IRCCS OSPEDALE POLICLINICO SAN MARTINO;Irccs Ospedale Policlinico San Martino;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 €;Commission Européenne;01/06/2018;31/05/2022;;;;Grant Manager 26;;;;
MATURE-NK;Norvège;OSLO UNIVERSITETSSYKEHUS HF;Oslo Universitetssykehus Hf;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 €;Commission Européenne;01/06/2018;31/05/2022;;;;Grant Manager 26;;;;
MATURE-NK;Allemagne;MEDIZINISCHE HOCHSCHULE HANNOVER;Medizinische Hochschule Hannover;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 €;Commission Européenne;01/06/2018;31/05/2022;;;;Grant Manager 26;;;;
MATURE-NK;Allemagne;MILTENYI BIOTEC BV & CO KG;Miltenyi Biotec Bv & Co Kg;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 €;Commission Européenne;01/06/2018;31/05/2022;;;;Grant Manager 26;;;;
MATURE-NK;Allemagne;MILTENYI BIOTEC GMBH ;Miltenyi Biotec Gmbh ;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 €;Commission Européenne;01/06/2018;31/05/2022;;;;Grant Manager 26;;;;
MATURE-NK;Israël;THE HEBREW UNIVERSITY OF JERUSALEM;The Hebrew University Of Jerusalem;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 €;Commission Européenne;01/06/2018;31/05/2022;;;;Grant Manager 26;;;;
MATURE-NK;Suisse;Universität Basel;Universität Basel;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 €;Commission Européenne;01/06/2018;31/05/2022;;;;Grant Manager 26;;;;
MATURE-NK;Allemagne;RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG;Ruprecht-Karls-Universitaet Heidelberg;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 €;Commission Européenne;01/06/2018;31/05/2022;;;;Grant Manager 26;;;;
MATURE-NK;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Immunité innée;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 €;Commission Européenne;01/06/2018;31/05/2022;;;;Grant Manager 26;;;;
MATURE-NK;Autriche;MEDIZINISCHE UNIVERSITAET WIEN;Medizinische Universitaet Wien;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 €;Commission Européenne;01/06/2018;31/05/2022;;;;Grant Manager 26;;;;
MATURE-NK;Espagne;UNIVERSIDAD POMPEU FABRA;Universidad Pompeu Fabra;;MAnufacturing of TUmour-REactive Natural Killer cells;Projet scientifique;biotech industry;bioinformatics;;;;3 351 662,28 €;Commission Européenne;01/06/2018;31/05/2022;;;;Grant Manager 26;;;;
MIAD;Grèce;Hellenic Pasteur Institute;Hellenic Pasteur Institute;;Microglia imaging in Alzheimer's disease;Projet scientifique;alzheimer;neurobiology;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;coordinateur;;;;;
MIAD;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Hub d'analyse d'images;Microglia imaging in Alzheimer's disease;Projet scientifique;alzheimer;neurobiology;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
MIAD;France;Institut Pasteur de Lille;Institut Pasteur De Lille;Molecular determinants of neurodegenerative diseases Laboratory;Microglia imaging in Alzheimer's disease;Projet scientifique;alzheimer;neurobiology;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
CaptoTryp;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Chimie Biologique Epigénétique;Molecular and structural tools for deciphering trypanosomatid-specific features of EIF4E in the translational machinery  ;Projet scientifique;trypanosomatid;;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;;
CaptoTryp;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Bio-Informatique Structurale;Molecular and structural tools for deciphering trypanosomatid-specific features of EIF4E in the translational machinery  ;Projet scientifique;trypanosomatid;;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
CaptoTryp;Brésil;Oswaldo Cruz Foundation (Fiocruz);Oswaldo Cruz Foundation (Fiocruz);;Molecular and structural tools for deciphering trypanosomatid-specific features of EIF4E in the translational machinery  ;Projet scientifique;trypanosomatid;;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
I-MOVE-COVID-19;France;AGENCE NATIONALE DE SANTE PUBLIQUE;Agence Nationale De Sante Publique;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;France;ASSISTANCE PUBLIQUE HOPITAUX DE PARIS;Assistance Publique Hopitaux De Paris;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;France;CENTRE HOSPITALIER UNIVERSITAIRE DE RENNES;Centre Hospitalier Universitaire De Rennes;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;France;CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER;Centre Hospitalier Universitaire Montpellier;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;Royaume-Uni;Department of Health;Department Of Health;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;Irlande;HEALTH SERVICE EXECUTIVE HSE;Health Service Executive Hse;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;coordinateur;;Grant Manager 1036;;;
I-MOVE-COVID-19;France;EPICONCEPT;Epiconcept;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;Suède;FOLKHALSOMYNDIGHETEN;Folkhalsomyndigheten;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;France;HOSPICES CIVILS DE LYON;Hospices Civils De Lyon;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;Lituanie;LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAS;Lietuvos Sveikatos Mokslu Universitetas;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;Royaume-Uni;NHS NATIONAL SERVICES SCOTLAND;Nhs National Services Scotland;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;Pays-Bas;RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU;Rijksinstituut Voor Volksgezondheid En Milieu;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;Espagne;INSTITUTO DE SALUD CARLOS III;Instituto De Salud Carlos Iii;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;Espagne;ORGANISMO AUTONOMO INSTITUTO DE SALUD PUBLICA Y LABORAL DE NAVARRA;Organismo Autonomo Instituto De Salud Publica Y Laboral De Navarra;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;Portugal;INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE;Instituto Nacional De Saude Dr. Ricardo Jorge;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;Portugal;MINISTERIO DA SAUDE - REPUBLICA PORTUGUESA;Ministerio Da Saude - Republica Portuguesa;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;Pays-Bas;STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG;Stichting Nederlands Instituut Voor Onderzoek Van De Gezondheidszorg;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;France;Institut Pasteur (Paris);Institut Pasteur (Paris);CNR Virus des infections respiratoires;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;Roumanie;INSTITUTUL NATIONAL DE CERCETARE-DEZVOLTARE MEDICO-MILITARA CANTACUZINO;Institutul National De Cercetare-Dezvoltare Medico-Militara Cantacuzino;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;Albanie;INSTITUTE OF PUBLIC HEALTH;Institute Of Public Health;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;France;SORBONNE UNIVERSITE;Sorbonne Universite;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;France;UNIVERSITE DE CORSE PASCAL PAOLI;Universite De Corse Pascal Paoli;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;Allemagne;VIENNA VACCINE SAFETY INITIATIVE EV;Vienna Vaccine Safety Initiative Ev;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
I-MOVE-COVID-19;Belgique;VRIJE UNIVERSITEIT BRUSSEL;Vrije Universiteit Brussel;;Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic;Projet scientifique;COVID-19 ;coronavirus;;;;2 849 428,32 €;Commission Européenne;16/03/2020;15/06/2022;;;;;Grant Manager 1036;;;
Neo-LIC;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Epidémiologie & modélisation de la résistance aux antimicrobiens;Neonatal acquisition of ESBL-PE in the community  of a low-income country  ;Projet scientifique;enterobacteriaceae;epidemiology;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;coordinateur;;;;;
Neo-LIC;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Hub Bioinformatique et Biostatistique;Neonatal acquisition of ESBL-PE in the community  of a low-income country  ;Projet scientifique;enterobacteriaceae;epidemiology;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
Neo-LIC;Madagascar;Institut Pasteur de Madagascar;Institut Pasteur De Madagascar;;Neonatal acquisition of ESBL-PE in the community  of a low-income country  ;Projet scientifique;enterobacteriaceae;epidemiology;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
Neovac;Sénégal;Institut Pasteur de Dakar;Institut Pasteur De Dakar;;NEOVAC;Santé publique;Hépatite;Vaccination;essai vaccinal;;;1 573 824,00 €;Fondation Total;07/07/1905;;;;;;;;;
Neovac;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Direction Scientifique Unité de Recherche et d'Expertise Epidémiologie des Maladies Emergentes;NEOVAC;Santé publique;Hépatite;Vaccination;;;;1 573 824,00 €;Fondation Total;07/07/1905;;;;;;;;;
Neovac;Burkina Faso;LAMIVAC;Lamivac;;NEOVAC;Santé publique;Hépatite;Vaccination;essai vaccinal;;;1 573 824,00 €;Fondation Total;07/07/1905;;;;;;;;;
Neovac;Madagascar;Institut Pasteur de Madagascar;Institut Pasteur De Madagascar;;NEOVAC;Santé publique;Hépatite;Vaccination;essai vaccinal;;;1 573 824,00 €;Fondation Total;07/07/1905;;;;;;;;;
NECESSITY;Pays-Bas;ACADEMISCH ZIEKENHUIS GRONINGEN;Academisch Ziekenhuis Groningen;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;France;ASSISTANCE PUBLIQUE HOPITAUX DE PARIS;Assistance Publique Hopitaux De Paris;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;France;ASSOCIATION FRANCAISE GOUGEROT-SJOGREN;Association Francaise Gougerot-Sjogren;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;France;ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK;Ecrin European Clinical Research Infrastructure Network;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;coordinateur;;Grant Manager 212;;;
NECESSITY;Royaume-Uni;GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.;Glaxosmithkline Research And Development Ltd.;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;France;HOPITAUX UNIVERSITAIRES DE STRASBOURG;Hopitaux Universitaires De Strasbourg;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;France;INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS;Institut De Recherches Internationales Servier Iris;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;Etats-Unis;BRISTOL-MYERS SQUIBB COMPANY CORP;Bristol-Myers Squibb Company Corp;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;Norvège;HELSE STAVANGER HF;Helse Stavanger Hf;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;Espagne;FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA;Fundacio Clinic Per A La Recerca Biomedica;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;Suède;KAROLINSKA INSTITUTET;Karolinska Institutet;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;Royaume-Uni;QUEEN MARY UNIVERSITY OF LONDON;Queen Mary University Of London;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;Italie;INNOVATION ACTA S.R.L.;Innovation Acta S.R.L.;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;Espagne;FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD;Fundacion Publica Andaluza Progreso Y Salud;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;Suisse;NOVARTIS PHARMA AG;Novartis Pharma Ag;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;Grèce;ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON;Ethniko Kai Kapodistriako Panepistimio Athinon;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;Royaume-Uni;THE UNIVERSITY OF BIRMINGHAM;The University Of Birmingham;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie Computationnelle;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;Pays-Bas;UNIVERSITAIR MEDISCH CENTRUM UTRECHT;Universitair Medisch Centrum Utrecht;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;France;UNIVERSITE DE BRETAGNE OCCIDENTALE;Universite De Bretagne Occidentale;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;France;UNIVERSITE DE PARIS;Universite De Paris;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;Royaume-Uni;UNIVERSITY OF NEWCASTLE UPON TYNE;University Of Newcastle Upon Tyne;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
NECESSITY;Italie;UNIVERSITA DEGLI STUDI DI UDINE;Universita Degli Studi Di Udine;;NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients;Projet scientifique;autoimmune disease;Primary Sjögren’s syndrome;;;;8 200 000,00 €;Commission Européenne;01/01/2019;31/12/2024;;;;;Grant Manager 212;;;
TopSpec;Suède;BIOMOTIF AB;Biomotif Ab;;Next generation precision antibody profiling - from science fiction to reality;Projet scientifique;immunology;drug development;antibodies;data analysis;;3 991 500,00 €;Commission Européenne;01/01/2019;30/06/2022;;;;;Grant Manager 378;;;
TopSpec;Suède;KAROLINSKA INSTITUTET;Karolinska Institutet;;Next generation precision antibody profiling - from science fiction to reality;Projet scientifique;immunology;drug development;antibodies;data analysis;;3 991 500,00 €;Commission Européenne;01/01/2019;30/06/2022;;;;;Grant Manager 378;;;
TopSpec;Royaume-Uni;THE NOTTINGHAM TRENT UNIVERSITY;The Nottingham Trent University;;Next generation precision antibody profiling - from science fiction to reality;Projet scientifique;immunology;drug development;antibodies;data analysis;;3 991 500,00 €;Commission Européenne;01/01/2019;30/06/2022;;;;;Grant Manager 378;;;
TopSpec;Pays-Bas;SPECTROMETRY VISION BV;Spectrometry Vision Bv;;Next generation precision antibody profiling - from science fiction to reality;Projet scientifique;immunology;drug development;antibodies;data analysis;;3 991 500,00 €;Commission Européenne;01/01/2019;30/06/2022;;;;;Grant Manager 378;;;
TopSpec;Suisse;SPECTROSWISS SARL;Spectroswiss Sarl;;Next generation precision antibody profiling - from science fiction to reality;Projet scientifique;immunology;drug development;antibodies;data analysis;;3 991 500,00 €;Commission Européenne;01/01/2019;30/06/2022;;;;;Grant Manager 378;;;
TopSpec;Grèce;FASMATECH EPISTIMONIKI KAI TECHNOLOGIKI ANONYMI ETAIREIA;Fasmatech Epistimoniki Kai Technologiki Anonymi Etaireia;;Next generation precision antibody profiling - from science fiction to reality;Projet scientifique;immunology;drug development;antibodies;data analysis;;3 991 500,00 €;Commission Européenne;01/01/2019;30/06/2022;;;coordinateur;;Grant Manager 378;;;
TopSpec;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Technologie et service Spectrométrie de masse pour la biologie (UtechS MSBio);Next generation precision antibody profiling - from science fiction to reality;Projet scientifique;immunology;drug development;antibodies;data analysis;;3 991 500,00 €;Commission Européenne;01/01/2019;30/06/2022;;;;;Grant Manager 378;;;
TopSpec;Allemagne;THERMO FISHER SCIENTIFIC (BREMEN) GMBH;Thermo Fisher Scientific (Bremen) Gmbh;;Next generation precision antibody profiling - from science fiction to reality;Projet scientifique;immunology;drug development;antibodies;data analysis;;3 991 500,00 €;Commission Européenne;01/01/2019;30/06/2022;;;;;Grant Manager 378;;;
MultiSeroSurv;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Malaria : Parasites et hôtes;Novel integrated serological surveillance of malaria and neglected tropical diseases;Projet scientifique;malaria;tropical diseases;Infectious diseases;;;1 500 000,00 €;Commission Européenne;01/02/2020;31/01/2025;;;coordinateur;;;;;
MultiSeroSurv;Sénégal;INSTITUT PASTEUR DE DAKAR;Institut Pasteur De Dakar;;Novel integrated serological surveillance of malaria and neglected tropical diseases;Projet scientifique;malaria;tropical diseases;Infectious diseases;;;1 500 000,00 €;Commission Européenne;01/02/2020;31/01/2025;;;;;;;;
ACRAS-R;Allemagne;Dresden University Bio-technology Centre;Dresden University Bio-Technology Centre;;One Health: AMR in environmental reservoirs and Colonizing antibiotic resistant bacteria;Projet scientifique;;;;;;130 680,00 €;Agence Nationale de la Recherche;01/01/2021;31/12/2023;;;coordinateur;;Grant Manager 1343;;;
ACRAS-R;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Epidémiologie & modélisation de la résistance aux antimicrobie;One Health: AMR in environmental reservoirs and Colonizing antibiotic resistant bacteria;Projet scientifique;;;;;;130 680,00 €;Agence Nationale de la Recherche;01/01/2021;31/12/2023;;;;;Grant Manager 1343;;;
ACRAS-R;Allemagne;Technische Universität Dresden;Technische Universität Dresden;;One Health: AMR in environmental reservoirs and Colonizing antibiotic resistant bacteria;Projet scientifique;;;;;;130 680,00 €;Agence Nationale de la Recherche;01/01/2021;31/12/2023;;;coordinateur;;Grant Manager 1343;;;
ACRAS-R;France;Institut Pasteur de Guadeloupe;Institut Pasteur De Guadeloupe;;One Health: AMR in environmental reservoirs and Colonizing antibiotic resistant bacteria;Projet scientifique;;;;;;130 680,00 €;Agence Nationale de la Recherche;01/01/2021;31/12/2023;;;;;Grant Manager 1343;Pan-genome Graph Algorithms and Data Integration | PANGAIA Project | H2020 | CORDIS | European Commission (europa.eu);;This EU-funded project is going to explore graph-based representation of large genome datasets and determine their advantages over traditional sequence-based presentation of pan-genomic data
ACRAS-R;France;Université de Limoges;Université De Limoges;;One Health: AMR in environmental reservoirs and Colonizing antibiotic resistant bacteria;Projet scientifique;AMR transmission;one health;;;;130 680,00 €;Agence Nationale de la Recherche;01/01/2021;31/12/2023;;;;;Grant Manager 1343;;;
OrganoEar;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Equipe Ida Plasticité des Circuits Auditifs Centraux  - Plasticity of Central Auditory Circuit;Organoids-on-chip: role of Sonic-Hedgehog signaling on the development of inner ear organoids;Projet scientifique;cochlea;;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
OrganoEar;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Plate-forme Technologique Biomatériaux et Microfluidique;Organoids-on-chip: role of Sonic-Hedgehog signaling on the development of inner ear organoids;Projet scientifique;cochlea;;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;;
OrganoEar;Corée du Sud;Institut Pasteur Korea;Institut Pasteur Korea;;Organoids-on-chip: role of Sonic-Hedgehog signaling on the development of inner ear organoids;Projet scientifique;cochlea;;;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
PANGAIA;Royaume-Uni;ILLUMINA CAMBRIDGE LTD;Illumina Cambridge Ltd;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 €;Commission Européenne;01/01/2020;31/12/2023;;;;;;;;
PANGAIA;Etats-Unis;CORNELL UNIVERSITY;Cornell University;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 €;Commission Européenne;01/01/2020;31/12/2023;;;;;;;;
PANGAIA;Slovaquie;GENETON S.R.O.;Geneton S.R.O.;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 €;Commission Européenne;01/01/2020;31/12/2023;;;;;;;;
PANGAIA;Italie;UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA;Universita' Degli Studi Di Milano-Bicocca;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 €;Commission Européenne;01/01/2020;31/12/2023;;;;;;;;
PANGAIA;Etats-Unis;The Pennsylvania State University;The Pennsylvania State University;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 €;Commission Européenne;01/01/2020;31/12/2023;;;;;;;;
PANGAIA;Pays-Bas;STICHTING NEDERLANDSE WETENSCHAPPELIJK ONDERZOEK INSTITUTEN;Stichting Nederlandse Wetenschappelijk Onderzoek Instituten;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 €;Commission Européenne;01/01/2020;31/12/2023;;;coordinateur;;;;;
PANGAIA;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 €;Commission Européenne;01/01/2020;31/12/2023;;;;;;;;This project constitutes a pioneering work that aim to characterize EVs that circulate among domestic and wild animals in central Africa, a geographical region that harbours a highly diverse wild fauna, where close contact between humans and herd animals are still common and where poor sanitation systems provide a conducive environment for EV transmissio
PANGAIA;Canada;Simon Fraser University;Simon Fraser University;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 €;Commission Européenne;01/01/2020;31/12/2023;;;;;;;;
PANGAIA;Japon;NATIONAL UNIVERSITY CORPORATION THEUNIVERSITY OF TOKYO;National University Corporation Theuniversity Of Tokyo;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 €;Commission Européenne;01/01/2020;31/12/2023;;;;;;;;
PANGAIA;Allemagne;UNIVERSITAET BIELEFELD;Universitaet Bielefeld;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 €;Commission Européenne;01/01/2020;31/12/2023;;;;;;;;The scientists from four institutes of Institut Pasteur International Network (Rome, Paris, Cambodia and Ivory Coast) will combine their expertise in virology, immunology and entomology to perform a comprehensive characterization of mechanisms underlying the interaction between DENV infection, mosquito vectors, and the early host antiviral immunit
PANGAIA;Slovaquie;UNIVERZITA KOMENSKEHO V BRATISLAVE;Univerzita Komenskeho V Bratislave;;Pan-genome Graph Algorithms and Data Integration;Projet scientifique;genome;data;;;;1 140 800,00 €;Commission Européenne;01/01/2020;31/12/2023;;;;;;;;
NIRV_HOST_INT;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Population genomics of co-evolution between non-retroviral RNA viruses and their hosts;Projet scientifique;biology;RNA virus;virology;;;1 686 875,00 €;Commission Européenne;01/05/2016;30/04/2022;;;;;;;;
NIRV_HOST_INT;Italie;UNIVERSITA DEGLI STUDI DI PAVIA;Universita Degli Studi Di Pavia;;Population genomics of co-evolution between non-retroviral RNA viruses and their hosts;Projet scientifique;biology;RNA virus;virology;;;1 686 875,00 €;Commission Européenne;01/05/2016;30/04/2022;;;coordinateur;;;;;
SADaniel;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie cellulaire des lymphocytes;Primary Yellow Fever immunization of HIV-infected individuals: impact of immune activation and inflammation in the innate and adaptive immune response to vaccine;Projet scientifique;HIV;yellow fever;vaccination;innate immunity;antibody response;176 800,00 €;ANSR;01/04/2019;31/03/2021;;;;;Grant Manager 126;;;Scientists from Institut Pasteur in Iran, French Guiana and Paris will combine their complementary expertise to develop the tools using Asaia spp. in order to produce and delivery double stranded RNA against two specific genes into the Anopheles mosquito vectors to reduce their vectorial capaci
SADaniel;Brésil;Oswaldo Cruz Foundation (Fiocruz);Oswaldo Cruz Foundation (Fiocruz);Laboratory of AIDS and Molecular Immunology;Primary Yellow Fever immunization of HIV-infected individuals: impact of immune activation and inflammation in the innate and adaptive immune response to vaccine;Projet scientifique;HIV;yellow fever;vaccination;innate immunity;antibody response;176 800,00 €;ANSR;01/04/2019;31/03/2021;;;Coordinateur;Projet financé;Grant Manager 126;;;
PolarNet;Royaume-Uni;CARDIFF UNIVERSITY;Cardiff University;;Principles of Polarity – Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 €;Commission Européenne;01/10/2015;30/09/2021;;;;;;;;
PolarNet;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Principles of Polarity – Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 €;Commission Européenne;01/10/2015;30/09/2021;;;;;;;3;The present project aims to demonstrate that the statistical signature of behavioural changes in mosquitoes after YFV infection can be leveraged to detect the virus circulation in transmission are
PolarNet;Pays-Bas;ELEVATE BV;Elevate Bv;;Principles of Polarity – Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 €;Commission Européenne;01/10/2015;30/09/2021;;;;;;;3;
PolarNet;France;INSTITUT CURIE;Institut Curie;;Principles of Polarity – Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 €;Commission Européenne;01/10/2015;30/09/2021;;;;;;;3;
PolarNet;Royaume-Uni;NDS Ltd.;Nds Ltd.;;Principles of Polarity – Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 €;Commission Européenne;01/10/2015;30/09/2021;;;;;;;3;Three Institutes of Institut Pasteur International Network (Dakar, Ivory Coast and Paris) involved in this project will combine their complementary expertise to investigate the burden and clinical presentations of EV-68 infections in pediatrics facilities in Senegal and Ivory Coast and to provide insights to the epidemiologic and genetic characteristics of EV-D68 in both countrie
PolarNet;Belgique;Union Biometrica BVBA;Union Biometrica Bvba;;Principles of Polarity – Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 €;Commission Européenne;01/10/2015;30/09/2021;;;coordinateur;;;;3;
PolarNet;Royaume-Uni;THE FRANCIS CRICK INSTITUTE LIMITED;The Francis Crick Institute Limited;;Principles of Polarity – Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 €;Commission Européenne;01/10/2015;30/09/2021;;;;;;;3;
PolarNet;Pays-Bas;Scientific Volume Imaging BV;Scientific Volume Imaging Bv;;Principles of Polarity – Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 €;Commission Européenne;01/10/2015;30/09/2021;;;;;;;3;The present project, which associates scientists from Institut Pasteur of New Caledonia, Paris and Cambodia, aims to identify the determinants of the emergence of minority serotypes during dengue outbreaks. The respective roles of viral and human factors in the emergence of a new serotype will be explored
PolarNet;Suisse;Universität Basel;Universität Basel;;Principles of Polarity – Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 €;Commission Européenne;01/10/2015;30/09/2021;;;;;;;3;
PolarNet;Allemagne;TECHNISCHE UNIVERSITAET DRESDEN;Technische Universitaet Dresden;;Principles of Polarity – Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 €;Commission Européenne;01/10/2015;30/09/2021;;;;;;;3;
PolarNet;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Principles of Polarity – Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 €;Commission Européenne;01/10/2015;30/09/2021;;;;;;;3;The scientists from three institutes of Institut Pasteur International Network (Paris, Shanghai and Laos) will combine their expertise to understand how hypoxic environment and host cellular restriction factors work hand in hand to annihilate HBV infection
PolarNet;Royaume-Uni;UNIVERSITY COLLEGE LONDON;University College London;;Principles of Polarity – Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 €;Commission Européenne;01/10/2015;30/09/2021;;;;;;;3;
PolarNet;Pays-Bas;UNIVERSITEIT UTRECHT;Universiteit Utrecht;;Principles of Polarity – Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity;Projet scientifique;biological sciences;cell polarity;stem cells;;;3 935 968,56 €;Commission Européenne;01/10/2015;30/09/2021;;;;;;;3;
One Health EJP;France;AGENCE NATIONALE DE LA SECURITE SANITAIRE DE L ALIMENTATION DE L ENVIRONNEMENT ET DU TRAVAIL;Agence Nationale De La Securite Sanitaire De L Alimentation De L Environnement Et Du Travail;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;3;Scientists from 3 institutes of Institut Pasteur International Network (Sofia, Paris and Brussels) will combine their expertise, spread across the fields of immunology, epigenetics, and infection biology to assess whether the epigenetic code of transcripts and the genomic organization of lung epithelial cells is modified by rheumatoid arthritis (RA) and influenza infection, and whether RA thereby increases the susceptibility to infection
One Health EJP;France;ASSOCIATION MED-VET-NET DE RECHERCHE SUR LES ZOONOSES;Association Med-Vet-Net De Recherche Sur Les Zoonoses;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Allemagne;BUNDESINSTITUT FUER RISIKOBEWERTUNG;Bundesinstitut Fuer Risikobewertung;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Lettonie;PARTIKAS DROSIBAS, DZIVNIEKU VESELIBAS UN VIDES ZINATNISKAIS INSTITUTSBIOR;Partikas Drosibas, Dzivnieku Veselibas Un Vides Zinatniskais Institutsbior;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;3;The consortium will gather scientists from 3 institutes of Institut Pasteur International Network, with expertise on structural biology, biochemistry and antibiotic resistance, to discover how mutations in PhoPQ and PmrAB cause PM resistance
One Health EJP;Royaume-Uni;Department of Health;Department Of Health;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Norvège;FOLKEHELSEINSTITUTTET;Folkehelseinstituttet;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Suède;FOLKHALSOMYNDIGHETEN;Folkhalsomyndigheten;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Danemark;STATENS SERUM INSTITUT;Statens Serum Institut;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;3;Scientists from three institutes from the Institut Pasteur International Network (Madagascar, Paris and Lille) with expertise in the field of plague, and collaborating within the framework of an Institut Pasteur International Unit, plan to investigate the involvement and the role of fleas in sylvatic plague maintenance and in human plague reappearance/re-emergence in Madagascar.
One Health EJP;Pologne;PANSTWOWY INSTYTUT WETERYNARYJNY - PANSTWOWY INSTYTUT BADAWCZY;Panstwowy Instytut Weterynaryjny - Panstwowy Instytut Badawczy;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Belgique;SCIENSANO;Sciensano;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;France;INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT;Institut National De Recherche Pour L'Agriculture, L'Alimentation Et L'Environnement;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;3;Scientists from three institutes from Institut Pasteur International Network (Paris, French Guiana and Bangui) will combine their expertise to analyze the impact of Vit.C seric levels on susceptibility to enteric infections and diarrhea in children in countries with a high diarrheal burden
One Health EJP;Estonie;University of Tartu;University Of Tartu;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Lituanie;NACIONALINIS MAISTO IR VETERINARIJOS RIZIKOS VERTINIMO INSTITUTAS;Nacionalinis Maisto Ir Veterinarijos Rizikos Vertinimo Institutas;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Irlande;NATIONAL UNIVERSITY OF IRELAND GALWAY;National University Of Ireland Galway;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;3;Scientists from instituts Pasteur in Paris, in Cambodia and in Madagascar will associate their expertise to determine in real-world conditions whether the long-term antibody response measured and cellular / humoral immunity parameters are comparable after three intradermal dose-sparing PEP sessions using Vero cell vaccine, compared to that after four sessions, before and after rabies vaccine boosting
One Health EJP;Allemagne;Friedrich-Loeffler-Institut;Friedrich-Loeffler-Institut;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Pays-Bas;RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU;Rijksinstituut Voor Volksgezondheid En Milieu;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;3;
One Health EJP;Suède;LIVSMEDELS VERKET;Livsmedels Verket;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;coordinateur;;;;4;Scientists from 4 institutes of Institut Pasteur International Network (Paris, Bangui, Cameroon and Madagascar) will combine their expertise to identify the mechanisms that generate genetic diversity in EV ecosystems and to understand how this diversity promotes the emergence of new virus lineages with modified phenotypic properties.
One Health EJP;Italie;ISTITUTO SUPERIORE DI SANITA;Istituto Superiore Di Sanita;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;4;
One Health EJP;Espagne;INSTITUTO DE SALUD CARLOS III;Instituto De Salud Carlos Iii;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;4;
One Health EJP;Royaume-Uni;THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS;The Secretary Of State For Environment, Food And Rural Affairs;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;4;
One Health EJP;Italie;ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA LOMBARDIA E DELL'EMILIA ROMAGNA BRUNO UBERTINI;Istituto Zooprofilattico Sperimentale Della Lombardia E Dell'Emilia Romagna Bruno Ubertini;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;This project is an integrative structural biology project bringing together scientists of the Institut Pasteur in Paris and in Korea with complementary expertise (biochemistry, biophysics, crystallography, ultra-structural bioimaging, HDX-MS, bio informatic)
One Health EJP;Italie;ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELL'ABRUZZO E DEL MOLISE G CAPORALE;Istituto Zooprofilattico Sperimentale Dell'Abruzzo E Del Molise G Caporale;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Espagne;INSTITUTO NACIONAL DE INVESTIGACION Y TECNOLOGIA AGRARIA Y ALIMENTARIA OA MP;Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria Oa Mp;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Portugal;INSTITUTO NACIONAL DE INVESTIGAÇAO AGRARIA E VETERINARIA;Instituto Nacional De Investigaçao Agraria E Veterinaria;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Suède;STATENS VETERINAERMEDICINSKA ANSTALT;Statens Veterinaermedicinska Anstalt;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Portugal;INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE;Instituto Nacional De Saude Dr. Ricardo Jorge;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Espagne;UNIVERSIDAD COMPLUTENSE DE MADRID;Universidad Complutense De Madrid;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Allemagne;ROBERT KOCH-INSTITUT;Robert Koch-Institut;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;Scientists from Institut Pasteur in Paris and in Guinea will combine their expertise to adapt the recently developed Specific High-sensitivity Enzymatic Reporter unLOCKing (SHERLOCK) technology that combines a CRISPR-Cas system and lateral flow test to the detection of trypanosomes.
One Health EJP;Finlande;RUOKAVIRASTO;Ruokavirasto;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Arbovirus et Insectes Vecteurs;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;République Tchèque;STATNI ZDRAVOTNI USTAV;Statni Zdravotni Ustav;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Irlande;TEAGASC - AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY;Teagasc - Agriculture And Food Development Authority;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;4;For this project, scientists from Institut Pasteur in Belgium and France (Lille, Paris) will join their experiences with those of their colleagues from St Petersburg to fully unlock the potential of their diagnostic platform
One Health EJP;Pays-Bas;STICHTING WAGENINGEN RESEARCH;Stichting Wageningen Research;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;4;
One Health EJP;Hongrie;NEMZETI ELELMISZERLANC-BIZTONSAGI HIVATAL;Nemzeti Elelmiszerlanc-Biztonsagi Hivatal;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;4;
One Health EJP;Hongrie;NEMZETI NEPEGESZSEGUGYI KOZPONT;Nemzeti Nepegeszsegugyi Kozpont;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;4;
One Health EJP;Roumanie;INSTITUTUL DE IGIENA SI SANATATE PUBLICA VETERINARIA;Institutul De Igiena Si Sanatate Publica Veterinaria;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;Three teams of two institutes of the IPIN (Fiocruz and Institut Pasteur Paris) will combine their complementary expertise to study the structure and molecular interactions of T. cruzi EIF4E factors with their different partners (protein/RNA) in the protein synthesis machinery
One Health EJP;Bulgarie;BULGARIAN FOOD SAFETY AGENCY;Bulgarian Food Safety Agency;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Autriche;AGES - OSTERREICHISCHE AGENTUR FUR GESUNDHEIT UND ERNAHRUNGSSICHERHEIT GMBH;Ages - Osterreichische Agentur Fur Gesundheit Und Ernahrungssicherheit Gmbh;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Estonie;VETERINAAR JA TOIDULABORATOORIUM;Veterinaar Ja Toidulaboratoorium;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;The current project brings together several scientists from Institut Pasteur International Network in the field of immunology and virology to study the immune responses initiated after dengue infection that provides protection from disease, but clears the virus efficientl
One Health EJP;République Tchèque;VYZKUMNY USTAV VETERINARNIHO LEKARSTVI;Vyzkumny Ustav Veterinarniho Lekarstvi;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Finlande;TERVEYDEN JA HYVINVOINNIN LAITOS;Terveyden Ja Hyvinvoinnin Laitos;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Danemark;DANMARKS TEKNISKE UNIVERSITET;Danmarks Tekniske Universitet;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;
One Health EJP;Royaume-Uni;UNIVERSITY OF SURREY;University Of Surrey;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;Teams from Institut Pasteur of Bangui and of Paris as well as external partners will combine their complementary expertise (epidemiology, virology, anthropology, zoology and environmental ecology) to develop a One health comprehensive approach for studing monkeypox in Central African Republic.
One Health EJP;Norvège;VETERINAERINSTITUTTET - NORWEGIAN VETERINARY INSTITUTE;Veterinaerinstituttet - Norwegian Veterinary Institute;;Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards;Projet scientifique;One Health;foodborne zoonoses;antimicroial resistance;emerging threats;;44 998 999,99 €;Commission Européenne;01/01/2018;31/12/2022;;;;;;;2;
RECoVER;Pays-Bas;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM;Academisch Medisch Centrum Bij De Universiteit Van Amsterdam;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 €;Commission Européenne;14/02/2020;13/02/2022;;;;;Grant Manager 1092;;2;
RECoVER;Allemagne;Charité - Universitätsmedizin Berlin;Charité - Universitätsmedizin Berlin;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 €;Commission Européenne;14/02/2020;13/02/2022;;;coordinateur;;Grant Manager 1092;;2;
RECoVER;Pays-Bas;ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM;Erasmus Universitair Medisch Centrum Rotterdam;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 €;Commission Européenne;14/02/2020;13/02/2022;;;;;Grant Manager 1092;;2;Mathematicians, biophysicians and biologists from 2 instituts of IPIN (Institut Pasteur Paris and Pasteur Research Pole Hong Kong) will combine their expertise to provide an integrated framework to analyze cell mechanics by combining imaging, and biophysical and computational approaches and to investigate the relation ship between host tissue mechanical forces and microbe
RECoVER;France;ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK;Ecrin European Clinical Research Infrastructure Network;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 €;Commission Européenne;14/02/2020;13/02/2022;;;;;Grant Manager 1092;;2;
RECoVER;Norvège;FOLKEHELSEINSTITUTTET;Folkehelseinstituttet;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 €;Commission Européenne;14/02/2020;13/02/2022;;;;;Grant Manager 1092;;2;
RECoVER;Royaume-Uni;INTENSIVE CARE NATIONAL AUDIT AND RESEARCH CENTRE;Intensive Care National Audit And Research Centre;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 €;Commission Européenne;14/02/2020;13/02/2022;;;;;Grant Manager 1092;;2;Four teams from two institutes of Institut Pasteur International Network (Paris and Cambodia) will combine their highly complementary skills (chemistry of epigenetic drugs, biology and epigenetics of the malaria parasite, Plasmodiumtransmission and Plasmodium drug resistance in the field) to develop alternative therapies by targeting epigenetics mechanism
RECoVER;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 €;Commission Européenne;14/02/2020;13/02/2022;;;;;Grant Manager 1092;;2;
RECoVER;Italie;FONDAZIONE PENTA - FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES - ONLUS;Fondazione Penta - For The Treatment And Care Of Children With Hiv Andrelated Diseases - Onlus;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 €;Commission Européenne;14/02/2020;13/02/2022;;;;;Grant Manager 1092;;2;
RECoVER;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 €;Commission Européenne;14/02/2020;13/02/2022;;;;;Grant Manager 1092;;2;
RECoVER;Pays-Bas;STICHTING KATHOLIEKE UNIVERSITEIT;Stichting Katholieke Universiteit;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 €;Commission Européenne;14/02/2020;13/02/2022;;;;;Grant Manager 1092;;2;This interdisciplinary project, which involves the concerted effort of four teams from the Institut Pasteur of Paris, the Institut Pasteur of Korea and external partners, represents the first step toward the generation of cochlear organoid
RECoVER;Belgique;UNIVERSITEIT ANTWERPEN;Universiteit Antwerpen;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 €;Commission Européenne;14/02/2020;13/02/2022;;;;;Grant Manager 1092;;2;
RECoVER;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 €;Commission Européenne;14/02/2020;13/02/2022;;;;;Grant Manager 1092;;2;
RECoVER;Chine;Institut Pasteur of Shanghai, Chinese Academy of Sciences;Institut Pasteur Of Shanghai, Chinese Academy Of Sciences;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 €;Commission Européenne;14/02/2020;13/02/2022;;;;;Grant Manager 1092;;3;Scientists from 3 institutes of Institut Pasteur International network (Paris, Cambodia and Madagscar) with complementary expertise will bring together in order to to develop and to validate, both in laboratory conditions and in field settings, the first point of care tests (POCTs) for the rapid detection of the etiological agent of rabies (with rabies virus - RABV) in human
RECoVER;Pays-Bas;UNIVERSITAIR MEDISCH CENTRUM UTRECHT;Universitair Medisch Centrum Utrecht;;Rapid European SARS-CoV-2 Emergency research Response;Projet scientifique;SARS-CoV-2;coronavirus;Infectious diseases;epidemics;;19 995 195,00 €;Commission Européenne;14/02/2020;13/02/2022;;;;;Grant Manager 1092;;3;
Autophagy in vitro;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;Reconstituting Autophagosome Biogenesis in vitro;Projet scientifique;autoimmune diseases;electron microscopy;cancer;;;1 499 726,00 €;Commission Européenne;01/04/2015;31/01/2021;;;;;;;3;
Autophagy in vitro;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Reconstituting Autophagosome Biogenesis in vitro;Projet scientifique;autoimmune diseases;electron microscopy;cancer;;;1 499 726,00 €;Commission Européenne;01/04/2015;31/01/2021;;;;;;;3;
INFRAVEC2;France;CENTRE DE COOPERATION INTERNATIONALE EN RECHERCHE AGRONOMIQUE POUR LEDEVELOPPEMENT - C.I.R.A.D. EPIC;Centre De Cooperation Internationale En Recherche Agronomique Pour Ledeveloppement - C.I.R.A.D. Epic;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;This project is the result of synergistic expertise within the Pasteur network (skeletal muscle research and stem cell biology, infectious diseases and sepsis). It aims to investigate in detail the mechanisms and the consequences of how muscle stem cells sense and respond to acute systemic pathogen-driven inflammation. 
INFRAVEC2;Italie;CENTRO AGRICOLTURA E AMBIENTE GIORGIO NICOLI SRL;Centro Agricoltura E Ambiente Giorgio Nicoli Srl;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;
INFRAVEC2;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;
INFRAVEC2;Suisse;Fondation Health Sciences e-Training;Fondation Health Sciences E-Training;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;The objectives of this project are to identify the different routes of ESBL-PE transmissions to newborns in the community and to suggest new strategies to control ESBL-PE acquisition in newbor
INFRAVEC2;France;INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT;Institut De Recherche Pour Le Developpement;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;
INFRAVEC2;Royaume-Uni;IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE;Imperial College Of Science Technology And Medicine;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;coordinateur;;Grant Manager 247;;2;
INFRAVEC2;Royaume-Uni;LIVERPOOL SCHOOL OF TROPICAL MEDICINE;Liverpool School Of Tropical Medicine;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;The Four teams from two institutes of Institut Pasteur International Network (Paris and Greece) will combine their highly complementary skills (genotoxicity and epigenetic changes, oncogenic cellular signaling, chemical drug design, mechanism of pathogenicity, host signaling pathways) to study the mechanisms responsible for infection-driven carcinogenesis
INFRAVEC2;Royaume-Uni;THE PIRBRIGHT INSTITUTE LBG;The Pirbright Institute Lbg;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;
INFRAVEC2;Espagne;INSTITUT DE RECERCA I TECNOLOGIA AGROALIMENTARIES;Institut De Recerca I Tecnologia Agroalimentaries;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;
INFRAVEC2;Italie;POLO D'INNOVAZIONE DI GENOMICA, GENETICA E BIOLOGIA SCARL;Polo D'Innovazione Di Genomica, Genetica E Biologia Scarl;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;
INFRAVEC2;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;Four teams from two institutes of Institut Pasteur International Network (Paris and UPS- Sao Paulo) will combine their scientific expertise (on plasmodial pre-erythrocytic stages, lentiviral vectorology, on humanized mouse models and on system vaccinology) to develop a novel method to map epitopes and validate protective antigens presented on the surface of infected human cells.
INFRAVEC2;Pays-Bas;STICHTING KATHOLIEKE UNIVERSITEIT;Stichting Katholieke Universiteit;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;
INFRAVEC2;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Arbovirus et Insectes Vecteurs;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;
INFRAVEC2;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Génomique des Insectes Vecteurs;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;
INFRAVEC2;Sénégal;INSTITUT PASTEUR DE DAKAR;Institut Pasteur De Dakar;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;3;The four teams belong to three institutions of the Institut Pasteur International Network (Paris, Yaoundé and Shanghai) and have internationally recognized expertise in epidemiology and SFV immunology, in structural studies of viral glycoproteins, in medical virology and in the identification of pathogens. They will examine the consequences of SFV infection on human health and investigate the Env structure
INFRAVEC2;Suisse;University of Zurich;University Of Zurich;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;3;
INFRAVEC2;Pays-Bas;TROPIQ HEALTH SCIENCES;Tropiq Health Sciences;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;3;
INFRAVEC2;République Tchèque;UNIVERZITA KARLOVA;Univerzita Karlova;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;3;
INFRAVEC2;Mali;UNIVERSITE DES SCIENCES DES TECHNIQUES ET DES TECHNOLOGIES DE BAMAKO;Universite Des Sciences Des Techniques Et Des Technologies De Bamako;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;3;The project consortium is composed of 3 groups with distinct and complementary expertise in neural stem cell biology, neurobiology, induced pluripotent stem cells technology, animal models of neurodegeneration, in vivo imaging and digital image processing, all aiming to decode the contribution of BIN1 in microglia activation during AD progressio
INFRAVEC2;Burkina Faso;MINISTERE DE LA SANTE;Ministere De La Sante;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;3;
INFRAVEC2;Grèce;IDRYMA TECHNOLOGIAS KAI EREVNAS;Idryma Technologias Kai Erevnas;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;3;
INFRAVEC2;France;Institut Pasteur de Nouvelle Calédonie;Institut Pasteur De Nouvelle Calédonie;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;Capitalizing on their strong background in the field of synthetic carbohydrate-based antibacterial vaccines (Shigella and Burkholderia), scientists from the Centre Armand-Frappier (Canada) and Institut Pasteur (Paris) aim to develop a safe and effective vaccine against campylobacteriosis through chemical synthesi
INFRAVEC2;Royaume-Uni;UNIVERSITY OF GLASGOW;University Of Glasgow;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;
INFRAVEC2;Pays-Bas;WAGENINGEN UNIVERSITY;Wageningen University;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;Three teams from two institutes of Institut Pasteur International Network (Paris and Montevideo) with complementary expertise (Legionella infection models, protein crystallization and structure analyses and chemical approaches to decipher epigenetic modifications) propose to combine their different strengths to characterize one of those newly discovered nucleomodulins of L. pneumophila at the functional and structural levels in order to understand its role during infectio
INFRAVEC2;Serbie;UNIVERZITET U NOVOM SADU, POLJOPRIVREDNI FAKULTET NOVI SAD;Univerzitet U Novom Sadu, Poljoprivredni Fakultet Novi Sad;;Research Infrastructures for the control of vector-borne diseases;Projet scientifique;research infrastructure;entomology;zoology;;;9 998 845,25 €;Commission Européenne;01/02/2017;31/12/2021;;;;;Grant Manager 247;;2;
NHL;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Direction internationale Pôle des opérations;Soutien au laboratoire NHL;Institutionnelle;Renforcement;;;;;5 000 000,00 €;Union Européenne / AFD;11/07/1905;;;;;;;;2;
NHL;Myanmar;NHL Myanmar;Nhl Myanmar;Direction internationale Pôle des opérations;Soutien au laboratoire NHL;Institutionnelle;Renforcement;;;;;5 000 000,00 €;Union Européenne / AFD;11/07/1905;;;;;;;;2;The scientists from the Institut Pasteur in Paris and Montevideo with complementary expertise allowing the use of multidisciplinary approaches (transcriptomics, proteomics, infectiology, cell biology and microbiology) will investigate the regulation of the adaptive response to oxidative stress by PerR1 and PerR2 in Leptospira
SPARK;Vietnam;Institut Pasteur in Ho Chi Minh City;Institut Pasteur In Ho Chi Minh City;;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;2;
SPARK;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;2;
SPARK;Australie;Walter & Eliza Hall Institute of Medical Research ;Walter & Eliza Hall Institute Of Medical Research ;;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;8;
SPARK;Australie;Peter Doherty Institute for Infection and Immunity;Peter Doherty Institute For Infection And Immunity;;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;8;
SPARK;Australie;Nossal Institute for Global Health, University of Melbourne;Nossal Institute For Global Health, University Of Melbourne;;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;8;
SPARK;Thaïlande;Mahidol University;Mahidol University;;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;8;
SPARK;Indonésie;Eijkman-Oxford Clinical Research Unit ;Eijkman-Oxford Clinical Research Unit ;;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;8;
SPARK;Australie;Commonwealth Scientific and Industrial Research Organisations ;Commonwealth Scientific And Industrial Research Organisations ;;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;8;
SPARK;Australie;Australian National University;Australian National University;;SPARK;Consortium;Renforcement;;;;;;;;;;;;;;;8;
SPECTRUM;Afrique du Sud;South Asia Field Epidemiology and Technology Network Inc. ;South Asia Field Epidemiology And Technology Network Inc. ;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;8;
SPECTRUM;Etats-Unis;TEPHINET;Tephinet;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Royaume-Uni;Imperial College London;Imperial College London;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Royaume-Uni;London School of Hygiene & Tropical Medicine ;London School Of Hygiene & Tropical Medicine ;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Vietnam;Institut Pasteur in Ho Chi Minh City;Institut Pasteur In Ho Chi Minh City;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Walter & Eliza Hall Institute of Medical Research (WEHI);Walter & Eliza Hall Institute Of Medical Research (Wehi);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Victoria State Government - Health and Human Services;Victoria State Government - Health And Human Services;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;University of New South Wales;University Of New South Wales;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Tupaia;Tupaia;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Papouasie Nouvelle-Guinée;Asia Pacific Leaders Malaria Initiative (APLMA);Asia Pacific Leaders Malaria Initiative (Aplma);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;The University of Melbourne - The Nossal Institute for Global Health;The University Of Melbourne - The Nossal Institute For Global Health;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;The University of Adelaide;The University Of Adelaide;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;TB Modelling and Analysis Consortium (TB-MAC);Tb Modelling And Analysis Consortium (Tb-Mac);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Papouasie Nouvelle-Guinée;Asia Pacific Malaria Elimination Network (APMEN);Asia Pacific Malaria Elimination Network (Apmen);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Queensland University of Technology (QUT);Queensland University Of Technology (Qut);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Public Health Laboratory Network (PHLN);Public Health Laboratory Network (Phln);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Papouasie Nouvelle-Guinée;PNG ICPMR;Png Icpmr;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Papouasie Nouvelle-Guinée;PNG IMR;Png Imr;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Papouasie Nouvelle-Guinée;PNG NMCP;Png Nmcp;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;International;OMS;Oms;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;NHMRC Centre of Research Excellence in Tuberculosis Control (TB-CRE);Nhmrc Centre Of Research Excellence In Tuberculosis Control (Tb-Cre);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Cambodge;National Center for Parasitology, Entomology, and Malaria Control ;National Center For Parasitology, Entomology, And Malaria Control ;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Murdoch Children's Research Institute (MCRI);Murdoch Children'S Research Institute (Mcri);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Monash University;Monash University;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Australie;Menzies School of Health Research;Menzies School Of Health Research;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;24;
SPECTRUM;Thaïlande;Mahidol University;Mahidol University;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Australie;La Trobe University;La Trobe University;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Australie;Kirby Institute;Kirby Institute;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Australie;James Cook University;James Cook University;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Cambodge;ICEMR Project;Icemr Project;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Indonésie;Eijkman-Oxford Clinical Research Unit ;Eijkman-Oxford Clinical Research Unit ;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Australie;CSIRO;Csiro;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Australie;Burnet Institute;Burnet Institute;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Australie;Australian Tuberculosis Modelling Network (AuTuMN);Australian Tuberculosis Modelling Network (Autumn);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Australie;Australian Partnership for Preparedness Research on Infectious Disease Emergencies (APPRISE);Australian Partnership For Preparedness Research On Infectious Disease Emergencies (Apprise);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Australie;Australian National University (ANU);Australian National University (Anu);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;12;
SPECTRUM;Australie;Australian Government - Department of Foreign Affairs and Trade;Australian Government - Department Of Foreign Affairs And Trade;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;26;
SPECTRUM;Australie;Australian Centre of Research Excellence in Malaria Elimination (ACREME);Australian Centre Of Research Excellence In Malaria Elimination (Acreme);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;26;
SPECTRUM;Papouasie Nouvelle-Guinée;STRIVE-PNG;Strive-Png;;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;26;
SPECTRUM;Papouasie Nouvelle-Guinée;Trilateral Project (Australia-China-PNG);Trilateral Project (Australia-China-Png);;SPECTRUM: a Centre of Research Excellence aimed at enhancing national and regional decision making to improve the control of infectious diseases, strengthen health systems and reduce these risks in Australia and the Asia Pacific region through collaboration, partnerships and model-based evidence to aid decision making;Consortium;Infectious diseases;health system;;;;;;;;;;;;;;26;
PHINDacces;Espagne;FUNDACIO CENTRE DE REGULACIO GENOMICA ;Fundacio Centre De Regulacio Genomica ;;Strengthening Omics data analysis capacities in pathogen-host interaction;Projet scientifique;Infectious diseases;Pathogen-Host interaction;Bioinformatics;network;omics;989 468,70 €;Commission Européenne;01/10/2018;30/09/2021;;;;;Grant Manager 220;;26;
PHINDacces;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV ;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev ;;Strengthening Omics data analysis capacities in pathogen-host interaction;Projet scientifique;Infectious diseases;Pathogen-Host interaction;Bioinformatics;network;omics;989 468,70 €;Commission Européenne;01/10/2018;30/09/2021;;;;;Grant Manager 220;;26;
PHINDacces;Allemagne;ROBERT KOCH-INSTITUT;Robert Koch-Institut;;Strengthening Omics data analysis capacities in pathogen-host interaction;Projet scientifique;Infectious diseases;Pathogen-Host interaction;Bioinformatics;network;omics;989 468,70 €;Commission Européenne;01/10/2018;30/09/2021;;;;;Grant Manager 220;;26;
PHINDacces;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie et Pathogenicite Fongiques;Strengthening Omics data analysis capacities in pathogen-host interaction;Projet scientifique;Infectious diseases;Pathogen-Host interaction;Bioinformatics;network;omics;989 468,70 €;Commission Européenne;01/10/2018;30/09/2021;;;;;Grant Manager 220;;26;
PHINDacces;Tunisie;INSTITUT PASTEUR DE TUNIS;Institut Pasteur De Tunis;;Strengthening Omics data analysis capacities in pathogen-host interaction;Projet scientifique;Infectious diseases;Pathogen-Host interaction;Bioinformatics;network;omics;989 468,70 €;Commission Européenne;01/10/2018;30/09/2021;;;coordinateur;;Grant Manager 220;;26;
LegiDOT;Uruguay;Institut Pasteur de Montevideo;Institut Pasteur De Montevideo;;Structural and functional characterization of a Dot1-like methyltransferase encoded by Legionella pneumophila: bacteria-induced epigenetics?;Projet scientifique;legionellosis;;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;coordinateur;;;;26;
LegiDOT;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie des bacteries intracellulaires;Structural and functional characterization of a Dot1-like methyltransferase encoded by Legionella pneumophila: bacteria-induced epigenetics?;Projet scientifique;legionellosis;;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;26;
LegiDOT;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Chimie Biologique Epigénétique;Structural and functional characterization of a Dot1-like methyltransferase encoded by Legionella pneumophila: bacteria-induced epigenetics?;Projet scientifique;legionellosis;;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;26;
VIRAGE;Pays-Bas;ACADEMISCH ZIEKENHUIS LEIDEN;Academisch Ziekenhuis Leiden;;Structural and functional outcomes of epitranscriptomic methylation of RNA virus genomes;Projet scientifique;coronaviruses;flaviviruses;;;;154 000,00 €;Agence Nationale de la Recherche;01/10/2020;30/04/2024;;;coordinateur;;Grant Manager 1398;;26;
VIRAGE;France;Ecole Nationale Supérieure de Chimie de Montpellier;Ecole Nationale Supérieure De Chimie De Montpellier;;Structural and functional outcomes of epitranscriptomic methylation of RNA virus genomes;Projet scientifique;coronaviruses;flaviviruses;;;;154 000,00 €;Agence Nationale de la Recherche;01/10/2020;30/04/2024;;;;;Grant Manager 1398;;26;
VIRAGE;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Virologie (Dpt);Structural and functional outcomes of epitranscriptomic methylation of RNA virus genomes;Projet scientifique;coronaviruses;flaviviruses;;;;154 000,00 €;Agence Nationale de la Recherche;01/10/2020;30/04/2024;;;;;Grant Manager 1398;;26;
VIRAGE;France;UNIVERSITE D'AIX MARSEILLE;Universite D'Aix Marseille;;Structural and functional outcomes of epitranscriptomic methylation of RNA virus genomes;Projet scientifique;coronaviruses;flaviviruses;;;;154 000,00 €;Agence Nationale de la Recherche;01/10/2020;30/04/2024;;;;;Grant Manager 1398;;26;
SAFE-Aqua;Espagne;BACMINE SL;Bacmine Sl;;SustainAble Farming for Effective Aquaculture;Projet scientifique;aquaculture;;;;;900 000,00 €;Commission Européenne;01/01/2017;31/12/2020;;;;;;;26;
SAFE-Aqua;Royaume-Uni;SWANSEA UNIVERSITY;Swansea University;;SustainAble Farming for Effective Aquaculture;Projet scientifique;aquaculture;;;;;900 000,00 €;Commission Européenne;01/01/2017;31/12/2020;;;coordinateur;;;;26;
SAFE-Aqua;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;SustainAble Farming for Effective Aquaculture;Projet scientifique;aquaculture;;;;;900 000,00 €;Commission Européenne;01/01/2017;31/12/2020;;;;;;;26;
SAFE-Aqua;Thaïlande;NATIONAL SCIENCE & TECHNOLOGY DEVELOPMENT AGENCY;National Science & Technology Development Agency;;SustainAble Farming for Effective Aquaculture;Projet scientifique;aquaculture;;;;;900 000,00 €;Commission Européenne;01/01/2017;31/12/2020;;;;;;;26;
SAFE-Aqua;Pays-Bas;WAGENINGEN UNIVERSITY;Wageningen University;;SustainAble Farming for Effective Aquaculture;Projet scientifique;aquaculture;;;;;900 000,00 €;Commission Européenne;01/01/2017;31/12/2020;;;;;;;26;
Rafts4Biotech;République Tchèque;ENANTIS SRO;Enantis Sro;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 €;Commission Européenne;01/01/2017;31/06/2021;;;;;;;26;
Rafts4Biotech;Espagne;AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS;Agencia Estatal Consejo Superior De Investigaciones Cientificas;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 €;Commission Européenne;01/01/2017;31/06/2021;;;;;;;26;
Rafts4Biotech;Suisse;EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH;Eidgenoessische Technische Hochschule Zuerich;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 €;Commission Européenne;01/01/2017;31/06/2021;;;;;;;26;
Rafts4Biotech;République Tchèque;FAKULTNI NEMOCNICE U SV. ANNY V BRNE;Fakultni Nemocnice U Sv. Anny V Brne;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 €;Commission Européenne;01/01/2017;31/06/2021;;;;;;;26;
Rafts4Biotech;Allemagne;GEORG-AUGUST-UNIVERSITAT GOTTINGEN STIFTUNG OFFENTLICHEN RECHTS;Georg-August-Universitat Gottingen Stiftung Offentlichen Rechts;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 €;Commission Européenne;01/01/2017;31/06/2021;;;coordinateur;;;;26;
Rafts4Biotech;Pays-Bas;RIJKSUNIVERSITEIT GRONINGEN;Rijksuniversiteit Groningen;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 €;Commission Européenne;01/01/2017;31/06/2021;;;;;;;3;
Rafts4Biotech;Italie;NAICONS SRL;Naicons Srl;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 €;Commission Européenne;01/01/2017;31/06/2021;;;;;;;3;
Rafts4Biotech;Espagne;SCIENSEED SL;Scienseed Sl;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 €;Commission Européenne;01/01/2017;31/06/2021;;;;;;;3;
Rafts4Biotech;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 €;Commission Européenne;01/01/2017;31/06/2021;;;;;;;47;
Rafts4Biotech;Autriche;ENGENES BIOTECH GMBH;Engenes Biotech Gmbh;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 €;Commission Européenne;01/01/2017;31/06/2021;;;;;;;47;
Rafts4Biotech;Danemark;BIOSYNTIA APS;Biosyntia Aps;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 €;Commission Européenne;01/01/2017;31/06/2021;;;;;;;47;
Rafts4Biotech;Allemagne;UNIVERSITATSMEDIZIN GREIFSWALD KORPERSCHAFT DES OFFENTLICHEN RECHTS;Universitatsmedizin Greifswald Korperschaft Des Offentlichen Rechts;;Synthetic bacterial lipid rafts to optimize industrial bioprocesses;Projet scientifique;bacteriology;industrial biotechnology;proteomics;mathematical model;;6 733 580,00 €;Commission Européenne;01/01/2017;31/06/2021;;;;;;;47;
DEHBV;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Rétrovirologie Moléculaire;Targeting hepatitis B virus cccDNA by cellular nucleases: towards viral elimination of chronic hepatitis B;Projet scientifique;hepatitis B;;;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;47;
DEHBV;Chine;Institut Pasteur of Shanghai, Chinese Academy of Sciences;Institut Pasteur Of Shanghai, Chinese Academy Of Sciences;;Targeting hepatitis B virus cccDNA by cellular nucleases: towards viral elimination of chronic hepatitis B;Projet scientifique;hepatitis B;;;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;coordinateur;;;;47;
DEHBV;Laos;Institut Pasteur du Laos;Institut Pasteur Du Laos;;Targeting hepatitis B virus cccDNA by cellular nucleases: towards viral elimination of chronic hepatitis B;Projet scientifique;hepatitis B;;;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;47;
TaME;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Chimie Biologique Epigénétique;Targeting Malaria Epigenetics;Projet scientifique;malaria;epigenetics;therapy;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;47;
TaME;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie des Interactions Hôte-Parasite;Targeting Malaria Epigenetics;Projet scientifique;malaria;epigenetics;therapy;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;47;
TaME;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Plate-Forme Centre de Production et Infection des Anophèles;Targeting Malaria Epigenetics;Projet scientifique;malaria;epigenetics;therapy;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;47;
TaME;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;Targeting Malaria Epigenetics;Projet scientifique;malaria;epigenetics;therapy;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;47;
m6A_RAIAV;Belgique;Sciensano;Sciensano;;The lung epitranscriptome and chromatin accessibility landscape in rheumatoid arthritis complicated by the flu;Projet scientifique;Rheumatoid arthritis;immunology;epigenetics;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;47;
m6A_RAIAV;France;Institut Pasteur (Paris);Institut Pasteur (Paris);UTECHS CB Technologie et Service Cytometrie et Biomarqueurs;The lung epitranscriptome and chromatin accessibility landscape in rheumatoid arthritis complicated by the flu;Projet scientifique;Rheumatoid arthritis;immunology;epigenetics;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;coordinateur;;;;47;
m6A_RAIAV;Bulgarie;Stephan Angeloff Institute;Stephan Angeloff Institute;;The lung epitranscriptome and chromatin accessibility landscape in rheumatoid arthritis complicated by the flu;Projet scientifique;Rheumatoid arthritis;immunology;epigenetics;;;50 000,00 €;Institut Pasteur;01/10/2020;30/09/2021;;;;;;;47;
FED-AMR;Danemark;Statens Serum Institut;Statens Serum Institut;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 685;;47;
FED-AMR;Pologne;National Veterinary Research Institute;National Veterinary Research Institute;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 685;;47;
FED-AMR;République Tchèque;National Institute of Public Health;National Institute Of Public Health;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;coordinateur;;Grant Manager 685;;47;
FED-AMR;Allemagne;Friedrich-Loeffler-Institut;Friedrich-Loeffler-Institut;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 685;;47;
FED-AMR;Allemagne;German Federal Institute for Risk Assessment;German Federal Institute For Risk Assessment;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 685;;47;
FED-AMR;Norvège;Norwegian Veterinary Institute;Norwegian Veterinary Institute;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 685;;47;
FED-AMR;Portugal;National Institute of Health;National Institute Of Health;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 685;;47;
FED-AMR;Irlande;National University of Ireland, Galway;National University Of Ireland, Galway;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 685;;47;
FED-AMR;France;Institut Pasteur (Paris);Institut Pasteur (Paris);CNR Bactéries anaérobies et botulisme;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 685;;47;
FED-AMR;Estonie;University of Tartu;University Of Tartu;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 685;;47;
FED-AMR;Autriche;Austrian Agency for Health and Food Safety;Austrian Agency For Health And Food Safety;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 685;;47;
FED-AMR;Royaume-Uni;University of Surrey;University Of Surrey;;The role of free extracellular DNA in dissemination of antimicrobial resistance over ecosystem boundaries along the food/feed chain;Projet scientifique;antimicrobial resistance;DNA;horizontal gene transfer;;;2 924 000,00 €;Commission Européenne;01/01/2020;30/06/2022;;;;;Grant Manager 685;;47;
FreeATPOC;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;Towards an instrument-free future of molecular diagnostics at the point-of-care;Projet scientifique;nucleic acid;molecular diagnostics;;;;3 052 500,00 €;Commission Européenne;01/01/2020;31/12/2023;;;;;Grant Manager 747;;47;
FreeATPOC;Grèce;GNOSIS DATA ANALYSIS IDIOTIKI KEFALAIOUCHIKI ETAIREIA;Gnosis Data Analysis Idiotiki Kefalaiouchiki Etaireia;;Towards an instrument-free future of molecular diagnostics at the point-of-care;Projet scientifique;nucleic acid;molecular diagnostics;;;;3 052 500,00 €;Commission Européenne;01/01/2020;31/12/2023;;;coordinateur;;Grant Manager 747;;47;
FreeATPOC;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Towards an instrument-free future of molecular diagnostics at the point-of-care;Projet scientifique;nucleic acid;molecular diagnostics;;;;3 052 500,00 €;Commission Européenne;01/01/2020;31/12/2023;;;;;Grant Manager 747;;47;
FreeATPOC;Royaume-Uni;UNIVERSITY COLLEGE LONDON HOSPITALSNHS FOUNDATION TRUST;University College London Hospitalsnhs Foundation Trust;;Towards an instrument-free future of molecular diagnostics at the point-of-care;Projet scientifique;nucleic acid;molecular diagnostics;;;;3 052 500,00 €;Commission Européenne;01/01/2020;31/12/2023;;;;;Grant Manager 747;;47;
FreeATPOC;Grèce;IDRYMA TECHNOLOGIAS KAI EREVNAS;Idryma Technologias Kai Erevnas;;Towards an instrument-free future of molecular diagnostics at the point-of-care;Projet scientifique;nucleic acid;molecular diagnostics;;;;3 052 500,00 €;Commission Européenne;01/01/2020;31/12/2023;;;;;Grant Manager 747;;47;
INFRAFRONTIER2020;Allemagne;AYOXXA BIOSYSTEMS GMBH;Ayoxxa Biosystems Gmbh;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;coordinateur;;;;47;
INFRAFRONTIER2020;Pays-Bas;ACADEMISCH ZIEKENHUIS GRONINGEN;Academisch Ziekenhuis Groningen;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;France;CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE;Centre Europeen De Recherche En Biologie Et Medecine;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Espagne;AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS;Agencia Estatal Consejo Superior De Investigaciones Cientificas;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Royaume-Uni;GENOME RESEARCH LIMITED;Genome Research Limited;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Italie;CONSIGLIO NAZIONALE DELLE RICERCHE;Consiglio Nazionale Delle Ricerche;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Portugal;FUNDACAO CALOUSTE GULBENKIAN;Fundacao Calouste Gulbenkian;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Grèce;BIOMEDCODE ELLAS ANONIMI ETERIA EPISTIMONIKIS KAI TEXNOLOGIKIS EREVNAS KAI EMBORIKIS EKMETALLEFSIS EPHARMOGON IATRIKIS;Biomedcode Ellas Anonimi Eteria Epistimonikis Kai Texnologikis Erevnas Kai Emborikis Ekmetallefsis Epharmogon Iatrikis;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Suède;KAROLINSKA INSTITUTET;Karolinska Institutet;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Grèce;BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING;Biomedical Sciences Research Center Alexander Fleming;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Allemagne;HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH;Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Allemagne;HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH;Helmholtz-Zentrum Fur Infektionsforschung Gmbh;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Danemark;KOBENHAVNS UNIVERSITET;Kobenhavns Universitet;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;47;
INFRAFRONTIER2020;Israël;TEL AVIV UNIVERSITY;Tel Aviv University;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Pays-Bas;STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS;Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Espagne;UNIVERSIDAD AUTONOMA DE BARCELONA;Universidad Autonoma De Barcelona;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Allemagne;MEDIZINISCHE HOCHSCHULE HANNOVER;Medizinische Hochschule Hannover;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Finlande;OULUN YLIOPISTO;Oulun Yliopisto;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Royaume-Uni;THE UNIVERSITY OF SHEFFIELD;The University Of Sheffield;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Allemagne;TSE SYSTEMS GMBH;Tse Systems Gmbh;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Royaume-Uni;UNITED KINGDOM RESEARCH AND INNOVATION;United Kingdom Research And Innovation;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;République Tchèque;USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE;Ustav Molekularni Genetiky Akademie Ved Ceske Republiky Verejna Vyzkumna Instituce;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Autriche;VETERINAERMEDIZINISCHE UNIVERSITAET WIEN;Veterinaermedizinische Universitaet Wien;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;31;
INFRAFRONTIER2020;Canada;Toronto Centre for Phenogenomics Inc;Toronto Centre For Phenogenomics Inc;;Towards enduring mouse resources and services advancing research into human health and disease;Projet scientifique;mouse;human health;network;;;4 968 252,16 €;Commission Européenne;01/01/2017;31/12/2021;;;;;;;31;
ASDENV;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Virologie structurale;Towards new vaccine strategies for dengue virus infection: identification of protective humoral immune responses in asymptomatic dengue-infected individuals  ;Projet scientifique;dengue;immunology;Infectious diseases;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;31;
ASDENV;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Anticorps en Thérapie et Pathologie;Towards new vaccine strategies for dengue virus infection: identification of protective humoral immune responses in asymptomatic dengue-infected individuals  ;Projet scientifique;dengue;immunology;Infectious diseases;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;31;
ASDENV;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Technologie et Service Cytometrie et Biomarqueurs (UTechS CB);Towards new vaccine strategies for dengue virus infection: identification of protective humoral immune responses in asymptomatic dengue-infected individuals  ;Projet scientifique;dengue;immunology;Infectious diseases;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;31;
ASDENV;Cambodge;Institut Pasteur du Cambodge;Institut Pasteur Du Cambodge;;Towards new vaccine strategies for dengue virus infection: identification of protective humoral immune responses in asymptomatic dengue-infected individuals  ;Projet scientifique;dengue;immunology;Infectious diseases;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;31;
HearLight;France;INSTITUT MINES-TELECOM;Institut Mines-Telecom;;Towards optogenetic cortical implants for hearing impaired;Projet scientifique;acoustics;physiotherapy;implants;artificial intelligence;phonetics;2 999 971,25 €;Commission Européenne;01/04/2021;31/03/2025;;;coordinateur;;Grant Manager 1109;;31;
HearLight;Norvège;NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NTNU;Norges Teknisk-Naturvitenskapelige Universitet Ntnu;;Towards optogenetic cortical implants for hearing impaired;Projet scientifique;acoustics;physiotherapy;implants;artificial intelligence;phonetics;2 999 971,25 €;Commission Européenne;01/04/2021;31/03/2025;;;;;Grant Manager 1109;;31;
HearLight;Suisse;NOVAGAN SARL;Novagan Sarl;;Towards optogenetic cortical implants for hearing impaired;Projet scientifique;acoustics;physiotherapy;implants;artificial intelligence;phonetics;2 999 971,25 €;Commission Européenne;01/04/2021;31/03/2025;;;;;Grant Manager 1109;;31;
HearLight;Suisse;Universität Basel;Universität Basel;;Towards optogenetic cortical implants for hearing impaired;Projet scientifique;acoustics;physiotherapy;implants;artificial intelligence;phonetics;2 999 971,25 €;Commission Européenne;01/04/2021;31/03/2025;;;;;Grant Manager 1109;;31;
HearLight;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Towards optogenetic cortical implants for hearing impaired;Projet scientifique;acoustics;physiotherapy;implants;artificial intelligence;phonetics;2 999 971,25 €;Commission Européenne;01/04/2021;31/03/2025;;;;;Grant Manager 1109;;31;
HearLight;Royaume-Uni;UNIVERSITY OF STRATHCLYDE;University Of Strathclyde;;Towards optogenetic cortical implants for hearing impaired;Projet scientifique;acoustics;physiotherapy;implants;artificial intelligence;phonetics;2 999 971,25 €;Commission Européenne;01/04/2021;31/03/2025;;;;;Grant Manager 1109;;31;
INFLANET;Allemagne;ACQUIFER IMAGING GMBH;Acquifer Imaging Gmbh;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 €;Commission Européenne;01/03/2021;28/02/2025;;;;;Grant Manager 974;;31;
INFLANET;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 €;Commission Européenne;01/03/2021;28/02/2025;;;;;Grant Manager 974;;31;
INFLANET;Hongrie;EOTVOS LORAND TUDOMANYEGYETEM;Eotvos Lorand Tudomanyegyetem;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 €;Commission Européenne;01/03/2021;28/02/2025;;;coordinateur;;Grant Manager 974;;31;
INFLANET;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 €;Commission Européenne;01/03/2021;28/02/2025;;;;;Grant Manager 974;;31;
INFLANET;Pays-Bas;STICHTING KATHOLIEKE UNIVERSITEIT;Stichting Katholieke Universiteit;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 €;Commission Européenne;01/03/2021;28/02/2025;;;;;Grant Manager 974;;31;
INFLANET;Espagne;UNIVERSIDAD DE MURCIA;Universidad De Murcia;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 €;Commission Européenne;01/03/2021;28/02/2025;;;;;Grant Manager 974;;31;
INFLANET;Royaume-Uni;THE UNIVERSITY OF SHEFFIELD;The University Of Sheffield;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 €;Commission Européenne;01/03/2021;28/02/2025;;;;;Grant Manager 974;;31;
INFLANET;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Macrophages et Développement de l'Immunité;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 €;Commission Européenne;01/03/2021;28/02/2025;;;;;Grant Manager 974;;31;
INFLANET;Slovaquie;SLOVENSKA TECHNICKA UNIVERZITA V BRATISLAVE;Slovenska Technicka Univerzita V Bratislave;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 €;Commission Européenne;01/03/2021;28/02/2025;;;;;Grant Manager 974;;31;
INFLANET;Slovaquie;TATRAMED SOFTWARE SRO;Tatramed Software Sro;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 €;Commission Européenne;01/03/2021;28/02/2025;;;;;Grant Manager 974;;18;
INFLANET;Pays-Bas;UNIVERSITEIT LEIDEN;Universiteit Leiden;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 €;Commission Européenne;01/03/2021;28/02/2025;;;;;Grant Manager 974;;18;
INFLANET;France;UNIVERSITE DE MONTPELLIER;Universite De Montpellier;;Training European Experts in Inflammation: from the molecular players to animal models and the bedside;Projet scientifique;inflammatory diseases;drug discovery;;;;3 977 117,28 €;Commission Européenne;01/03/2021;28/02/2025;;;;;Grant Manager 974;;18;
ImageInLife;Allemagne;ACQUIFER AG ;Acquifer Ag ;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Espagne;4D - NATURE IMAGING CONSULTING SL;4D - Nature Imaging Consulting Sl;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;France;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS;Centre National De La Recherche Scientifique Cnrs;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Allemagne;CARL ZEISS NTS GMBH;Carl Zeiss Nts Gmbh;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Allemagne;DITABIS DIGITAL BIOMEDICAL IMAGING SYSTEMS AG;Ditabis Digital Biomedical Imaging Systems Ag;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Espagne;FUNDACIO INSTITUT DE CIENCIES FOTONIQUES;Fundacio Institut De Ciencies Fotoniques;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Royaume-Uni;THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE;The Chancellor Masters And Scholars Of The University Of Cambridge;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Belgique;Union Biometrica BVBA;Union Biometrica Bvba;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;coordinateur;;;;18;
ImageInLife;Royaume-Uni;THE MANCHESTER METROPOLITAN UNIVERSITY;The Manchester Metropolitan University;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Macrophages et Développement de l'Immunité;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Slovaquie;SLOVENSKA TECHNICKA UNIVERZITA V BRATISLAVE;Slovenska Technicka Univerzita V Bratislave;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;France;PHASEVIEW ;Phaseview ;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;France;SORBONNE UNIVERSITE;Sorbonne Universite;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Pays-Bas;UNIVERSITEIT LEIDEN;Universiteit Leiden;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;Slovaquie;TATRAMED SOFTWARE SRO;Tatramed Software Sro;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;;18;
ImageInLife;France;UNIVERSITE DE MONTPELLIER;Universite De Montpellier;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;Interactive Computing E-Infrastructure for the Human Brain Project | ICEI Project | H2020 | CORDIS | European Commission (europa.eu);;
ImageInLife;Allemagne;UNIVERSITATSKLINIKUM HEIDELBERG;Universitatsklinikum Heidelberg;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;;;
ImageInLife;France;UNIVERSITE PARIS-SACLAY;Universite Paris-Saclay;;Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease;Projet scientifique;biological imaging;data;;;;3 562 028,64 €;Commission Européenne;01/01/2017;30/06/2021;;;;;;;;
TRACeR-TB;Belgique;Sciensano;Sciensano;;Transcriptional Response for AntimiCrobial Resistance detection in TB;Projet scientifique;tuberculosis;antibioresistance;diagnostic;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;coordinateur;;;;;
TRACeR-TB;Russie;Institut Pasteur de Saint-Petersbourg;Institut Pasteur De Saint-Petersbourg;;Transcriptional Response for AntimiCrobial Resistance detection in TB;Projet scientifique;tuberculosis;antibioresistance;diagnostic;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
TRACeR-TB;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Pathogénomique mycobactérienne integrée;Transcriptional Response for AntimiCrobial Resistance detection in TB;Projet scientifique;tuberculosis;antibioresistance;diagnostic;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
TRACeR-TB;France;Institut Pasteur de Lille;Institut Pasteur De Lille;;Transcriptional Response for AntimiCrobial Resistance detection in TB;Projet scientifique;tuberculosis;antibioresistance;diagnostic;;;250 000,00 €;Institut Pasteur;01/10/2019;30/09/2021;;;;;;;;
TranSYS;Pays-Bas;ACADEMISCH ZIEKENHUIS GRONINGEN;Academisch Ziekenhuis Groningen;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 €;Commission Européenne;01/09/2019;31/08/2023;;;;;Grant Manager 509;;;
TranSYS;Allemagne;BIOMAX INFORMATICS AG;Biomax Informatics Ag;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 €;Commission Européenne;01/09/2019;31/08/2023;;;;;Grant Manager 509;;;
TranSYS;Pays-Bas;ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM;Erasmus Universitair Medisch Centrum Rotterdam;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 €;Commission Européenne;01/09/2019;31/08/2023;;;;;Grant Manager 509;;;
TranSYS;Belgique;KATHOLIEKE UNIVERSITEIT LEUVEN;Katholieke Universiteit Leuven;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 €;Commission Européenne;01/09/2019;31/08/2023;;;coordinateur;;Grant Manager 509;;;
TranSYS;Espagne;BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION;Barcelona Supercomputing Center - Centro Nacional De Supercomputacion;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 €;Commission Européenne;01/09/2019;31/08/2023;;;;;Grant Manager 509;;;
TranSYS;Royaume-Uni;SHIVOM VENTURES LIMITED;Shivom Ventures Limited;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 €;Commission Européenne;01/09/2019;31/08/2023;;;;;Grant Manager 509;;;
TranSYS;Luxembourg;UNIVERSITE DU LUXEMBOURG;Universite Du Luxembourg;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 €;Commission Européenne;01/09/2019;31/08/2023;;;;;Grant Manager 509;;;
TranSYS;Espagne;FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III;Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 €;Commission Européenne;01/09/2019;31/08/2023;;;;;Grant Manager 509;;;
TranSYS;Royaume-Uni;THE GOLDEN HELIX FOUNDATION;The Golden Helix Foundation;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 €;Commission Européenne;01/09/2019;31/08/2023;;;;;Grant Manager 509;;;
TranSYS;Allemagne;LIFEGLIMMER GMBH;Lifeglimmer Gmbh;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 €;Commission Européenne;01/09/2019;31/08/2023;;;;;Grant Manager 509;;;
TranSYS;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 €;Commission Européenne;01/09/2019;31/08/2023;;;;;Grant Manager 509;;;
TranSYS;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie computationnelle;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 €;Commission Européenne;01/09/2019;31/08/2023;;;;;Grant Manager 509;;;
TranSYS;Slovénie;UNIVERZA V LJUBLJANI;Univerza V Ljubljani;;Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine;Projet scientifique;big data;data analysis;;;;3 937 798,80 €;Commission Européenne;01/09/2019;31/08/2023;;;;;Grant Manager 509;;;
CLOSPORE;Royaume-Uni;ASTELLAS PHARMA EUROPE LTD;Astellas Pharma Europe Ltd;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;France;BIOMERIEUX SA;Biomerieux Sa;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Finlande;Atria Suomi Oy;Atria Suomi Oy;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Royaume-Uni;Green Biologics Ltd.;Green Biologics Ltd.;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Royaume-Uni;Ipsen Pharmaceuticals;Ipsen Pharmaceuticals;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Royaume-Uni;LANZATECH UK LTD;Lanzatech Uk Ltd;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Pays-Bas;NIZO FOOD RESEARCH BV;Nizo Food Research Bv;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Pays-Bas;PURAC BIOCHEM BV;Purac Biochem Bv;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Finlande;HKScan Ltd;Hkscan Ltd;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Royaume-Uni;THE UNIVERSITY OF NOTTINGHAM;The University Of Nottingham;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Finlande;SaarioinenOy;Saarioinenoy;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Finlande;Snellmanin Lihanjalostus Oy;Snellmanin Lihanjalostus Oy;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Pays-Bas;STICHTING WAGENINGEN RESEARCH;Stichting Wageningen Research;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;France;METABOLIC EXPLORER SA;Metabolic Explorer Sa;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
CLOSPORE;Portugal;UNIVERSIDADE NOVA DE LISBOA;Universidade Nova De Lisboa;;UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION;Projet scientifique;bacteriology;clostridial spores;training;;;3 910 777,56 €;Commission Européenne;01/01/2015;31/12/2018;;;;;;;;
TwinnToInfect;Royaume-Uni;THE FRANCIS CRICK INSTITUTE LIMITED;The Francis Crick Institute Limited;;Unleash IMM’s research excellence in immunity and infection through twinning to infect Lisbon and Portugal with its increase in competitiveness and innovation;Projet scientifique;sustainable science;innovation network;;;;1 000 000,00 €;Commission Européenne;01/01/2016;31/12/2018;;;;;;;;
TwinnToInfect;Portugal;INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES;Instituto De Medicina Molecular Joao Lobo Antunes;;Unleash IMM’s research excellence in immunity and infection through twinning to infect Lisbon and Portugal with its increase in competitiveness and innovation;Projet scientifique;sustainable science;innovation network;;;;1 000 000,00 €;Commission Européenne;01/01/2016;31/12/2018;;;coordinateur;;;;;
TwinnToInfect;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Immunité innée;Unleash IMM’s research excellence in immunity and infection through twinning to infect Lisbon and Portugal with its increase in competitiveness and innovation;Projet scientifique;sustainable science;innovation network;;;;1 000 000,00 €;Commission Européenne;01/01/2016;31/12/2018;;;;;;;;
PDZnet;France;CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE;Centre Europeen De Recherche En Biologie Et Medecine;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 €;Commission Européenne;01/09/2016;31/08/2020;;;;;;;;
PDZnet;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 €;Commission Européenne;01/09/2016;31/08/2020;;;;;;;;
PDZnet;Danemark;NOVO NORDISK A/S;Novo Nordisk A/S;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 €;Commission Européenne;01/09/2016;31/08/2020;;;;;;;;
PDZnet;France;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Institut National De La Sante Et De La Recherche Medicale;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 €;Commission Européenne;01/09/2016;31/08/2020;;;coordinateur;;;;;
PDZnet;Allemagne;JOHANN WOLFGANG GOETHE UNIVERSITAT FRANKFURT AM MAIN;Johann Wolfgang Goethe Universitat Frankfurt Am Main;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 €;Commission Européenne;01/09/2016;31/08/2020;;;;;;;;
PDZnet;Danemark;KOBENHAVNS UNIVERSITET;Kobenhavns Universitet;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 €;Commission Européenne;01/09/2016;31/08/2020;;;;;;;;
PDZnet;Allemagne;SYSTASY BIOSCIENCE GMBH;Systasy Bioscience Gmbh;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 €;Commission Européenne;01/09/2016;31/08/2020;;;;;;;;
PDZnet;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Immunité innée;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 €;Commission Européenne;01/09/2016;31/08/2020;;;;;;;;
PDZnet;Italie;UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA;Universita Degli Studi Di Roma La Sapienza;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 €;Commission Européenne;01/09/2016;31/08/2020;;;;;;;;
PDZnet;Suède;UPPSALA UNIVERSITET;Uppsala Universitet;;Unraveling Principles of PDZ-mediated Cell Signaling;Projet scientifique;proteomics;stem cells;cancer;brain diseases;;3 733 514,66 €;Commission Européenne;01/09/2016;31/08/2020;;;;;;;;
PfAVAL;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Infection et Immunité Paludéennes- Malaria Infection and Immunity;Validation of Plasmodium falciparum antigens targeted by human CD8+ T cells using T Cell Receptor-expressing reporter cells.;Projet scientifique;malaria;vaccine;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
PfAVAL;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Laboratoire commun Institut Pasteur- Theravectys;Validation of Plasmodium falciparum antigens targeted by human CD8+ T cells using T Cell Receptor-expressing reporter cells.;Projet scientifique;malaria;vaccine;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
PfAVAL;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Biologie des Interactions Hôte-Parasite;Validation of Plasmodium falciparum antigens targeted by human CD8+ T cells using T Cell Receptor-expressing reporter cells.;Projet scientifique;malaria;vaccine;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
PfAVAL;Brésil;Scientific Platform Pasteur - University of Sao Paulo;Scientific Platform Pasteur - University Of Sao Paulo;;Validation of Plasmodium falciparum antigens targeted by human CD8+ T cells using T Cell Receptor-expressing reporter cells.;Projet scientifique;malaria;vaccine;;;;250 000,00 €;Institut Pasteur;01/10/2020;30/09/2022;;;;;;;;
VEO;Pays-Bas;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM;Academisch Medisch Centrum Bij De Universiteit Van Amsterdam;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Espagne;AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS;Agencia Estatal Consejo Superior De Investigaciones Cientificas;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Pays-Bas;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM;Academisch Medisch Centrum Bij De Universiteit Van Amsterdam;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Italie;ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA;Alma Mater Studiorum - Universita Di Bologna;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Grèce;ARISTOTELIO PANEPISTIMIO THESSALONIKIS;Aristotelio Panepistimio Thessalonikis;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Grèce;ARISTOTELIO PANEPISTIMIO THESSALONIKIS;Aristotelio Panepistimio Thessalonikis;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Italie;ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA;Alma Mater Studiorum - Universita Di Bologna;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Espagne;AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS;Agencia Estatal Consejo Superior De Investigaciones Cientificas;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Suisse;ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE;Ecole Polytechnique Federale De Lausanne;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Pays-Bas;CENTRAAL BUREAU VOOR DE STATISTIEK;Centraal Bureau Voor De Statistiek;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Pays-Bas;CENTRAAL BUREAU VOOR DE STATISTIEK;Centraal Bureau Voor De Statistiek;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Pays-Bas;ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM;Erasmus Universitair Medisch Centrum Rotterdam;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;France;INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER;Institut Francais De Recherche Pour L'Exploitation De La Mer;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;France;INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER;Institut Francais De Recherche Pour L'Exploitation De La Mer;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Allemagne;EUROPEAN MOLECULAR BIOLOGY LABORATORY;European Molecular Biology Laboratory;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Allemagne;Friedrich-Loeffler-Institut;Friedrich-Loeffler-Institut;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Allemagne;Friedrich-Loeffler-Institut;Friedrich-Loeffler-Institut;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Pays-Bas;RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU;Rijksinstituut Voor Volksgezondheid En Milieu;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Pays-Bas;RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU;Rijksinstituut Voor Volksgezondheid En Milieu;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Hongrie;EOTVOS LORAND TUDOMANYEGYETEM;Eotvos Lorand Tudomanyegyetem;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Royaume-Uni;THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS;The Secretary Of State For Environment, Food And Rural Affairs;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Royaume-Uni;THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS;The Secretary Of State For Environment, Food And Rural Affairs;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;coordinateur;;Grant Manager 698;;;
VEO;Hongrie;EOTVOS LORAND TUDOMANYEGYETEM;Eotvos Lorand Tudomanyegyetem;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Danemark;KOBENHAVNS UNIVERSITET;Kobenhavns Universitet;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Danemark;KOBENHAVNS UNIVERSITET;Kobenhavns Universitet;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Royaume-Uni;THE UNIVERSITY OF EDINBURGH;The University Of Edinburgh;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Italie;UNIVERSITA DEGLI STUDI DI PADOVA;Universita Degli Studi Di Padova;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Italie;UNIVERSITA DEGLI STUDI DI PADOVA;Universita Degli Studi Di Padova;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Modélisation mathématique des maladies infectieuses;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Danemark;DANMARKS TEKNISKE UNIVERSITET;Danmarks Tekniske Universitet;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Danemark;DANMARKS TEKNISKE UNIVERSITET;Danmarks Tekniske Universitet;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Suède;UPPSALA UNIVERSITET;Uppsala Universitet;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
VEO;Suède;UPPSALA UNIVERSITET;Uppsala Universitet;;Versatile Emerging infectious disease Observatory;Projet scientifique;Infectious diseases;data;risk assessment;monitoring;antimicrobial resistance;16 719 370,63 €;Commission Européenne;01/01/2020;31/12/2024;;;;;Grant Manager 698;;;
ViBrANT;France;BIOMERIEUX SA;Biomerieux Sa;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Portugal;BIOMODE 2, S.A.;Biomode 2, S.A.;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Portugal;CENTITVC - CENTRO DE NANOTECNOLOGIA E MATERIAIS TECNICOS FUNCIONAIS E INTELIGENTES ASSOCIACAO;Centitvc - Centro De Nanotecnologia E Materiais Tecnicos Funcionais E Inteligentes Associacao;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Royaume-Uni;Digitronix Ltd;Digitronix Ltd;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Allemagne;EBERHARD KARLS UNIVERSITAET TUEBINGEN;Eberhard Karls Universitaet Tuebingen;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Royaume-Uni;ELISHA SYSTEMS LIMITED;Elisha Systems Limited;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Royaume-Uni;Eluceda Ltd;Eluceda Ltd;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Suède;LUNDS UNIVERSITET;Lunds Universitet;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Allemagne;JOHANN WOLFGANG GOETHE UNIVERSITAT FRANKFURT AM MAIN;Johann Wolfgang Goethe Universitat Frankfurt Am Main;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Finlande;HELSINGIN YLIOPISTO;Helsingin Yliopisto;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 €;Commission Européenne;01/01/2018;30/06/2022;;;coordinateur;;;;;
ViBrANT;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Bio-Informatique Structurale;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Norvège;UNIVERSITETET I OSLO;Universitetet I Oslo;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Royaume-Uni;UNIVERSITY OF HULL;University Of Hull;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Royaume-Uni;UNIVERSITY OF LEEDS;University Of Leeds;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;;
ViBrANT;Portugal;UNIVERSIDADE DO MINHO;Universidade Do Minho;;VIral and BacteRial Adhesin Network Training;Projet scientifique;bacteriology;microbiology;;;;3 925 220,40 €;Commission Européenne;01/01/2018;30/06/2022;;;;;;;;
Virus-X;Pologne;A&A BIOTECHNOLOGY SC;A&A Biotechnology Sc;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 €;Commission Européenne;01/04/2016;31/03/2020;;;;;;;;
Virus-X;Norvège;ArcticZymes AS;Arcticzymes As;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 €;Commission Européenne;01/04/2016;31/03/2020;;;;;;;;
Virus-X;Pays-Bas;BIO-PRODICT BV;Bio-Prodict Bv;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 €;Commission Européenne;01/04/2016;31/03/2020;;;;;;;;
Virus-X;Suède;LUNDS UNIVERSITET;Lunds Universitet;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 €;Commission Européenne;01/04/2016;31/03/2020;;;;;;;;
Virus-X;Suède;SAROMICS BIOSTRUCTURES AB;Saromics Biostructures Ab;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 €;Commission Européenne;01/04/2016;31/03/2020;;;;;;;;
Virus-X;Allemagne;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV;Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 €;Commission Européenne;01/04/2016;31/03/2020;;;coordinateur;;;;;
Virus-X;Norvège;UNIVERSITETET I BERGEN;Universitetet I Bergen;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 €;Commission Européenne;01/04/2016;31/03/2020;;;;;;;;
Virus-X;France;Institut Pasteur (Paris);Institut Pasteur (Paris);;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 €;Commission Européenne;01/04/2016;31/03/2020;;;;;;;;
Virus-X;Allemagne;UNIVERSITAET BIELEFELD;Universitaet Bielefeld;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 €;Commission Européenne;01/04/2016;31/03/2020;;;;;;;;
Virus-X;Pologne;UNIWERSYTET GDANSKI;Uniwersytet Gdanski;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 €;Commission Européenne;01/04/2016;31/03/2020;;;;;;;12;
Virus-X;France;UNIVERSITE CLERMONT AUVERGNE;Universite Clermont Auvergne;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 €;Commission Européenne;01/04/2016;31/03/2020;;;;;;;12;
Virus-X;Royaume-Uni;UNIVERSITY OF DURHAM;University Of Durham;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 €;Commission Européenne;01/04/2016;31/03/2020;;;;;;;12;
Virus-X;Allemagne;UNIVERSITY OF STUTTGART;University Of Stuttgart;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 €;Commission Européenne;01/04/2016;31/03/2020;;;;;;;12;
Virus-X;Islande;PROKAZYME EHF. ;Prokazyme Ehf. ;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 €;Commission Européenne;01/04/2016;31/03/2020;;;;;;;12;
Virus-X;Islande;MATIS OHF;Matis Ohf;;Virus-X: Viral Metagenomics for Innovation Value;Projet scientifique;virology;bacteriology;ecology;;;7 964 092,50 €;Commission Européenne;01/04/2016;31/03/2020;;;;;;;12;
ZikaPLAN;Pays-Bas;ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM;Erasmus Universitair Medisch Centrum Rotterdam;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;12;
ZikaPLAN;France;FONDATION MERIEUX;Fondation Merieux;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;12;
ZikaPLAN;Belgique;KATHOLIEKE UNIVERSITEIT LEUVEN;Katholieke Universiteit Leuven;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;12;
ZikaPLAN;Belgique;PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE;Prins Leopold Instituut Voor Tropische Geneeskunde;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;12;
ZikaPLAN;Royaume-Uni;LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER;London School Of Hygiene And Tropical Medicine Royal Charter;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;12;
ZikaPLAN;Royaume-Uni;ST GEORGE'S HOSPITAL MEDICAL SCHOOL;St George'S Hospital Medical School;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;12;
ZikaPLAN;Royaume-Uni;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;The Chancellor, Masters And Scholars Of The University Of Oxford;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;15;
ZikaPLAN;Suisse;SCHWEIZERISCHES TROPEN- UND PUBLIC HEALTH-INSTITUT;Schweizerisches Tropen- Und Public Health-Institut;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;15;
ZikaPLAN;Suède;UMEA UNIVERSITET;Umea Universitet;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;15;
ZikaPLAN;Etats-Unis;LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY;La Jolla Institute For Allergy And Immunology;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;15;
ZikaPLAN;Royaume-Uni;THE UNIVERSITY OF LIVERPOOL;The University Of Liverpool;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;15;
ZikaPLAN;Sénégal;INSTITUT PASTEUR DE DAKAR;Institut Pasteur De Dakar;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;15;
ZikaPLAN;Etats-Unis;THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL;The University Of North Carolina At Chapel Hill;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;15;
ZikaPLAN;France;Institut Pasteur (Paris);Institut Pasteur (Paris);Interactions Virus-Insectes;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;15;
ZikaPLAN;Royaume-Uni;UNIVERSITY OF GLASGOW;University Of Glasgow;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;15;
ZikaPLAN;Colombie;UNIVERSIDAD DEL VALLE;Universidad Del Valle;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;15;
ZikaPLAN;Royaume-Uni;UNIVERSITY OF ULSTER;University Of Ulster;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;15;
ZikaPLAN;Cuba;INSTITUTO DE MEDICINA TROPICAL PEDRO KOURI;Instituto De Medicina Tropical Pedro Kouri;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;15;
ZikaPLAN;Brésil;INSTITUTO BUTANTAN;Instituto Butantan;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;15;
ZikaPLAN;Colombie;FUNDACION UNIVERSIDAD DEL NORTE;Fundacion Universidad Del Norte;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;15;
ZikaPLAN;Brésil;FUNDACAO UNIVERSIDADE DE PERNAMBUCO;Fundacao Universidade De Pernambuco;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;15;
ZikaPLAN;Brésil;Oswaldo Cruz Foundation (Fiocruz);Oswaldo Cruz Foundation (Fiocruz);;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;4;
ZikaPLAN;Brésil;FUNDACAO DE APOIO A UNIVERSIDADE DE SAO PAULO;Fundacao De Apoio A Universidade De Sao Paulo;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;coordinateur;;Grant Manager 19;;4;
ZikaPLAN;Brésil;ASSOCIACAO TECNICO CIENTIFICA ESTUDO COLABORATIVO LATINO AMERICANO DE MALFORMACAO CONGENITAS;Associacao Tecnico Cientifica Estudo Colaborativo Latino Americano De Malformacao Congenitas;;Zika Preparedness Latin American Network;Projet scientifique;zika;entomology;virology;infectious diseases;;11 566 373,75 €;Commission Européenne;01/10/2016;31/03/2021;;;;;Grant Manager 19;;4;

`;

      console.log(CSVToJSON(convert));
    </script>
  </body>
</html>
